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Abstract 
Type I diabetics need regular injections of insulin to survive. Insulin allows the 
cells of the body to extract glucose from the blood supply to use as fuel. Without 
insulin the cells turn to other backup fuel sources, this can cause side effects that 
are quickly fatal or gradual wasting of the bodies tissues. The use of insulin, 
however, is not danger free, as an incorrect dosage can quickly lead to the 
reduction of glucose circulating in the blood to drop to a dangerously low level. 
Without glucose circulating in the blood supply the brain quickly runs out of fuel 
causing coma and death. 
Because of this, a means to constantly monitor blood glucose levels has been 
sought for the last two decades. With such a device, diabetics could judge the 
correct amount of insulin to inject and be warned of low blood glucose levels. 
However, to date no reliable portable system has been produced. Recent 
developments in fibre optic biosensor technology, suggested a possible route to 
achieves this goal. The work in this thesis presents the development and testing of 
such a sensor. 
The sensor presented in this thesis is based around a commercial fibre optic blood 
gas sensor, the Paratrend 7. The oxygen-sensing element of this device was 
modified into a glucose sensor using polymer membranes incorporating the 
enzymes glucose oxidase and catalase. The research was aimed at building a 
glucose sensor that could be developed into a working blood glucose sensor in the 
minimum amount of time if the research proved successful. For this reason the 
Paratrend 7 sensor system was chosen to provide a clinically tested sensor core 
around which the glucose sensor could be built. 
The initial experiment, which used a Paratrend 7 sensor coated in polyHEMA and 
glucose oxidase, produced a sensor of diameter of 700µm with a range of 0 to 
4mM/1 of glucose and a 90% response time of <100 seconds in a solution with a 
15% oxygen tension. The sensor design was then developed to incorporate the 
enzyme catalase to protect the glucose oxidase and an outer diffusion limiting 
polyHEMA membrane This produced a sensor with a range of 0 to 6 mM/l and a 
response time of <100 seconds. The method of coating the sensors was'then 
improved, through a series of stages, until an optomised dip coating technique was 
developed. This technique produced sensors with ranges (in 7.5KPa oxygen 
tension solutions) between 0 to 3mM/l and 0 to lOmM/1, response times of <100 
seconds in some cases and with diameters of 300µm. By using a partial 
polyurethane outer coat the range of the sensors was increased form 0 to 4mM/l 
up to 0 to 24mM/1, in one case, with 90% response times in the 100 to 500 second 
range. The sensors were then sterilised using gamma radiation and their 
performance before and after sterilisation examined. The gamma sterilisation was 
found to cause a reduction in the range of the sensors, for example 0 to 24 m /I 
down to 0 to 14mM/l in one case. The affect of 24 hour operation in a 5mM/1 
solution of glucose and storage, for up to three months, was then investigated. 
Both processes were found to reduce the operational range of the sensors, 0 to 20 
reduced to 0 to 15 mM/i, in one case, for 24 hour operation and form 0 to 15mM/1 
reduced to 0 to 11mM/1 in one case for a storage time of three months. 
The use of the enzymes glucose oxidase and catalase together in a fibre optic 
sensor has not been previously reported in the literature as far as can be 
ascertained. The comparison of sensor performance before and after gamma 
sterilisation also appears to be unique as does the gamma sterilisation of a fibre 
optic glucose sensor. 
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1. Introduction 
1 Introduction 
Diabetes Mellitus 
Diabetes mellitus is a disease that prevents the cellular uptake of glucose. There 
are two categories of diabetes, type I and type II. Type I diabetes is the most 
severe but also the least common of the two diseases, accounting for only 20% of 
cases of diabetes (approximately 0.25% of the population of the UK). This 
research work is only concerned with the treatment of type I diabetes for which 
blood glucose monitoring and appropriate insulin dosages are essential for 
survival of the patient. Type II is usually controlled with simple dietary measures 
and limited medication, blood glucose monitoring is often not required. Type I 
diabetes tends to affect the young with the most common age of incidence at 12 
years (Green, Sjolie et al. 1997). Type II diabetes usually occurs in older people 
around the age of 60 (Jones and Gill 1997). 
A glucose sensor would be of little or no use to type II diabetics, for type I 
diabetics however, it would be of great use possibly preventing coma or even 
death. Its role would be to detect hypoglycaemia, potentially fatal side effect of 
the insulin treatment that type I diabetics need to stay alive. Type II diabetes will 
not therefore be discussed further in this thesis, and instead this work will focus 
on type I diabetes alone. 
1.1 Etiology of diabetes 
Type I diabetes is caused when the body loses the ability to produce the hormone 
insulin. Insulin is used to regulate the amount of glucose in the blood by 
stimulating cellular uptake of glucose by cells and suppressing production of 
glucose by the liver (Kruszynska 1997). The amount of insulin produced is 
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carefully managed by the body to maintain the blood glucose level at a constant 
healthy level. Insulin is normally produced in ß-cells, which are structures in the 
pancreas within the islets of Langerhans. In type I diabetes, the ß-cells have been 
destroyed, one hypothesis is that this is due to an autoimmune disease. In this 
case, the body's own immune system mistakenly attacks the ß-cells. As the ß- 
cells are progressively destroyed, the amount of insulin produced reduces until no 
insulin production is possible. The symptoms of diabetes are tiredness, thirst, a 
large increase in the amount of urine passed (polyuria) and weight loss (Jones and 
Gill 1997). Type I diabetes has been shown to be due to a combination of genetic 
predisposition and the environmental conditions, such as exposure to certain 
viruses (Jones and Gill 1997). 
The diagnosis of diabetes is based on a technique known as an oral glucose 
tolerance test (OGTT). This involves a patient fasting for between 8 to 14 hours, 
after which a blood glucose test is taken. They are then given a 75g oral glucose 
load. A test of the patient's blood two hours after this is taken and compared with 
the fasting glucose value. If the results of the blood tests are within the ranges 
shown in table 1. then the patient has a reduced ability to control their blood 
glucose level and is most likely diabetic (WHO, 1999). 
Whole blood Whole capillary Plasma of venous 
blood blood 
Fasting value >=6.1 >=6.1 >=7.0 
(mom) 
Post glucose load >= 10.0 >= 11.1 >= 11.1 
(mM/l) 
Table 1. Blood glucose values used for the diagnosis of diabetes 
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1.2 Insulin therapy of type I diabetes 
The only treatment for type I diabetes is insulin therapy in the form of daily 
injections, without this treatment type I diabetics would die as their cells would be 
unable to absorb glucose to use as fuel. With insulin injections the symptoms of 
type I diabetes can be removed as blood glucose levels return to a quasi-normal 
level and the fuel supply is returned to the cells (Banting and Best 1922). 
However, insulin injections cannot replace the glucose control system of a healthy 
individual, which constantly measures the amount of glucose in the blood and 
releases an appropriate amount of insulin. This control system can handle the 
constant changes in supply and demand of glucose in the body and keep the 
glucose concentrations to within a very narrow range of between 4 to 6m /l 
(Kruszynska 1997; Pickup 1997). 
With insulin therapy, the correct amount of insulin to be injected can be difficult 
to judge. This is because the absorption and uptake of insulin can be affected by a 
number of physiological factors. In addition, the blood glucose measurement 
techniques currently available only give a single measurement and can be painful 
and inconvenient to use. This means that patients have a poor idea of the level of 
blood glucose they have, and therefore, the amount of insulin to inject (Linde 
1997; Amiel 1998). A means of quickly and constantly measuring blood glucose 
levels would allow the patient to administer the correct amount of insulin and 
keep the blood glucose levels to within a normal range. 
1.2.1. Current methods of Blood glucose measurement 
Diabetics currently measure their blood glucose levels using small, portable 
devices that measure the glucose concentration in a small drop of blood taken 
from a finger or in urine samples. However, due to the pain and/or inconvenience 
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of these techniques these measurements are only taken a few times a day. This 
gives a poor representation of the constantly changing blood glucose levels 
Even with insulin injections and the use of glucose meters, a diabetic patient on 
insulin therapy will experience plasma glucose concentrations of from 1 to 
15mM/l and above compared to 4 to 6 mMJl of a healthy individual. As will be 
discussed later, these excursions outside of the normal glucose range will cause 
damage to the small blood vessels of the body. These lead to chronic and often 
fatal complications of diabetes (Kruszynska 1997; Pickup 1997). 
1.2.2. The long and short-term complications of insulin treated 
diabetes 
Diabetes treated with insulin has two main dangers associated with it; these are 
hypoglycaemia and the long-term complications caused by hyperglycaemia. 
Hypoglycaemia (blood glucose concentrations of below 3mM/l) is a short-term 
risk of insulin therapy. It is caused by a number of factors such as an overdose of 
insulin, insufficient glucose uptake by the cells of the body and disease (Williams 
and Pickup 1997). 
1.2.3. Insulin induced hypoglycaemia 
Hypoglycaemia first affects the brain; this is because unlike other tissues, which 
have alternative fuel sources, the brain depends almost exclusively on blood 
glucose as its fuel (Kruszynska 1997). As glucose levels drop below 2.8mM/1, 
cognitive function is impaired as the neurons of the brain have insufficient fuel to 
function correctly, once below 1mM/1, coma and possibly death occur. 
Hypoglycaemia affects from 25 to 30% of insulin dependent diabetics every year 
and causes two to four percent of all deaths in insulin treated diabetics (Krentz 
and Nattrass 1997). 
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1.2.4. The long-term complications of insulin treated diabetes 
due to hyperglycaemia 
As insulin therapy gives only limited control of glycaemic (glucose) levels, blood 
glucose concentrations are often above normal. The constantly high level of 
glucose (hyperglycaemia) leads to damage to the microvascular system of the 
body. This damage accumulates over a number of years and leads to a number of 
pathological conditions. Forty or fifty percent of type I diabetics will develop a 
range of conditions, which include retinopathy, nephropathy and neuropathy. The 
larger blood vessels can also be affected leading to atheroma. Long-term 
complications lead to type I diabetics having four to seven times the mortality rate 
of non-diabetics (Jones and Gill 1997). 
1.2.5. The Diabetes control and complication trial (DCCT) and 
intensive insulin therapy of diabetes 
Intensive insulin therapy involves much stricter control of blood glucose levels 
than is achieved in normal insulin therapy. This is done by an increase in the 
number of blood glucose tests and insulin injections compared with normal insulin 
therapy regimes (Amiel 1998; Pickup 1998). It has been demonstrated (in the 
DCCT, 1993), that intensive insulin therapy reduces the occurrence of the long 
term complications of type I diabetes. 
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1.2.6. The DCCT and the reduced risk of long-term diabetic 
complications 
The DCCT trial involved a study of insulin treated type I diabetics following a 
regime of `intensive insulin therapy', which involved increased blood glucose 
tests and insulin injections compared to normal insulin treatment. The goal was to 
keep their blood glucose levels to within a more normal range compared to 
standard insulin therapy. It was found that, compared to normal insulin regimes, 
intensive insulin therapy reduced diabetic retinopathy by 35 to 70%, kidney 
complications were reduced by between 39% and 54% and other complications 
were significantly reduced. However, the incidence of severe hypoglycaemia 
increased by a factor of between two and three (DCCT 1993). Therefore, although 
providing a large improvement in the long-term outlook of diabetes, the 
associated risks in the short-tem are also increased. This increase in 
hypoglycaemia was probably due to the normal glucose range and the 
hypoglycaemic range being very close together. This made it very easy for 
patients to accidentally administer too much insulin and lower their blood glucose 
levels into the hypoglycaemic range. 
1.2.7. Purpose of the research 
The objective of this research was to develop a sensor capable of continuously and 
reliably monitoring blood glucose levels to improve the management of type I 
diabetes. Its development could help reduce or prevent both the long-term 
complications and hypoglycaemic episodes of insulin treated type I diabetes. 
To safeguard against hypoglycaemia, the blood glucose concentration would need 
to be measured constantly and an alarm given if glucose levels approached 
hypoglycaemia. Constant monitoring of glucose levels would also allow the 
correct dosage of insulin to be calculated and administered. Unfortunately, at date 
of print, there exists no method of constantly measuring glycaemic levels reliably 
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using a portable device. It is for these reasons that a means has been sought for 
approximately twenty years to continuously measure blood glucose 
concentrations. 
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1.3 Glucose sensor performance requirements 
There are several performance requirements to be considered, these are outlined in 
table 2. 
Measurement range 0 to 25mM/1(Claremont 1987) 
90% response time <240 seconds (Femquist-Forbes, Linde et al. 
1988; Schmidtke, Freeland et al. 1998). 
Resolution 1 MM/1 
Measurement error No error in a single measurement greater than 
±0.3 mM/l below a blood glucose concentration 
of 2.8 mM/l or 10% of any other single 
measurement (Claremont 1987). 
Specificity Other chemical species must have no affect on 
the sensor (Claremont 1987). 
Size (of the sensing Less than a 25 gauge, needle (-0.5 mm) if 
element) invasive (Claremont 1987). 
Operational life span 24 hours minimum (Claremont 1987). 
Calibration Ideally calibrated only once during use or 
calibrated at production (Claremont 1987). 
Sterilisation Must -, withstand irradiation or chemical 
sterilisation to be of use. 
Shelf life In the order of three months. 
Cost. Cheap (Claremont 1987). 
Operation Simple (Claremont 1987). 
Table 2. The sensor performance requirements 
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1.3.1. Glucose concentration measurement range 
The glucose concentration measurement range of the sensor will need to cover the 
healthy physiological region, (3.7 to 6.7mM/1), the hypoglycaemic region (0 to 
2.8mM/1) and the hyperglycaemic region (6.7 to 50mM/1) as shown in figure 1. 
Although for hyperglycaemia, measurements of up to 25mM/1 have been proposed 
as a sufficient upper limit for a practical glucose sensor. The proposed sensor will 
therefore need to operate over a glucose concentration range of at least 0 to 25 
mM/l (Claremont 1987; DCCT 1991; Frier 1997; Pickup 1997). 
Glucose concentration 
50 MM/1 
6.7 mM/I 
3.7 mM/1 
2.8 mM/I 
0 MM/1 
rrrirrririiirririrriiiiiýiiriririri 
riririiiiýiýirriiiiiiiriiriiýiiiiri 
riiiiiiiiiiiririrriiiýiiiiiiiiiriri 
riiriiiiiiiiiiiiriirifiririirriiiii 
riýiiiiiiiiiiiiiriýiiiiýiiiiriiiiii 
riiiiiiiiriiriiiiiiiirrriiirriirrrii 
riiiiiiiiiiiýiiiiiiiiiiriiiiiiiiiir 
rrriiiriiiiiiiiiiiiiiiiiiiiiiiriiii 
riiiiiiriiiiiiiiiiiiiiiiiiiiiiiiiir 
riiriiiiiriiiiriiiiirirýiiiiiiiiriir 
Hyperglycaemic region 
Healthy physiological 
region 
// 
Boundary between 
healthy and 
Hypoglycaemic region 
Figure 1. Physiological glucose concentration ranges 
hypoglycaemic region 
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1.3.2. The 90% response time of the sensor 
The 90% response time of the sensor, to glucose concentration changes, should be 
sufficiently short to handle the fastest glucose concentration change possible in- 
vivo. These will most likely occur, and are potentially most dangerous, following 
an injection of insulin. The most rapid plasma glucose concentration drop induced 
by an insulin injection in a healthy human subject reported in the reviewed 
literature was measured at 2.5 mM/l in 30 minutes, approximately 12 min/mM/1 
decrease (Femquist-Forbes, Linde et al. 1988). In a study using rats, however, an 
insulin induced glucose concentration decrease was measured at 4.5 min/mM/1 in 
subcutaneous tissue and 5.6 min/mM/1 in the blood stream (Schmidtke, Freeland 
et al. 1998). Assuming, that the same rate of glucose decrease could occur in 
humans and that this is the fastest possible glucose concentration change, then the 
sensor will have to possess a 90% response time of less than 240 seconds. With 
this response time the sensor will be able to respond the fastest glucose decrease 
that will be encountered in-vivo. 
7 
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1.3.3. Resolution, measurement error and drift 
The values of signal resolution and measurement error that can be tolerated are 
dictated by the size of the boundary between the normal and hypoglycaemic 
glucose concentration regions. This is because an error in a blood glucose 
measurement that led to a hypoglycaemic blood glucose concentration falsely 
being classified as being in the normal or hyperglycaemic region could prove 
fatal. Therefore, the sensor must be able to reliably distinguish between 
hypoglycaemia and other regions. 
To achieve this reliability, the sensor will ideally have a resolution (smallest 
detectable difference in the glucose measurement) of 1 mM/1. This will allow the 
sensor to distinguish the lowest normal physiological glucose concentration (3.7 
mM/1) from the upper hypoglycaemic limit (2.8 mM/1). As well as resolution, the 
measurement error will affect the reliability of the sensor. Above 2.8 mm/l, no 
single measurement should have an error of greater than 10% of the true value 
being measured. Incorporating this error with the resolution limit gives a possible 
error in the lower normal glucose concentration of 3.7 ± 1.0 mM/l, so the true 
value could be 4.7 mM/1 or 2.7 mM/l, just inside the hypoglycaemic region. For 
concentrations below 2.8 mM/1 measurement errors are academic to an extent as it 
may be sufficient to indicate that the patient is experiencing hypoglycaemia. 
However, if measurements are to be taken in the hypoglycaemic region an error of 
±0.3 mM/l should be aimed for. 
As the sensor will be taking continuous measurements, it may be possible to take 
an average of measurement over a period. If, for example, a measurement was 
taken every second then the values could be averaged over say a minute. 
However, the safety of such an averaged blood glucose value is dependent on the 
frequency of measurements and the maximum possible rate that blood glucose 
concentrations can decrease from normal to hypoglycaemic concentrations 
(Claremont 1987; DCCT 1991; Frier 1997; Pickup 1997). In addition, a trend of 
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measurements could be monitored and steps taken to adjust glucose levels when 
potentially dangerous trends were detected, i. e. glucose levels decreasing while in 
the lower half of the normal glucose range. 
1.3.4. The specificity of the sensor to glucose 
The sensor signal must be specific to glucose and therefore immune from the 
effects of other analytes in the blood. The most obvious chemicals that may 
interfere with the sensors are other sugars. In blood, besides glucose, the other 
sugars that are present are pentose (4.05mM/1, L-Xylulose (4.01mM/l) and 
galactose (,: z0.09mM/l), fortunately their concentration is small compared to that 
of glucose (; t6 mM/l) (Diem and Lenter 1975). Other analytes in the blood and 
even conditions such as ambient light or temperature may also have an effect on 
the sensor, although this will depend on the detection scheme being used and is 
discussed in Chapter 2. 
1.3.5. Sensing element size 
The sensor should, ideally, have a diameter of no greater than a 25-gauge needle, 
a diameter of roughly 0.5 mm. This would allow the sensor to be implanted into 
subcutaneous tissue with the minimum amount of pain. In addition, the response 
of the body's tissue to an implant is possibly related, at least in part, to the size of 
the wound it inflicts on insertion. The safety of the sensor may also be affected by 
its dimensions, as the greater the wound size the greater the chance of infection 
gaining access from the outside world. These considerations will be expanded in 
Chapter 3 (Claremont 1987). 
12 
1. Introduction 
1.3.6. Operational life span 
The operational life span of the sensor should be between 12 and 24 hours. This 
would allow the sensor to operate overnight to monitor nocturnal glucose levels 
and warn of nocturnal hypoglycaemia. In addition, an entire 24-hour monitoring 
period could be covered with the use of only one or two sensors. This would avoid 
the patient having to insert several sensors per day, which would be painful and 
inconvenient. It may be possible to create a sensor with a longer operational 
lifetime. However, infection may become an issue with longer implantation times, 
creating problems with safety and operation. 
1.3.7. Calibration of the sensor 
Ideally, the sensor would be calibrated once, over its full operational range, before 
implantation and would then operate accurately for the duration of its use. 
However, in practice, the sensor will most likely require an in vivo re-calibration 
shortly after implantation. This calibration would probably be a one-point 
measurement, against a gold standard blood glucose assay, to deal with baseline 
changes in the signal caused by effects of implantation. A one-point calibration 
would be the most practical, as cycling a patient through the complete 
pathological blood glucose range would not be practical. In addition, the sensor 
may require re-calibrating at set intervals during its operation to deal with signal 
drift. These in vivo calibrations would have the advantage that any effects of the 
tissue response to the presence of the sensor and the sensor signal drift would be, 
at least partially, compensated for. 
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1.3.8. Sterilisation of the sensor 
Obviously for the safety of the patient, any implanted sensor would need to be 
sterilised before implantation. As well as improved safety, sterilisation may also 
reduce errors in the sensor signal that would be caused by the tissues' reaction to 
any pathogens on the sensors surface, as will be explored in Chapter 2. The 
sterilisation process may also have an effect on the sensors performance 
characteristics, such as its measurement range or shelf life. Allowances for these 
changes will have to be made for in the design of a practical sensor. The sensor 
developed here is later shown to survive sterilisation using gamma radiation with 
some changes in performance (Woedtke, Julich et al. 2002). 
1.3.9. The shelf life of the sensor 
The sensor will have to be stable when stored between being produced and use. A 
shelf life of at least two to three months would most likely satisfy this 
requirement. Ideally, the sensor should be able to be stored at room temperature, 
although if chemical or biological components are used in the sensing element, 
refrigeration or other special storage conditions may be required. 
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2 Methods and principles of glucose measurement 
A range of different techniques has been applied to the problem of continuous blood 
glucose measurement. These range from non-invasive infrared spectroscopy approaches 
to invasive needle style electrochemistry (Heinemann 2000; McNichols and Cote 2000). 
A discussion of these techniques is presented in this chapter. Special attention is paid to 
the enzyme based electrochemical glucose sensors as their enzyme layer technology is 
employed in the fibre optic sensor design presented in this thesis. 
2.1 Electrochemical glucose sensors 
Glucose in blood can be detected directly using a pair of electrodes held at an 
appropriate electrical potential. The electric potential causes a chemical reaction to 
occur between the glucose and the surface of the electrode. This chemical reaction in 
turn produces a flow of electric current through the electrodes. This current can then be 
measured and is proportional to the concentration of glucose. However, the large 
electric potentials needed to achieve this lead to interference from other chemicals in the 
blood, which also react with the surface of the electrode masking the glucose dependent 
signal (Lemke and Lustermann 1991). 
To solve this problem, electrochemical glucose sensors detect glucose indirectly 
through the products of another chemical reaction that involve glucose. These products 
can be detected using much lower electrical potentials than is needed to directly 
measure glucose. These types of sensors, therefore, are relatively interference free 
(Lemke and Lustermann 1991). However, interference from other substances in the 
blood is still a problem. 
These sensors are usually needle type sensors, which can be inserted through the skin 
into the subcutaneous area or into a blood vessel (Claremont, Sambrook et al. 1986). 
The electrode is often platinum, silver, or carbon with a reference electrode (needed to 
complete the electrical circuit) made of steel, silver or silver chloride. Instead of needle 
style sensors, some sensors are miniaturised and totally implanted along with all the 
15 
2. Methods and principles of glucose measurement 
necessary electronics and a power supply to provide a radio link with the outside 
(Gilligan, Schults et al. 1994; Updike, Shults et al. 2000). 
The majority of electrochemical glucose sensors use the enzyme glucose oxidase 
(GOD), which promotes a reaction between glucose and oxygen to produce gluconic 
acid and hydrogen peroxide (H202), as shown in Equation 1 (Fisher, Rebrin et al. 1994). 
Measurements of the oxygen or hydrogen peroxide (both of which can be detected with 
low electrical potentials) are then used to calculate the concentration of glucose present. 
Equation 1. glucose + oxygen 
glucose oxidase 4 gluconic acid + H2O2 + 7kcal 
(Bourdillon, Bourgeois et al. 1980; Fisher, Rebrin et al. 1994) . 
2.1.1. Oxygen based electrochemical glucose sensors 
In oxygen based sensors, the enzyme is coated onto the electrode usually mixed into a 
polymer matrix such as Poly(2-hydroxyethyl methacrylate) (HEMA). This forms an 
enzyme HEMA (EH) membrane. The glucose and oxygen diffuse into the membrane 
and react through the catalytic action of the GOD, the waste products of the reaction 
then diffuse out of the membrane as shown in figure 2. The reaction in the enzyme layer 
is shown in Equation 1, and at the electrode is shown in Equation 2. 
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Equation 2.02 + 4H+ + 4e- -- 2H20 
(Hall 1990) 
Gluconic 
02 Glucose H0122 acid 
H2O2 
-º GOD 10 
Gluconic acid 
l 2H202 0 40H- 
2e A2e 
7 
The electrode held at 
-650mV relative to a reference electrode 
Figure 2. The chemical reaction in the enzyme membrane 
Biocompatible and 
protective membrane 
Enzyme layer 
Electrode 
If the EH layer is constructed with the appropriate diffusion characteristics, with low 
permeability, as will be discussed in chapter 3, the glucose concentration alone will 
control the rate at which oxygen is consumed. So, the glucose concentration can be 
calculated by measuring the rate of oxygen consumption, which is calculated from the 
decrease in the oxygen tension measured at the electrode. 
As the electrode consumes oxygen during the measurement, problems can arise from 
the oxygen in the sensors environment being exhausted by the sensor. This is dealt with 
by an appropriate choice of membrane diffusion characteristics, with lower permeability 
to glucose than oxygen, see chapter 3, or by modulating the potential of the electrode, 
which involves switching the potential on and off several times a second (between 50 
and 100Hz). This prevents the area immediately adjacent to the electrode becoming 
depleted of oxygen (Hall 1990). 
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Electrochemical oxygen sensors, although far more interference free than their glucose 
counterparts are subject to interference from other constituents in the blood and are also 
vulnerable to interference from some anaesthetic gasses such as halothane and nitrous 
oxide (Hall 1990). 
2.1.2. The stoichiometric limitation problem of oxygen based 
electrochemical glucose sensors 
Oxygen based electrochemical sensors, and all sensors which use GOD to detect 
glucose, suffer from the problem of the low concentration of oxygen compared to 
glucose in body tissue. The relative concentration of oxygen and glucose in tissue is 
roughly 0.2mM/l to 5.5mM/l respectively (Gough, Leypoldt et al. 1982). The oxygen 
concentration can also vary in different parts of the body (Zhang and Wilson 1993). 
This tends to limit the range of the glucose sensor, as there is not enough oxygen to fuel 
the oxidation of glucose at higher glucose concentrations. 
Differentially permeable membranes allow oxygen to diffuse freely into the EH 
membrane while reducing the flux of glucose. This increases the range of the sensor, as 
less oxygen is required to fuel the enzyme reaction, and reduces the effect of the 
stoichiometric limitation. Appropriate choices of membrane permeability can also be 
used to produce a sensor with a linear response to glucose (Wilson and Turner 1992). 
Another strategy to overcome the stoichiometric oxygen limitation was a radially- 
symmetrical sensor proposed by Gough, Lucisano et al. 1985. The radially-symmetric 
sensor design is shown in figure 3. With this design, glucose can diffuse into the front of 
the sensor but not the sides due to the hydrophobic gas permeable layer. Oxygen, 
however, can diffuse through all sides of the sensor. It was found that aspect ratios (face 
to side area) of 1/3 gave optimal performance. A second oxygen sensor was used along 
side the glucose sensor as a reference. This allowed a differential oxygen measurement 
to be taken between the two sensors that cancelled out the effects of ambient oxygen 
fluctuation. 
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Figure >. The radiallN - symmetric glucose sensor design 
This sensor had a range of 0 to 500mg/dl (0 to 27.7mM! 1). However. its 90% response 
time was 8 to 12 minutes when implanted into the femoral veins of rabbits and dogs. 
The sensor operated well despite 25% increases in the ambient oxygen tension. 
However. there was a ten-minute lag between blood glucose concentration changes and 
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the sensor response (Gough, Lucisano et al. 1985; Gough, Armour et al. 1986). The 
range of this sensor is more than sufficient for blood glucose measurement; however, its 
slow response time in vivo is too slow to be used as a hypoglycaemic alarm. 
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2.1.3. Recycling of oxygen using the enzyme catalase 
An alternative way to overcome the stoichiometric oxygen limitation is to use a second 
enzyme catalase (CAT) in conjunction with the GOD. CAT is an enzyme that is used by 
the body to break down H202 to form oxygen and water, as shown in Equation 3. The 
oxygen produced can be used to fuel the GOD promoted reaction in the EH membrane, 
which helps redress the problem of oxygen limitation. 
As well as producing oxygen, CAT serves a second role in protecting the GOD enzyme. 
Once produced the H2O2 breaks down in solution with water to form a hydroxyl radical 
(OH), this is highly reactive and can destroy or damage GOD and CAT. So, by removing 
the H2O2 the CAT protects the GOD (Tse and Gough 1987; Wilson and Turner 1992; 
Lledias, Rangel et al. 1998). 
Equation 3.2H202 CAT 4 2H20+02 
(Mathews and Holde 1990). 
2.1.4. Mediated electrochemical glucose sensors 
To overcome the stoichiometric limitation problems of GOD based electrochemical 
measurement, a new breed of sensors was developed that dispensed with the need for 
oxygen in the sensor operation. The technique employed used what is known as an 
`oxygen mediator'. The role of oxygen in the oxidation of glucose is to remove two 
electrons from the GOD enzyme. The enzyme then uses its depleted electronic state to 
break the glucose down into gluconolactone, which then dissolves to become gluconic 
acid. The oxygen can be replaced by an appropriate chemical (oxygen mediator), which 
will shuttle electrons from the enzyme to an electrode as shown in figure 4. where 
ferrocene is used as the oxygen mediator. 
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2e ' 2Ferricinium GOD (red) 
Gluconolactone 
2Fenocene GOD (OX) Glucose 
GOD (red) glucose oxidised reduced form [added ei 
GOD(0) oxidised form [removed e] 
(Pickup, Shaw et al. 1989) 
Figure 4. Electron mediation 
The use of a mediator has another advantage in that the electrode can be held at much 
lower potentials than in other sensor designs, which removes some of the interference 
problems caused by other analytes (Pickup, Shaw et al. 1989). 
2.1.5. Hydrogen peroxide based electrochemical glucose sensors 
As well as the consumption of oxygen, the production of hydrogen peroxide can also be 
used to measure glucose concentrations. The H202 is produced as GOD promotes the 
breakdown of glucose, as shown in Equation 1. Hydrogen peroxide is detected by using 
an electrode, which is kept at approximately 700mV relative to a reference electrode, as 
shown in figure 5 and Equation 4. The amount of hydrogen peroxide present is 
calculated from the current flowing through the electrodes. 
Equation 4. H2O2 + 700mV 02 + 2H+ + 2e- 
(Shichri, Yamasaki et al. 1982) 
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Figure 5. The basic design of H202 based glucose sensors 
Because of the size of the polarisation voltage needed to measure H202,700mV, the 
process can be influenced by other analytes in the blood, such as ascorbate, 
paracetamol, and urate (Kusano 1989; Shaw, Claremont et al. 1991; Fisher, Rebrin et al. 
1994). The problem of interference is dealt with by coating the electrodes in membranes 
such as cellulose, nafion, and poly(m-phenylenediamine) amongst others, which prevent 
interfering species from reaching the electrode surface (Kusano 1989; Moussey, 
Harrison et al. 1993; Ward, Jansen et al. 2002; Yang, Chung et al. 2002). However, 
interference can still be a problem that reduces the reliability of hydrogen peroxide 
electrochemical sensors. 
2.2 Glucose measured from exudates 
Sweat is a slow process and only occurs under certain conditions, which makes it 
unsuitable for glucose measurement (Guilbault and Palleschi 1995; Kost, Mitragotri et 
23 
2. Methods and principles of glucose measurement 
al. 2000). However, there are a number of ways to promote the passage of subcutaneous 
fluid to the surface of the skin, including suction, iontophoresis and ultrasound 
techniques. 
2.2.1. Suction effusive fluid glucose measurements 
The application of a negative air pressure to the surface of the skin causes a 
subcutaneous fluid or suction effusive fluid (SEF) to be drawn out. The glucose 
concentration in this fluid is then measured using electrochemical techniques. When 
applied to healthy subjects blood glucose concentrations were successfully measured. 
However, there was a delay of 10 to 20 minutes between the glucose concentrations of 
the SEF when compared to serum glucose, the SEF values were also 19 to 33% of the 
serum values. There was also some damage caused to the skin by this technique 
(Kayashima, Arai et al. 1991). A similar study on type II diabetics demonstrated similar 
correlations between SEF and serum values (0.92) but with roughly a 15-minute delay 
between serum and SEF values (Kikuchi, Kayashima et al. 1996). The delay in changes 
between the SEF and serum values makes the sensor too slow to be used as a 
hypoglycaemic alarm. The damage caused to the skin of the patient would also mean 
that the sensor would not be practical for use with diabetics due to their reduced ability 
to heal (Jones and Gill 1997). 
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2.2.2. lontophoresis promoted exudates glucose measurements 
Iontophoresis, sometimes referred to as reverse iontophoresis in this application, is a 
technique where an electric current is passed through the skin and subcutaneous tissue 
between two electrodes. Although glucose carries no charge, it is caught up from the 
fluid flow of charged analytes in the subcutaneous fluid, that flow through the skin to 
the electrodes. The glucose concentration of the fluid that arrives at the electrodes is 
then measured again using electrochemical technology. As with suction techniques, 
there was some skin damage detected. This approach allows measurement of the 
glucose concentration over a period of at least five minutes rather than at a particular 
point (Rao, Guy et al. 1995; Tamada, Bohannon et al. 1995). Although, due to its slow 
response time, (20 minutes), this would not provide a hypoglycaemic alarm or method 
for insulin dose adjustment, it has been turned into a commercial device called the 
Glucowatch produced by Signus Inc. The Glucowatch has been employed to deliver a 
means of monitoring blood glucose concentration trends in diabetics over a 12-hour 
period but not to adjust insulin dosage (Garg, Potts et al. 1999). As with suction effusive 
fluids, the slow response and skin damage mean that this would not be suitable as a 
hypoglycaemic alarm or to adjust insulin dosage. 
2.2.3. Exudate glucose measurements through ultrasonic techniques 
Ultrasound has also been used to promote the transport of glucose across the skin barrier 
(Kost, Mitragotri et al. 2000). Short duration ultrasonic pulses were applied to the skin, 
followed by the application of negative air pressure. It was found that short applications 
of ultrasound in two-minute bursts would increase the glucose flux across skin by a 
factor of 570, compared to unassisted flux with only suction. The increased glucose flux 
remained for 15 hours after each burst and then decreased to normal after 24 hours. No 
skin damage caused by the ultrasound was reported, but the suction apparatus did leave 
a transient imprint on the skin. There was a 30-minute lag-time between glucose levels 
measured and the corresponding core blood glucose levels. However, once this delay 
was accounted for, the measured glucose approached the core glucose levels with only 
one clinically dangerous error out of 53 in vivo measurements on type I diabetics (Kost, 
Mitragotri et al. 2000). Again, due to the lag-time, this technique is too slow to be used 
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to adjust insulin dosage or detect hvpoglvcaemia. The issue of long term effects of 
breaking down the skin's diffusion resistance to fluids, with regard to infection and 
damage. would have to be evaluated. 
2.2.4. Microdialysis glucose sensors 
These techniques use a small bore double lumen needle covered in a dialysis membrane. 
which is inserted into subcutaneous tissue. Fluid is circulated inside the membrane and 
glucose diffuses into the fluid from the tissue serum surrounding the probe. figure 6. 
The glucose gathered is then measured and this is used to calculate the blood glucose 
level. 
Double lumen 
needle 
Subcutaneous 
tissue 
'U 
Dialysate and 
Glucose flow 
FDialysis 
membrane 
Figure 6. Design of the microdialysis probes 
Flow of 
dialvsate 
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The basic design of the microdialysis probe is shown in figure 6 (Sternberg, Meyerhoff 
et al. 1995). Once collected, the glucose concentration in the dialysate is measured by a 
variety of methods. These include a GOD method (Bolinder, Ungerstedt et al. 1992), a 
GOD/peroxidase test and an amperometric glucose sensor (Sternberg, Meyerhoff et al. 
1995; Rhemrev-Boom, Tiessen et al. 2002), Fourier transform infrared spectroscopy 
(FT-IR spectroscopy) (Bittner, Heise et al. 1997) and a hydrogen peroxide glucose 
sensor (Hashiguchi, Sakakida et al. 1994). The response time of microdialysis is slow as 
the dialysate can take several minutes to equilibrate with the surrounding tissue. 
2.3 Fibre-optic glucose sensors 
These sensors generally use optical fibres that have glucose sensitive chemistry along 
with a fluorescent dye immobilised at the tip. The fluorescence emission of the dyes is 
affected indirectly by the presence of glucose. A number of techniques using fibre- 
optics have been developed and, as this research is into the development of a fibre-optic 
sensor, these approaches are described here in detail. 
Optical fibres transmit light using the principle of total internal reflection, briefly this 
involves light being reflected from the interface of two optical materials of different 
refractive indexes. The basic design of a fibre is shown in figure 7. below, the core of 
the optical fibre is made from a material with a higher refractive index than the cladding 
material, any light launched down the fibre within a certain range of angles range 
(known as the numerical aperture) will be reflected from the boundary of the core and 
cladding and travel down the fibre. There are two main types of optical fibre, multimode 
and single-mode fibres. Multimode fibres, like the type shown in figure 7, have a core 
that is large enough to allow several different paths (modes) to propagate down the 
fibre. Single mode fibres have a core that will allow only a single path to be taken by 
light travelling down its length. The majority of biosensor fibre-optic systems use 
multimode fibres. Depending on the materials used in their construction optical fibres 
can carry light from visible (0.4µm) up to the mid infrared wavelengths (20µm) 
(Ashworth and Narayanaswamy 1989; Kellener, Gobel et al. 1995; Kolimbiris 2000) 
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Core Cladding 
Light ray 
Figure 7. A multimode optical fibre 
When used in sensing applications, optical fibres are used to transmit light to and/or 
from the target material of interest. Optical fibres can be used to simply collect light 
from an illuminated sample, which is then examined using spectroscopic techniques. 
Alternatively the cladding can be removed from a section of the fibre and this section 
placed in contact with a chemical sample. Light travelling through the core interacts 
with material in contact with the surface of the fibre by means of an evanescent wave 
the spectrum of the resulting light emerging at the end of the fibre then contains 
information about the material in contact with the fibre. In many applications, as will be 
discussed later in this chapter, optically active chemical species are immobilised onto 
the tip of a fibre. The optical fibre is then used to illuminate the immobilised chemical 
materials and collect any emission light produced through photochemical processes. 
These chemicals interact with the target species of interest and their optical emission is 
altered as will be described in chapter 4 (Ashworth and Narayanaswamy 1989). 
There are several factors that can affect the optical signals carried by optical fibres, 
some of the main process are discussed here. The fibre its self will cause signal 
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attenuation that is wavelength dependent in its magnitude. Bending of the optical fibre 
will cause a loss in optical signal as a result of changes in the boundary between the 
core and cladding. To compensate for these changes, as well as the measurement optical 
signal a reference optical signal is often used. This reference signal is of a wavelength 
that is not affected by the sensing chemistry, by monitoring its intensity, any changes in 
the transmission characteristics of the system can be compensated for. Light from the 
outside environment can also cause interference in the signal this is compensated for by 
either shielding the measurement system form light or modulating the illumination light 
and then removing none modulated signal components from the returning light 
(Ashworth and Narayanaswamy 1989). 
2.3.1. Fibre-optic glucose affinity sensors 
A glucose affinity sensor was designed and built by Schultz, Mansouri et al. 1982; 
Mansouri and Schultz 1984. The sensor used the process of reversible binding of 
glucose to the lectin concanavalin A, (ConA). The glucose competes for binding to the 
ConA with another sugar, dextran, which is labelled with a fluorescent dye, fluorescein 
(FITC), to form FITC-dextran. The concentration of the FITC-dextran can be measured 
using fluorescence intensity measurements (discussed in Chapter 4). The ConA was 
immobilised onto the inner side of a section of dialysis tubing, see figure 8. This tubing 
was sealed at one end, with the other end fixed to an optical fibre to form an enclosed 
cavity. The sensor assembly was small enough to be inserted through a 23-gauge 
needle. 
The FITC-dextran cannot pass out of the dialysis tubing due to its size (molecular 
weight of 70,000 atomic mass units), however, glucose can freely move between the 
outside solution and the interior of the tube. Because of this freedom of movement, the 
concentration of glucose inside the dialysis cavity will be equal to that in the bulk 
solution. Any glucose inside the dialysis cavity will displace the FITC-dextran from the 
ConA on the walls of the dialysis tubing. The amount of FITC-dextran in free solution 
(inside the dialysis cavity) will be proportional to the amount of glucose present in the 
outside solution. 
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During in vitro tests, the sensor proved to have a range of zero to 8mg/ml (44mM/1) and 
a random error of ± 0.13 mg/ml (0.7mM/1). Its 90% response time was, however, 
around five minutes to step changes in glucose concentration of between 1 and 6mM/l, 
although it was suggested by the authors that it might be possible to reduce this by a 
different choice of dialysis tubing. The sensor was found to be sensitive to temperature 
fluctuations and pH, although in a healthy body both of these only vary by a limited 
amount. The sensor was unaffected by oxygen fluctuations and plasma constituents but 
due to its slow response time, the sensor is not suitable for use as a hypoglycaemic 
alarm. 
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Figure 8. A glucose affinity sensor described by Schultz, Mansouri et al. 1982; 
Mansouri and Schultz 1984. 
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Some years later, (Meadows and Schultz 1993) created a modified version of the above 
sensor. The immobilised ConA was replaced with free-floating tetramethylrhodamine 
isothiocyanate labelled Concanavalin A (TRITC-ConA). When the TRITC-ConA binds 
to FITC-dextran, it quenches (prevents fluorescence emission) the FITC-dextrans 
fluorescent emission. As before, the FITC-dextran competes with glucose for the 
TRITC-ConA. Therefore, the amount of fluorescence quenching is proportional to the 
concentration of glucose. Like the FITC-dextran, the TRITC-ConA is too large to 
escape from the dialysis membrane. The TRITC-ConA also has a fluorescent emission 
wavelength of its own. This was used as an optical reference signal to measure any 
changes in the optical parameters of the system. However, the design exhibited baseline 
drift and a loss of dynamic range, which made it unusable in the space of only two 
hours. Until this problem is resolved, the sensor is of no use as a blood glucose sensor. 
2.3.2. Oxygen based fibre-optic glucose sensors 
A glucose sensor with an oxygen optrode (optical glucose sensor) was made by Schaffar 
and Wolfbeis 1990. The oxygen sensor was created by immobilising a fluorescent dye 
in silicone onto the tip of a fibre-optic cable of 8mm in diameter. The dye was quenched 
in proportion to the presence of oxygen. GOD was then immobilised on top of the 
oxygen sensor and glucose measured via the oxygen reduction during the oxidation of 
glucose, in the same way as the electrochemical GOD based sensors. The range of the 
best sensors was 0.04 - 2mM/l but this was extended to 5mM/1 with the use of a dialysis 
membrane, with a response time of one minute. By using a 500111 dialysis encased fluid 
filled cell placed around the sensor, the range was further increased to 1-200 mM with a 
response time of three to five minutes. The size of this sensor would be too large to be 
practical, although its range and response time (with the dialysis membrane) is more 
than sufficient for the needs of a glucose sensor. The size of the sensor will have to be 
reduced for it to be a practical sensor. In addition, as this sensor uses the same GOD 
technology as the electrochemical oxygen based sensors, it will encounter the same 
range and stoichiometric problems. 
In a very similar sensor design to the above, oxygen consumption was also used to 
measure glucose by Moreno-Bondi, Wolfbies et al. 1990. The sensor consisted of GOD 
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immobilised onto a layer of carbon, below this was a layer of silicone containing an 
oxygen sensitive fluorescence dye. An optical fibre bundle was then used to illuminate 
the sensor and collect the emission light. The sensor had a range of 0.06-1mM glucose 
in air-saturated solutions, with a response time of six minutes. Although having a high 
sensitivity, the sensor would be of no use as a practical sensor for diabetes due to its 
limited range. In addition, the subcutaneous tissue or blood stream would have a lower 
free oxygen tension than air. The response time is also too slow to be useful clinically. 
Tests of the sensor for interference from the other sugars; saccharose, fructose, lactose 
and galactose at 100mM showed no signal changes. The sensors had a lifetime of 12 
months when stored at 4°C. The fabrication reproducibility was very good with 
different sensors having almost identical calibration curves. 
Another fluorescent oxygen sensor coated in GOD was used to measure glucose 
concentrations by Li and Walt 1995; Healey, Li et al. 1997. The oxygen sensitive dye 
and the GOD were immobilised onto the tip of an optical fibre bundle, using a photo- 
polymerisation technique. This technique allowed very small sensing sites, around 50 
micrometers in diameter, to be deposited on the surface of the fibre. The sensing areas 
were fabricated with a double layered polymer cone as shown in figure 9. To 
compensate for oxygen variations, other sensing areas were fabricated on the sensing 
end of the fibre that measured only the oxygen concentration in the environment of the 
sensor. This allowed a differential measurement to be taken between the oxygen 
reference and the glucose sensing sites that would remove the effect of background 
oxygen variations. 
The small size of the sensing sites allowed several sites to be fabricated on the end of 
the imaging fibre bundle. The fibre-optic bundle comprised of three to six thousand 
individual fibres. The individual sensing sites were imaged by a charge-coupled device 
(CCD) camera attached to the other end of the fibre bundle. Each site could be given a 
different thickness of EH, allowing different sites to cover different ranges of glucose 
concentration. Tests of this system demonstrated an accuracy of 0.6mM over the range 
0-2mM glucose over a range of oxygen tensions (down to ýt-1OKPa), with a response 
time of 9-28s, and the probe was found to operate for two days in an in-vitro 
environment 
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Figure 9. The design of the multiple sensing site fibre optic glucose sensor. 
A highly sensitive fibre optic glucose sensor of only ten micrometers in diameter was 
constructed by Rosenzweig and Kopelman 1996. Again. the sensor operated by 
measuring the oxygen consumption as glucose was oxidised by GOD using 
fluorescence quenching of an oxygen sensitive fluorescent dye. The miniaturisation of 
the sensor was achieved by heating the tip of a 100µm diameter optical fibre with a 
laser beam and pulling the tip into a fine point. A mixture of dye and GOD in an 
acrvlimide support was then coated onto the tip of the optical fibre using a 
photopolvmerisation technique. Using this construction method sensors were fabricated 
with sensing areas only a few microns across. This miniaturised sensor gave very fast 
response times. 95% response from aI to 5mM steps in 1.5 seconds and a recovery of 
two seconds. The sensor range was from 0.7 to 10 mM with high sensitivity. The only 
limitation of the sensor was the short lifetime of four to six days. This is short compared 
with larger sensors. which have been known to operate for several weeks. The reason 
for this reduced lifetime was thought to be due to the effective increase of enzyme 
activity, which is related to the surface area to volume ratio of the EH layer. With a Eli 
layer so small. the amount of enzyme is much less than in larger sensors. This means 
that any enzyme deactivation or loss will affect the sensor far more rapidly than larger 
sensors that have more enzyme to spare. 
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2.3.3. Fibre-optic glucose sensors using optical absorption of GOD 
A glucose sensor based on the absorption changes of GOD was constructed by 
Chubdova, Vrbova et al. 1996. The sensor operated by measuring the change in the 
optical absorption of the GOD coenzyme FAD. In the presence of glucose, the FAD is 
converted to FADH2 and then oxidised back to FAD as shown in figure 10. 
Hydrogen 
D-glucose GOD. FAD peroxide 
S-gluconolactone GOD. FADH2 Oxygen 
Figure 10. The GOD optcal sbsorption based glucose sensor 
The GOD was covalently linked to a nylon net, which in turn was fixed to a HEMA 
layer. This assembly was then attached to the common end of a bifurcated optical fibre 
bundle. The absorption of the FAD was measured and used to calculate the 
concentration of glucose. Glucose concentrations could be measured in a range of 2 to 
10mM in air saturated solutions, the response times of the sensor ranged from seconds 
to five minutes for lower concentrations; regeneration time of the sensor was two to 
fifteen minutes. The sensor was shown to be almost insensitive to pH changes, 
compared to the enzyme free solution. Maximum catalytic activity of the EH membrane 
was found to be at 37°C. The ambient oxygen concentration did affect the lower 
detection limit of the sensor. A test of the sensor in nitrogen-saturated solution, showed 
that the glucose detection limit had lowered to 0.45mM/l. Adding catalase to the test 
solution raised the lower glucose detection limit by 35%. This was thought to be due to 
oxygen being recycled as the catalase broke down hydrogen peroxide to produce water 
and oxygen. The oxygen limitation problems and the response times are outside those 
required for a hypoglycaemic alarm. 
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2.4 Non-invasive measurements 
2.4.1. Near infrared spectroscopy 
The most desirable method of measuring blood glucose would be a totally non-invasive 
technique as this would be painless and convenient. To this end, there has been a large 
amount of research into possible non-invasive glucose sensing using near infrared 
spectroscopy (NIRS). This is due to the fact that it was known that a region of the 
infrared spectrum, the near infra red region (NIR), can penetrate tissue deeply enough to 
interact with blood rich tissue. This region is often termed the therapeutic window. 
Values quoted in the published literature for the therapeutic window vary, as do the 
values of penetration depth of light in this spectral region. 
Infrared spectroscopy is an established technique used for in vitro chemical analysis. It 
has been adapted to in vivo measurement with limited success; however, the technique 
has to date proved too unreliable to be used as a method for insulin adjustment. 
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Wavelength range Comments Reference 
Min Max 
(nm) (cm) (nm) (cm-') 
600 16667 1200 8333 (Boulnois 1985) 
700 14286 1300 7692 Significant amounts of light (Glaister 1988) 
can be transmitted through 
several cm of tissue in this 
band. 
700 14286 1000 10000 Light is transmitted through (Ferrari, Wei et al. 
soft and hard tissues of the 1989) 
head. * 
700 14286 1300 7692 Above 1300nm, all photons (Jobsis 1977) 
are stopped past a few mm 
of tissue. 
700 14286 900 11111 Light penetrates up to (Fantini, 
several cm. Franceschini-Fantini 
et al. 1995) 
700/14 900 11111 Tissue is relatively (Faris, Thorniley et 
286 transparent to NIR light. al. 1991) 
714 14006 2500 4000 Light can penetrate (Haaland, Robinson 
I mm -l cm. et al. 1992) 
* Bone is a relatively low absorbing material in the NIR, (Ferrari, Wei et al. 1989), with 
a low and featureless absorbance spectrum in the range 650 - 900nm (15385-11111 cm- 
1) (Firbank, Hiraoka et al. 1993). 
Table 3. Values quoted in the literature of the therapeutic window. 
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Diffuse Reflectance Transmission 
Measurements on the finger using a Through a finger using light of 800 - 
wavelength range from 900 - 1200nm 1000nm (12500-10000cm-1) (soda, 
(11111-8333cm-1) (Jagemann, Taniguichi et al. 1994). 
Fischbacher et al. 1995). 
Measurements were carried out on the Through a forger using light from 750 - 
forehead and forearm at 715 (13986cm- 1300nm (13333-7692cm-1) (Robinson, 
1) and 815nm (12270cm-1) (Blasi, Eaton et al. 1992). 
fantini et al. 1995). 
Carried out studies on foetal heads using Through the forearm using laser diodes 
wavelengths of 775nm (12903cm-1)' of 778nm (12854cm-1)' 813nm 
805nm (12422cm-1)' 845nm (12300cm-1), 867nm (11534cm-1) and 
(11834cm-1) and 905nm. (11050cm-1) 904nm (11062cm-1) (Cope and Delpy 
(Faris, Thorniley et al. 1991)- 1988). 
Used LED's Of 715nm (13986cm-1) and 
850nm (11765cm-1) on measurements of 
the thigh and forearm (Fantini, 
Franceschini-Fantini et al. 1995). 
Performed measurements of infant's head 
at 650 - 1000nm (15385-10000cm-1) 
(Cooper, Elwell et al. 1996). 
Table 4. Examples of diffuse reflectance and transmission experiments reported in the literature 
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2.4.2. Data analysis of NIR spectra 
The spectral signature of glucose in the NIR region, which the therapeutic window 
occupies, is very weak and not well defined. In addition, the spectral features of other 
blood analytes, such as water and haemoglobin, dwarf the spectrum of glucose making 
concentration measurements problematic. Because of this, highly sensitive data analysis 
techniques have to be used to calculate the glucose concentration. Commonly used 
multivariate techniques are partial least squares (PLS) and principle component 
regression (PCR) (Heise, Marbach et al. 1992; Bhandare, Mendelson et al. 1993; 
Bhandare, Mendleson et al. 1994; Heise and Marbach 1994; Martens and Naes 1994; 
Jagemann, Fischbacher et al. 1995). Artificial neural nets (ANN), (Patterson 1996), 
have also been used to create calibration models for glucose spectra with some success 
by Jagemann, Fischbacher et al. 1995 . They have also been combined with 
PLS to 
produce a hybrid calibration model by Bhandare, Mendelson et al. 1993. Despite some 
success in measuring glucose using NIRS, the weakness of the spectral signature of 
glucose and the interference from other analytes in the blood makes this method too 
unreliable. 
2.4.3. Photoacoustic glucose sensors 
Photoacoustic spectroscopy (PAS) works by selectively exposing a small volume of the 
liquid to a pulse of focused light; this causes localised heating followed by expansion 
produced. This thermal expansion of the liquid creates an acoustic wave, which travels 
out from the point of illumination. The profile of this acoustic wave is related to the 
geometry and energy of the incident light beam and to the concentration of component 
chemicals in the illuminated region. It is possible to calculate the concentration of 
component chemicals in the solution from acoustic signal measurements (Skoog and 
Leary 1992; Christison and MacKenzie 1993; MacKenzie, Christison et al. 1993). An 
advantage of PAS over normal spectroscopy is that it is less susceptible to scattering 
effects, which interfere with the standard spectroscopy techniques (MacKenzie, 
Christison et al. 1993). This may also offer greater sensitivity than NIRS for the weak 
concentrations such as glucose in blood (Quan, Cristison et al. 1993). This improvement 
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in sensitivity is because all the available energy of the light pulse, including the 
scattered portion, is still involved in the creation of the acoustic wave. In traditional NIR 
spectroscopy a large proportion of the incident light is lost due to scattering 
(MacKenzie, Christison et al. 1993). PAS has been used in a few investigations into 
non-invasive glucose measurement (Pan, Qui et al. 1988; Christison and MacKenzie 
1993; Quan, Cristison et al. 1993). The research into this technique is limited and the 
improvement in reliability over NIRS techniques has not been demonstrated at this time. 
2.5 Miscellaneous techniques 
2.5.1. Optical polarimetry based glucose measurement 
A number of groups have described the development and evaluation of non-invasive 
optical polarimetry systems to monitor in vivo glucose concentration of the eye 
(Rabinovitch, March et al. 1982) looked at the possibility of measuring optical rotation 
in the eye due to the effects of glucose. The apparatus used was capable of resolving 
2x10 4 degrees of rotation, which allowed the detection of glucose down to 0.02% 
concentration. March, Rabinovitch et al. 1982 also carried out an investigation using 
optical rotation to measure glucose concentrations in samples of animal aqueous 
humour. The results showed a limited relationship between the glucose levels and the 
optical rotation. Cote, Fox et al. 1992 performed in vitro studies with solutions of 
glucose from zero to 1000mg/dl (0-55.5mmol/I). They found a correlation coefficient of 
0.997 between polarisation and glucose concentration. More recent studies have also 
suggested that the delay between blood glucose concentrations and glucose 
concentration of the aqueous humor is only in the region of five minutes (Cameron, 
Baba et al. 2001). This technique, like PAS glucose sensing, has not been researched in 
depth and requires more work to investigate whether its performance is suitable for 
treating hypoglycaemia. 
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2.5.2. Raman spectroscopic glucose measurement 
Raman spectroscopy was used in a preliminary investigation on glucose sensing in vitro 
samples of aqueous solutions of glucose. Raman spectroscopy uses the wavelength shift 
in light scattered from the target molecule. The samples of water containing lactic acid 
and urea were illuminated with a laser (514.5 nm) and the Raman scattered light at 90° 
was then collected. The results showed a correlation coefficient between predicted and 
known concentrations for glucose of 0.9952 over a range of glucose concentrations of 0 
to 555 mM/l. Good correlations were also found with lactic acid and urea (Jenkins and 
White 1981; Geotz, Cote et al. 1995/7). However, the wavelengths used in this 
technique will probably not penetrate the skin deeply enough to allow measurement of 
blood rich tissue. 
2.5.3. Modulated laser glucose measurement techniques 
Spanner and Niebner 1996 used three NIR semiconductor lasers each of a different 
wavelength to measure glucose concentrations in aqueous solutions. The measurement 
system combined the laser diodes with a novel modulation technique. The absorption of 
each laser beam was then measured and combined to provide a value of the glucose 
concentration. This system was used to measure a series of glucose solutions from 0 to 
55.5 mM/l (0-1000 mg/dl). A correlation was found between the measured glucose and 
predicted glucose levels of 0.96. Much more research is required to demonstrate the 
performance of this technique before it can be considered as a viable blood glucose 
sensing technique. 
2.5.4. Kromoscopic glucose measurement 
Sodickson and Block 1994 used a technique called Kromoscopic analysis to measure 
glucose concentrations in aqueous solutions. Kromoscopic analysis is based on the 
human colour vision system. Human colour perception can classify the colour of an 
object in real time and without independent measurement of the illuminating spectrum. 
In theory, Kromoscopic analysis could offer the same capabilities. The technique 
worked by using an array of NIR detectors each with a different spectral performance 
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profile. The combination of the response of each of these sensors to the spectra of light 
that has passed through tissue, hypothetically, could be used to calculate the glucose 
concentration. Kromoscopic analysis can also separate pulsate and non-pulsate 
components of the optical signal. This may allow the optical contribution of arterial 
blood in the signal to be isolated from the rest of the tissue and background by taking 
measurements of only the pulsate signal. In vitro experiments were carried out from 0 to 
0.6 mM/l and in varying temperature 0-0.7°C, which have a large effect on optical 
absorption. The experiments showed that the glucose signal could be separated from the 
temperature variations. As with modulated lasers, this technique requires much more 
research to be carried out before it can be considered as a viable technique. 
2.5.5. Measurement of glucose concentrations using scattering of 
light 
As mentioned earlier, in spectroscopic techniques, scattering of light by tissue is a 
constant source of signal loss. However, as opposed to viewing the scattering as a 
barrier to glucose measurement, some investigations have sought to use this scattering 
process as a means to measure glucose concentrations (Kohl, Cope et al. 1994; Maier, 
Walker et al. 1994; Kohl, Essenpreis et al. 1995). A proportion of optical scattering in 
tissue is due to mismatches in the refractive indices of the extra cellular fluid (ECF) and 
the cellular membrane. Changes in glucose levels will in turn change the value of nECF, 
(where nECF is the refractive index for the ECF), whereas the value of ncell, (ncell is 
the refractive index for the cellular membrane), is assumed to be relatively constant. 
Changes in blood glucose levels will cause changes in the value of nECF, So any changes 
in the scattering of blood should be due to changes in nECF, and be related to changes in 
blood glucose levels. An in vivo test on one healthy subject (non-diabetic) was then 
carried out using a spectrometer capable of measuring the reduced scattering coefficient 
of tissue. A relationship was found between blood glucose levels and ngs (Maier, 
Walker et al. 1994). Much more research is required to show the performance of this 
system. 
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2.5.6. Measurement of glucose using electrical capacitance 
A glucose sensor using a capacitance sensor has been reported by Cheng, Wang et al. 
2001. The sensor consisted of an electrode with an insulating polymer layer 
immobilised onto its surface. This polymer layer has glucose receptive sites imprinted 
onto it using electropolymerisation with glucose molecules as a template. Glucose can 
then bind to these sites changing the capacitance of the electrode polymer layer. The 
sensor showed a decrease in capacitance with increasing glucose concentrations over a 
range 0 to 40mM/l in vitro. The sensor showed little or no interference from ascorbic 
acid and fructose. However, signal drift was observed for operational periods of greater 
than 10 hours. The sensors built showed a relative standard deviation of 6% in 
repeatability tests at 5mM/l. As no results for decreasing glucose concentrations were 
given, so the reversibility of the glucose binding process has not been demonstrated. 
2.6 Blood glucose measurement in subcutaneous tissue 
The subcutaneous layer is made up of inhomogeneous connective tissue and blood 
vessels situated below the dermal and epidermal layers (Gray 2000). The interstitial 
fluid in the subcutaneous tissue should reflect the venous glucose concentration closely 
enough to be used as a measurement of core blood glucose levels (Service, O'brien et al. 
1997). 
Subcutaneous implantation removes the dangers posed by clots as no major blood 
vessels are involved; unfortunately, infection is still a risk though this may be reduced 
as the infection would be localised (Pickup and Williams 1997). The sensors would 
probably take the form of a wire style glucose sensor, which would be inserted just 
under the skin (Claremont, Sambrook et al. 1986; Fischer, Ertle et al. 1987; Moatti- 
Sirat, Capron et al. 1992; Bobbioni-Harsch, Rohner-Jeanrenaud et al. 1993). 
There are some differences in the glucose values measured in subcutaneous tissue and 
core blood levels measured with these sensors, particularly during changing glucose 
concentrations (Velho, Froguel et al. 1989; Schmidt, Slutter et al. 1993; Sternberg, 
Meyerhoff et al. 1996; Schmidtke, Freeland et al. 1998). The response of the 
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subcutaneous tissue to the implantation of the sensor and to any infection, which is 
brought with it or gains access to the site later, will affect the performance of the sensor 
(Daley, Shearer et al. 1990). This is due to swelling, oedema and increased glucose 
uptake around the implantation site caused by trauma, infection and the tissues reaction 
to the sensor material. This will all affect the local glucose concentrations and diffusion 
rates from tissue to the sensor (Fisher, Rebrin et al. 1994). The pain of having the sensor 
implanted will also be present, although these problems could be removed by complete 
implantation of the sensor and its associated electronics and power source. 
2.6.1. Completely implanted glucose sensor systems 
A sensor implanted in a dog, which incorporated all necessary telemetry electronics for 
an electrocatalytic enzymatic sensor, operated for three to five months. However, the 
sensor was 7cm in diameter, much of the space was required for the battery supply; a 
sensor this size is impractical for human use (Updike, Shults et al. 2000). A smaller 
device, 26 mm in diameter and with 18 mm depth, has been developed with a battery 
life of one year. Glucose measurement was achieved using an amperometric sensor 
coated with GOD and the signal from glucose concentrations from 0 to 19.35 MM/1 was 
linear in in-vitro tests (Beach, Kuster et al. 1999). Another completely implanted 
electrochemical sensor with its own on board telemetry system tested in healthy dogs 
allowed measurements to be taken at four minutes intervals over a three-month period. 
The sensors consisted of a7x1 cm disc, each with bioprotective membrane to protect 
the active sensing site. Once implanted subcutaneously the sensors initially gave zero 
readings after one to five days of implantation they started producing unstable signals; 
between seven and fourteen days of implantation the sensors presented a stable signal 
that could be used for glucose measurements. The sensors were found to have long-term 
instability (42 days) making them unsuitable for clinical measurements. It was proposed 
that a monthly re-calibration would produce a viable sensor. The range of the sensors 
was found to be limited by tissue oxygen concentrations. Both sensors were found to 
have an in vitro upper limit of 33.3 mMJ1 but different in vivo limits of 27.8 mM/1 and 
17.5 mM/I of glucose. A limited time difference in the order of a few minutes between 
subcutaneous and serum blood glucose levels could be seen in the results. Examination 
of the explanted sensor showed that it had been encapsulated in an outer layer of 
fibrocytes and collagen and an inner layer composed of granulation tissue incorporating 
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many small blood vessels. However, the authors pointed out that the fibrous capsule 
will progressively contain less vascular tissue as time goes on, causing oxygen 
limitation to become an increasing factor with implant age. However, suggestions were 
made that growth factors or microarchitectures may be useful to promote longer-term 
vascularisation (Gilligan, Schults et al. 1994). 
Another method of creating a totally implanted glucose sensors was investigated by 
Tolosa, Malak et al. 1997 who used a Concanavalin-A (Con-A) labelled with a 
fluorescent dye Cy5. The absorption and emission wavelengths of the dye were in the 
near infrared region, allowing the excitation and emission light top pass through the 
skin. The fluorescence lifetime of the dye would be reduced by glucose binding 
reversibly to the Con-A. The sensor proposed would consist of a sample of the dye 
labelled Con-A implanted in the subcutaneous tissue. This would then be excited using 
a light source outside the body and the resulting emission measured and used to 
calculate the concentration of glucose. Fluorescence lifetime changes were measured for 
glucose concentrations from 0 to 100 mM/1 for increasing concentrations in vitro. 
However, problems were encountered with the reversibility of the binding of the Con-A 
and the glucose due to the attachment of the dye which resulted in problems measuring 
decreasing glucose concentrations (Tolosa, Malak et al. 1997). 
2.7 Conclusions of glucose measurement techniques 
The drawbacks of the various measurement techniques are shown in table 5 below. 
Non-invasive glucose measurement techniques, although potentially the most attractive 
approach, have many technical hurdles to overcome before they can produce a reliable 
measurement system. Infrared systems, including photoacoustic techniques, are 
handicapped by the weakness of the glucose spectral signature. The spectral signature of 
the many chemical species further complicates this problem. Alternatively, they rely on 
weak relationships with scattering coefficients or novel measurement systems, which 
are still in very early stages of development. Measurements of the eye require the 
measurement of rotational angles to an accuracy level that is at the limit of current 
technology. Microdialysis measurements, although more reliable, tend to be slow and 
there are questions over how well it represents the tissue glucose concentrations. The 
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electrochemical sensor designs have shown the greatest progress in producing a 
working sensor, however, they are dogged by interference problems. -The most 
promising technology seems to be the fibre-optic sensor designs, especially the GOD 
based systems. These sensor designs can exploit the enzyme membrane technology 
developed for the electrochemical sensors but couple it with an interference free oxygen 
sensing core. 
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Glucose measurement Comments 
technique 
Electrochemical glucose The voltages needed to detect glucose directly leads to interference form 
sensors. other blood constituents. 
Oxygen based electrochemical Improved performance compared to electrochemical glucose sensors but 
glucose sensors. still experience interference. In addition, the use of GOD leads to 
problems of oxygen imitation. 
Radially-symmetric, catalase Improved ability to handle oxygen limitations but still susceptible to 
and mediated oxygen based interference from other blood constituents. 
electrochemical glucose 
sensors. 
Hydrogen peroxide glucose Experiences interference from other blood analytes. Again susceptible to 
sensors. problems of oxygen limitation problems. 
Glucose measurement through The response time of these sensors is too slow to be used as a 
exudates extraction assisted by hypoglycaemic alarm. The damage cause to the skin would also be a 
iontophoresis, ultrasound or problem for diabetics due to their reduced ability to heal (Kayashima, 
suction Arai et al. 1991; Rao, Guy et al. 1995; Kost, Mitragotri et al. 2000). 
Microdialysis sensors The slow response of these sensors probably excludes them for use as a 
hypoglycaemic alarm 
Fibre optic glucose sensors Affinity sensors are too slow and show base-line signal drift. The 
oxygen-based sensors use the same GOD technology as the 
electrochemical sensors but do not suffer from problems of interference. 
With improvement in range and oxygen limitation immunity this type of 
sensor is probably the best candidate as a hypoglycaemic alarm. 
NIRS, Photoacoustic sensors The weakness of the spectral signature and interference from other blood 
analytes makes this technique too unreliable. 
Other techniques These techniques require much more research to demonstrate if their 
performance is suitable for a blood glucose sensor. 
Subcutaneous sensors with Subcutaneous sensors will have to possess a long operational lifetime 
sensor and telemetry (-12 months) to be practical. The discrepancies between blood and 
equipment fully implanted. subcutaneous values will have to be understood and controlled (Updike, 
Shults et al. 2000). 
Table 5. Summary of blood glucose measurement methods 
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3 Principles of glucose oxidase based enzyme sensors 
The sensor presented in this thesis uses a GOD and CAT enzyme layer 
surrounding a fibre-optic oxygen sensor. The details of the chemistry and physics 
of the operation of such enzyme layers are presented in this chapter. 
3.1.1. Basic enzyme theory 
Enzymes are proteins that catalyse specific chemical reactions. Some enzymes 
operate alone, relying only on their protein structure to operate, whilst others use 
cofactors, which can be either, a metal ion or an organic molecule known as a 
coenzyme. Most enzymes have a characteristic pH at which their activity is at a 
maximum (Lehnniger 1972). 
3.1.2. Structure and operation of enzymes 
Each type of enzyme possesses a unique structure, which will accommodate only 
its target chemical species, known as a substrate. This unique structure means that 
the enzyme will only promote one specific chemical reaction involving its target 
substrate. Enzymes operate by binding the target substrates to a specific region on 
its surface called an active site. When the substrates attach to the active site the 
enzyme and the substrates structure are distorted. This combined enzyme- 
substrate structure promotes the chemical reaction between the two target species, 
this is known as the `induced fit' hypothesis. Once combined the new products of 
the reaction detach from the enzyme and leave it free to accept new substrate 
molecules (Mathews and Holde 1990). 
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3.1.3. The Michaelis-Menten relationship 
This relationship defines the rate at which enzymes will catalyse a reaction. 
Considering the most basic case of an enzyme (E), which reacts with substrate (S) 
to form the enzyme substrate complex (ES) as shown in Equation 5. The (ES) 
complex then breaks down to form the free enzyme (E) and the products (P), see 
equation 6. 
k 
Equation 5. E+S 
ýý 
ES 
E 
k2 
k 
Equation 6. ES 
ýý 
E+P 
F 4 
Key to terms used: 
kl to k4 are rate constants for the reactions. 
E Total enzyme concentration (free and combined enzyme). 
ES The concentration of enzyme substrate complex. 
S Total concentration of substrate. 
P Total concentration of product. 
The enzyme reaction has a maximum reaction rate, Vm., also known as a reaction 
velocity, in steady state conditions this reaches a maximum value when there is 
enough substrate in solution to bind with all of the available enzyme (Lehnniger 
1972). 
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The reaction rate (v) is given by the Michaelis-Menten equation shown in 
Equation 7. This equation assumes that there is enough substrate available in 
solution to combine with all of the enzyme present in solution. It is also assumed 
that the rate of the reverse reactions E+P-+EP and ES -aE +S is so small as to be 
neglected. 
Equation 7. v=V 
S] 
The Michaelis-Menten equation KM +[S] 
The Michaelis-Menten constant, KM is equal to the substrate concentration at 
which the velocity is half the maximum possible value. The Michaelis-Menten 
constant has dimensions of moles/litre. The KM constant is an experimentally 
determined value, in an ideal situation it is given by Equation 8. 
+ Equation 8. KM = 
k2 k3 
k 1 
The value of KM is independent of the enzyme concentration but may vary with 
structure of the substrate, pH and temperature. In enzymes which react with more 
than one substrate, each substrate has a KM of its own (Lehnniger 1972). 
3.1.4. Enzyme reactions involving more than one substrate and 
product 
When enzymes react with two substrates and two or more products are produced 
there are three possible ways the reaction can proceed; 
(a) Random substrate binding. 
The two substrates can bind to the enzyme in any order (Mathews 
and Holde 1990). 
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(b) Ordered substrate binding 
One substrate must bind to the enzyme first before the other (Mathews 
and Holde 1990). 
(c) The ping-pong mechanism 
One substrate binds to the enzyme and its product are released. Then 
the second substrate binds to the enzyme and its product is released. 
GOD is thought to follow this type of process (Mathews and Holde 
1990; Wilson and Turner 1992) 
3.1.5. Characteristics and operation of glucose oxidase 
As described in chapter 2, glucose oxidase catalyses the oxidation of glucose to 
produce gluconolactone and hydrogen peroxide as shown in Equation I and 9. 
glucose + oxygen 
glucose oxidase gluconic acid + H202 + 7kcal Equation 1 
(Bourdillon,. Bourgeois et al. 1980; Fisher, Rebrin et al. 1994) . 
Equation 9. C6H1206 + 02 GOD " C6H1006 + H202 
The glucose oxidase enzyme is a dimer composed of two identical subunits to 
form a globular protein of 8nm average diameter. Its molecular mass lies between 
15 151x103 and 186x103 Daltons. GOD has a coenzyme of two flavin adenine 
dinucleotide (FAD) molecules. Its catalytic activity fails at pH values below two 
and greater than eight. Temperatures above 40°C denature the enzyme and the 
activity of the enzyme is inhibited by heavy metals such as mercury, lead and 
silver and a handful of other chemicals (Wilson and Turner 1992). 
52 
3. Principles of glucose oxidase based enzyme sensors 
The overall relation promoted by GOD is believed to operate as follows, the GOD 
first combines with glucose to form: - 
Equation 10. EoX +GK, > Ered +0-d- gluconolactone 
Where Ered is the reduced form of the enzyme E0X is the oxidised form of the 
enzyme and ß-d- gluconolactone is C6H1006 , which combines with water 
to 
form gluconic acid. 
The reduced enzyme then reacts with oxygen to form a hydrogen peroxide 
enzyme complex. This complex then breaks down. 
Equation 11. Ered +02 K E0XH202 -K )E0 +H202 
Therefore, the enzyme has three kinetic constants associated with each step of the 
reaction (k1, k2 and k3). 
GOD has two Michaelis-Menton constants one for glucose at infinite oxygen and 
another for oxygen at infinite glucose concentration. 
The Michalis-Menten constant for glucose at infinite oxygen (Kr, ) is given by: - 
Equation 12. KG = 
K3 
K, 
The Michalis-Menten constant for oxygen at infinite glucose (K0) is given by: - 
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Equation 13. KO = 
K3 
KZ 
The reaction rate (v) (in free solution) is given by: - 
Equation 14. V= 
VmaxCoCc 
CGCO +KGCO +KQCG 
Where Vmax is the maximum rate of the reaction, CG is the concentration of 
glucose and Co is the concentration of oxygen 
(Leypoldt 1981) 
For the free enzyme the overall Michaelis-Menton constant for GOD has been 
found to be between 5.9 and 6.2 mM/l at atmospheric oxygen tensions. When 
covalently bound this rises to 8.8 and 10 mM/1 in atmospheric oxygen (Arica and 
Hasirici 1993) 
3.1.6. Characteristics and operation of catalase 
Catalase uses iron as its coenzyme and has a Michaelis-Menton constant of 25 
mM and an optimal pH of 7.6. The reaction promoted by catalase is shown in 
equation below in Equation 15. 
Equation 15.2H202 CAT > 2H20 + 02 
(Mathews and Holde 1990). 
Combining the enzymes GOD and CAT in a membrane leads to the following 
overall reactions as shown in Equation 17. First, the GOD promotes the 
breakdown of glucose using oxygen and producing gluconolactone and H202. The 
54 
3. Principles of glucose oxidase based enzyme sensors 
CAT then breaks down the H202 to produce oxygen that can be used for oxidation 
of further glucose molecules. The overall reaction is shown in Equations 16 and 
17 and the final reaction is shown in Equation 18. 
Equation 16. C6H1206 + OZ GOD 4 C6H1006 + H202 
(Wilson and Turner 1992) 
Equation 17.2C6H1206 +02 +20 GOD+CAT >2C6HI006 +2H202 
L 20+2H2O 
Which can be written: - 
Equation 18. glucose +- O2 GOD+CAT gluconic acid 
(Tse and Gough 1987) 
In steady state situations one oxygen molecule can be used to oxidise two glucose 
molecules, this will reduce the oxygen requirements of the sensor. Not all of the 
H202 will be available for recycling as a proportion will diffuse out of the 
membrane or break down to hydroxyl radicals before it can be broken down by 
the CAT. Experimentally, the addition of CAT to a GOD based sensor was found 
to reduce the lower oxygen limit of the sensor by 35% (Tse and Gough 1987; 
Chubdova, Vrbova et al. 1996) 
3.2 Polymer matrices used to encapsulate enzymes 
The enzyme membranes have two roles, first they must provide a structure to hold 
the GOD and CAT in proximity to the sensor. Secondly, they alter the 
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performance of the sensors by various physical interactions with the enzymes, 
substrates and products. 
The first of these physical effects is a diffusion barrier to glucose and oxygen, 
hydrogen peroxide and gluconolactone. These diffusion effects are known as 
internal mass transport resistance. Other than diffusion resistances, the physical 
processes of substrate partitioning and boundary layer effects will also affect the 
reaction kinetics described in more detail below. 
There are a variety of materials that have been used as an enzyme support. 
Amongst these are bovine serum albumin (Johnson, Mastrototaro et al. 1992; 
Moussey, Harrison et al. 1993; Yang, Atanasov et al. 1997), cellulose (Yang, 
Atanasov et al. 1997), HEMA (Shaw, Claremont et al. 1991). 
3.2.1. Mass transport resistances 
Mass transport resistances are the resistance to flow that substrates and products 
will experience as they diffuse in and out of the membrane. Glucose and oxygen 
will suffer mass transport resistances when diffusing in and out of the membrane. 
The rate at which H202 and gluconic acid diffused out of the membrane will also 
be reduced (Leypoldt 1981; Cussler 1988; Yang, Atanasov et al. 1997). 
3.2.2. Substrate partitioning 
Substrate partitioning may also affect the reaction rate; this is a process where a 
membrane can hold a greater or smaller concentration of a substrate than would be 
found in free solution. This phenomenon is caused by the polymer chains having 
an overall charge, which repels like charged substrates and attracts oppositely 
charged ones. An example of this is the use of cellulose acetate to reduce the 
interference effect of ascorbate and urate on hydrogen peroxide electrode sensors. 
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The urate and ascorbate are negatively charged and were repelled by the 
negatively charged nafion membrane (Yang, Atanasov et al. 1997). 
3.2.3. Inherent and apparent reaction rates 
The effects of the membrane lead to a modification of the rates of reaction of the 
GOD and CAT immobilised in the membrane. Two modified versions of reaction 
rate are used to represent these effects, these are the inherent and the apparent (or 
effective) reaction rate. The inherent reaction rate is the reaction rate when 
substrate partitioning is present but not mass transport resistance. Apparent 
reaction rate is the reaction rate when substrate partitioning and mass transport 
resistances are present (Leypoldt 1981). 
3.2.4. Boundary layer effects 
As well as the mass transport effects of the membrane there are diffusion effects 
caused by the boundary layer between the liquid and the membrane, this is known 
as external transport resistance. Interestingly, stirring of the solution will not 
remove boundary layer effects (Leypoldt 1981). 
3.2.5. Immobilisation and cross-linking of enzymes 
When GOD and CAT are dissolved with the polymer HEMA in an ethanol water 
mixture and then allowed to dry, the polymer chains will entrap the enzymes in a 
mesh structure or matrix (Shaw, Claremont et al. 1991). To reduce the chances of 
the enzymes being washed out of the membrane or `leached' into the solution and 
to impart improved stability and performance on the enzyme, it has often been 
chemically immobilised. The immobilisation is achieved by creating chemical 
bonds from the enzyme to the polymer lattice or creates bonds between the 
enzyme molecules. Several chemicals have been used for this, including 
glutaraldehyde (Claremont, Sambrook et al. 1986; Armour, Lucisano et al. 1990; 
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Cronenberg, Groen et al. 1991; Zhang and Wilson 1993), urea and formaldehyde 
(Entcheva and Yotova 1994). GOD has also been immobilised using 
electrochemical deposition (Troupe, Drummond et al. 1998). 
3.2.6. Effects of immobilisation on enzyme performance 
Immobilisation can change the Michaelis-Menten constant of the enzymes. This is 
due to steric and conformational changes in the enzymes when it chemically 
interacts with the polymer matrix. In the absence of inherent and apparent kinetic 
effects, this alteration of reaction kinetics is known as the intrinsic kinetic 
parameter. It will often be different from the enzyme kinetics in free solution, this 
effect is combined with the effects of the mass transport resistances and substrate 
partition caused by the polymer support itself. Immobilisation has been found to 
decrease or increase the KM value of GOD compared to free solution (Arica and 
Hasirici 1993). There may be alterations to the enzymes sensitivity to temperature 
and pH stability and irradiation. For example, increased thermal stability of GOD 
of up to 70°C for 1 hour when immobilised onto glass beads with little or no loss 
of activity was reported by Wilson and Turner 1992; Woedtke, Julich et al. 2002. 
3.2.7. The use of polyurethane as a differential diffusion 
barrier 
Several groups have used polyurethane as a differentially permeable barrier to 
improve the range and linearity of oxygen based glucose sensors and to redress 
the stoichiometric problem. In practice, these membranes are created by dip 
coating the sensors in weak solutions of the polymer. This creates a cover over 
only parts of the EH membrane surface; polyurethane was applied to glucose 
sensors in this way by Shichri, Yamasaki et al. 1982; Claremont, Sambrook et al. 
1986; Shaw, Claremont et al. 1991. Instead of using an outer layer, some groups 
have immobilised the GOD into polyurethane. In this case, although the 
polyurethane is hydrophobic, fissures and discontinuities in the membrane allow 
glucose to enter the membrane to a limited extent (Gilligan, Schults et al. 1994). 
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3.2.8. The effect of membrane dimensions and composition on 
sensor performance 
The range, linearity and response time of GOD based glucose sensors are 
controlled most simply by the dimensions and composition of the enzyme 
membrane in which they are coated. Enzyme membranes can operate in two 
modes, reaction control and diffusion control. 
3.2.9. Reaction controlled mode 
In reaction control, the mass transport resistances are negligible and the reaction 
rate is determined by the kinetics of the immobilised enzyme. In this situation, the 
response of the sensor is non-linear and the response time is concentration 
dependent. The sensor response characteristics are also vulnerable to pH changes 
and enzyme deactivation or loss. 
3.2.10. Diffusion controlled mode 
In diffusion controlled mode, pH and enzyme deactivation or loss have little effect 
on the response of the sensor. The response is quasi linear and response time is 
independent of concentration. The sensitivity of the sensor is determined by the 
membrane permeability. To produce a diffusion controlled system the membrane 
must be loaded with a high concentration of enzyme and possess a low 
permeability (Gough, Leypoldt et al. 1982). The diffusion constants of the 
membrane and therefore the response of the sensor are controlled by the 
dimensions, materials used as the polymer support and the immobilisation strategy 
of the enzyme. If a sufficient amount of enzyme is deactivated or lost the sensor 
will revert to a reaction controlled mode. 
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3.3 Mathematical models of enzyme based sensors 
As a tool to aid enzyme based sensor design, several mathematical models of 
immobilised enzyme systems have been created (Schulmeister and Pfeiffer 1993). 
Steady state and `transient responses have been modelled and confirmed 
experimentally. They have also been used to predict sensor responses with some 
success (Leypoldt and Gough 1984; Olsson, Lundback et al. 1986; Tse and Gough 
1987; Lemke 1988; Neykov and Georgiev 1998; Rinken and Tenno 2001). These 
models tend to be large and require rigorous mathematical approaches to their 
solution (Leypoldt 1981; Scchulmeister 1990). Because of their complexity and 
the length of time to produce a working model, as well as the difficulty of 
producing an enzyme membrane to exact dimensions and composition 
experimentally to match a model, no mathematical models were created to aid the 
design of the glucose sensor in this investigation. 
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4 The theory of luminescence based glucose sensing 
The glucose sensor design proposed in this thesis uses a fluorescence oxygen 
sensor as a core coated in GOD enzyme. The oxygen concentrations are measured 
using the interaction of oxygen with a fluorescent dye. Briefly, the dye absorbs 
light at one wavelength and then emits light of a slightly longer wavelength. The 
presence of oxygen reduces the amount of light emitted by the dye, through 
complex electromagnetic mechanisms. The process consumes no oxygen so, in 
this respect, can be thought of as an ideal sensor. 
To understand the fluorescence sensing technique used in this sensor it will be 
necessary to review the fundamentals of luminescence theory of which 
fluorescence is a subset. 
4.1 General luminescence theory and oxygen measurement 
Fluorescence is a form of luminescence, a group of photochemical processes that 
also includes phosphorescence and chemoluminescence. Fluorescence and 
phosphorescence form a sub-group of luminescence called photoluminescence. 
Chemoluminescence involves the emission of light from an electronically excited 
chemical created through a chemical reaction. In fluorescence and 
phosphorescence, the electronic orbits of the chemical (species) are excited by the 
absorption of one or more photons. These excited species then seek to return to an 
electronically relaxed state, as they are compelled to do by the laws of physics. 
They achieve this by releasing their excess energy in the form of a photon. 
The fluorescence process takes a few nanoseconds to complete; in contrast, the 
phosphorescence mechanism can endure for seconds. In both fluorescence and 
phosphorescence, the light that is emitted at the end of the process is usually of a 
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longer wavelength than the absorbed light. This effect is known as a `Stokes 
shift'. Rarely, the emitted and absorbed wavelengths are the same, this is known 
as `resonance fluorescence' (Skoog and Leary 1992). 
4.1.1. Electronic excitation by photon absorption 
When a species absorbs a photon with a wavelength within the visible or ultra 
violet spectrum, the photon interacts with a specific part of the molecule known as 
the chromophore. The choromophore becomes electronically excited and an 
electron in its structure gains energy and moves from a lower energy state to a 
higher one. 
4.1.2. Electronic spin 
Electron spin is a quantum mechanical process analogous to an intrinsic angular 
momentum that can take one of two possible different directions, up or down, 
with respect to a specified axis (French and Taylor 1991). In any electronic orbit, 
there can be a maximum of two electrons following the same orbit and these must 
be of opposite spin as stated by the Pauli exclusion principle. This effect is known 
as spin pairing, even if the electrons move to different orbits they can remain 
paired. If this happens it creates what is known as a singlet state. Even though the 
two electrons are separated if one changes spin the other will change to the 
opposite value. After separation, the electrons can lose their spin coupling to 
create what is called a triplet state and both are free to orientate themselves to 
either up or down spin. 
The difference between fluorescence and phosphorescence is that spins are 
changed in phosphorescence but not in fluorescence. This is the cause of the 
difference in the relative lifetimes of fluorescence and phosphorescence events 
(10"5 to 10"8s) to (10-4 to seconds) respectively. The probability of a singlet to 
triplet or triplet to singlet event is much smaller than a singlet to singlet event. The 
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more likely the event, the more quickly it occurs on average (Gewehr 1991; 
Skoog and Leary 1992). 
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A Jablonski diagram of the molecular energy states of molecules (Gewehr 1991; 
Turo 1991; Lakowickz 1999). 
Figure 11. The energy states of excited molecules and their paths to lower 
energy states 
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4.1.3. De-excitation of electronic energy levels 
Once a species is electronically excited, it has three possible paths to a lower 
energy state. These are a route either through changes in vibrations of the 
structure of the molecule, the release of a photon or a combination of vibration 
and photon release. The release of a photon will only happen if the vibration route 
has a low probability of occurring. As can be seen from figure 11, following the 
absorption of a photon the electron can and usually does move to lower energy 
levels by vibrational relaxation. Even if a photon is emitted, it is usually from a 
lower energy level than the one the molecule was initially excited to. As the 
energy being released is now less than the amount absorbed, the photon emitted 
possesses less energy and therefore a longer wavelength. This causes the `Stokes 
shift' of the wavelength of the emitted photon to a longer wavelength than the 
absorbed photon. 
4.1.4. Internal conversion 
One path by which an electron can move to a lower energy level without releasing 
a photon is internal conversion. It is a complex process, which involves electrons 
jumping to a nearby lower energy level and internal conversion can also cause 
predissociation. In this process an excited electron moves from a higher electronic 
state to the upper vibrational level of a lower electronic state. The energy imparted 
to this vibrational level is enough to rip the bond apart, breaking the molecule in 
two. This has a tendency to occur in large molecules, which tend to contain weak 
bonds between some atoms. 
Another process that can cause destruction of bonds is `dissociation'; in this 
process the electron of the chromophore section of the molecule absorbs so much 
energy from the arriving photons that the bond attaching the chromophore to the 
rest of the molecule ruptures. There is no intersystem crossing involved in 
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dissociation, the molecule is simply broken apart by the energy of the absorbed 
photons (Skoog and Leary 1992). 
4.1.5. Intersystem crossing 
Intersystem crossing is the process where an electron changes spin and moves 
from a singlet to triplet state or triplet to singlet state. It is found more commonly 
in molecules with large atoms or atomic groups such as Cl, Br, I, NO2 and CHO 
(the internal heavy atom effect). In these molecules spin orbit coupling, a process 
where the orbit of an electron causes a magnetic torque on its spin, increases the 
likelihood of a spin change (Gewehr 1991; Turo 1991; Skoog and Leary 1992). 
4.1.6. De-excitation by photon emission 
Fluorescence and phosphorescence are the two processes that allow molecules to 
move to less energetic states by emission of a photon. As mentioned earlier, 
fluorescence involves the release of a photon to allow a molecule to move from a 
singlet state to a ground state with no change in spin. Phosphorescence occurs 
when a photon is released from a triplet state to allow the molecule to drop to the 
ground state following a change in electron spin (Gewehr 1991; Turo 1991; Skoog 
and Leary 1992). 
4.1.7. Quantum yield of fluorescence 
The fluorescent quantum yield can be defined as the ratio of the number of 
photons emitted by a sample to the number of photons absorbed (Gewehr 1991). 
In fluorescence the excited singlet state has three options available to reach a 
ground state shown in figure 11. These routes are internal conversion, intersystem 
crossing (singlet to triplet) and fluorescence with corresponding rate constants, k;,, 
i 
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ksT and kf respectively. The total rate of deactivation of the lowest excited singlet 
state (Si) denoted J; is given in Equations 19 and 20. 
Equation 19. JS = 
d[S, ] 
dt 
Equation 20. J; = -(k f+ k1 + k, 
ý IS1 
where [S1] is the concentration of molecules in the S1 state. 
Fluorescence quantum yield (4k) 
The rate of fluorescence quantum yield can be expressed as Jf= -kf [S, ] and the 
rate of absorption is Ja. In the steady state situation Jo = Js which from the above 
definition of quantum yield gives Equation 21. 
Equation 21. f= 
kf 
kr + k; c +k 
ST 
Is 
Phosphorescence quantum yield (4 v) 
The total rate of deactivation of the lowest triplet state, (Ti in figure 11) is given 
by Equations 22 and 23. 
Equation 22. J! = 
d[T, I 
dt 
Equation 23. J; = -(kp + k, )[T ] 
66 
4. The theory of luminescence based glucose sensing 
kp is the rate constant of phosphorescence, k, ' is the rate constant for intersystem 
crossing from the triplet to singlet state and the concentration of the molecules in 
the Ti triplet state is [TI]. 
Phosphorescence quantum yield is the composite of two other quantities. These 
are the fraction of molecules in the Tl state that emit a photon (a quantity known 
as the phosphorescence quantum efficiency O) and the fraction of molecules in 
the Ti state that cross over to the Sl state by intersystem crossing (known as the 
triplet quantum yield IT) as shown in Equation 24. 
Equation 24. '= 0p *(D T 
Using these definitions of 6p and (DT and the definition of quantum yield we get 
the quantum yield of phosphorescence given in Equation 25. 
k ksr 
Equation 25. (1)p = ,sp 
is 
sT kp + ku kf+k,, +k 
(Gewehr 1991) 
4.1.8. Quenching of fluorescence and phosphorescence 
Quenching is a process where the presence of another molecule causes the excited 
molecule to move from an excited singlet or triplet state to a ground state without 
the release of a photon. Quenching is sometimes divided into two categories, 
dynamic or diffusional quenching and static quenching. Dynamic quenching 
involves an interaction between the fluorophore (fluorescing molecule) and 
quenching species while the fluorophore is in an excited state. Static quenching 
involves the fluorophore and the quenching species forming a complex while the 
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fluorophore is in a ground state (Sharma and Sculman 1999). There are two types 
of quenching mechanisms, photochemical and photophysical. 
Photochemical quenching involves a chemical reaction between the excited 
molecule and another molecule in the solvent or the solvent itself. 
Photophysical quenching does not involve chemical reactions but relies on a 
number of other mechanisms. Photophysical processes are divided into two 
groups. The first group is self quenching where the excited molecule is quenched 
by molecules of its own type. The second group is impurity quenching which 
involves a different species of molecule. Impurity quenching is further subdivided 
into electron transfer, external heavy atom effect and energy transfer (Gewehr 
1991; Turo 1991). 
4.1.9. Electron transfer 
Electron transfer involves two atoms approaching each other closely enough for 
their electron clouds to overlap and electron exchange to take place between the 
excited molecule and the quenching molecule. This allows the excited molecule to 
transfer its excess energy to the quenching molecule via the exchanged electron 
(Turo 1991). 
4.1.10. The external heavy atom effect 
The external heavy atom effect operates in the same manner as its internal 
counter-part, mentioned earlier in section 4.1.5, by promoting changes of electron 
spin causing movement between singlet to triple states. This reduces fluorescence 
or phosphorescence by allowing the excited molecule to de-excite via a different 
route as shown in figure 11. 
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4.1.11. Energy transfer 
Energy transfer involves the transfer of electronic energy from the excited 
molecule to the quenching molecule through either the process of Coulombic 
interaction or the radiative `trivial' mechanism. 
The process of Coulombic interaction involves electrostatic coupling of the 
excited and quenching molecules. The motion of the excited electron around the 
molecular framework of the excited molecule causes its electrostatic field to 
oscillate. This oscillating electrostatic field then causes electrostatic forces to be 
exerted on the electronic structure of any nearby molecule. If the electronic 
structure of the nearby molecule has an appropriate configuration, a resonance 
condition can be set up between the two molecules. This allows energy to be 
transferred between the molecules and leads to the fluorophore being quenched. 
The trivial mechanism involves the excited molecule releasing a photon but this 
photon is absorbed by the quenching molecule. This absorption can only take 
place if the absorbing molecule has the appropriate electronic structure (Turn 
1991). 
4.1.12. The Stern-Volmer equation of quenching 
The Stern-Volmer (S-V) equation relates the quantum yield of phosphorescence 
or fluorescence to the rate of dynamic quenching and the quencher concentration 
(Rasimas, Berglund et al. 1996). The presence of the quenching species gives an 
excited luminescent molecule a new route of deactivation. For the case of 
fluorescence, the rate of deactivation of the Si state, Equation 20, now becomes 
Equation 26. 
Equation 26. J, ,Q= -(k f+k; c +kT+ 
kQ MIS, ] 
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Where kQ is the quenching constant and [Q] is the concentration of the quenching 
species. The quantum yield of fluorescence in the presence of the quencher is 
shown in Equation 27. 
Equation 27. cQ = 
kf 
fkf+k, + k, + kQ [Q] 
The situation for phosphorescence follows in a similar manner with the rate of Tl 
deactivation being given by Equation 28. 
Equation 28. J,, Q = -(kp + k, ý + kQ [Q])[T, ] 
Assuming that quenching only affects the triplet state the phosphorescence 
quantum yield derived from Equation 24 becomes Equation 29. 
k ksr 
Equation 29.1 
p=° sr kp+k, 
s +kQ[Q] 
kf+k,, +ks 
The above equations have assumed that the quenching constant for both 
phosphorescence and fluorescence is the same, this may not always be the case 
and different terms would have to be incorporated into the above equations 
(Gewehr 1991). The S-V equations can be derived by dividing the quantum yield 
without quenching by the quantum yield with quenching. For fluorescence, 
equation 21 is divided by Equation 27 to give Equation 30. 
ST 
Equation 30. 
Of 
=kf+k, ý 
+ k, s + 
kQ [Q] 
ýQ kf +k, c +ksr 
The lifetime of a singlet state is given by: 
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Equation 31. rs1 kf +k,, +ku 
Substituting 31 into 30 yields equation 32. 
Equation 32. Q =1 + kQrs [Q] 
I 
Equation 33. Q =1 + KQ [Q] 
This is the S-V equation for fluorescence quenching. 
For phosphorescence equation 30 is rewritten as equation 34. 
(D 3 
Equation 34. P=kp+ 
kIs + kQ [Q] 
cp pkp+k, ýs 
The lifetime of the triplet state is given by equation 35: 
1 
Equation 35. TT = kp+k, 
s 
Substituting equation 34 into 35 gives equation 36. 
Equation 36. 
(D 
(DP 
=1 + kQrr [Q] 
This can be rearranged, using kQ in place of kQrT, to give equation 37. 
Equation 37. 
±Q 
=1+KQ[Q] 
P 
S-V equation for phosphorescence quenching (Gewehr 1991). 
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4.1.13. Oxygen quenching 
Molecular oxygen is a highly efficient quencher of luminescent species. Oxygen 
atoms have four electrons that are used for bonding. When in it's diatomic form, 
six electrons form bonds between the two atoms. Two electrons go into 
antibonding orbitals that counteract one of the three bonds. These two unpaired 
(not spin coupled) electrons in different orbitals constitute a triplet state (Gewehr 
1991). This triplet-ground state of oxygen, known as 3E oxygen, is composed of 
two individual triplet states termed 10 oxygen and 1E oxygen. Due to this 
electronic structure, oxygen has very low excitation energies. This makes it a very 
efficient quencher of a large number of different fluorophores through energy 
transfer mechanisms and will quench both singlet and triplet states (Turo 1991). 
A modified S-V equation is used to describe quenching by oxygen as shown in 
Equation 38 and 39. 
Equation 38.1° = 
z° 
Iz 
Equation 39. 
j 
10 
=1 + kg zo [O2 ] 
(Gewehr 1991) 
Where Io , To are the intensity and lifetime at zero oxygen concentration and I, t 
are the intensity and lifetime at oxygen concentration [02]. Using a modified 
Smoluchowski equation (used to describe diffusion-reaction processes) to 
describe kg. The value of kg is dependent on the physical constants of the system. 
Equation 40. kg = 4, r1VP (DD + DA )103 
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N is Avagadro's constant, p is a constant which is determined by the value of the 
radius of interaction of the oxygen and the species that is quenched and the 
probability of each collision. The constants DD and DA are the diffusion constants 
for diffusion of the donor (the quenched species) and the acceptor (oxygen in this 
case) (Gewehr 1991; Turo 1991). 
4.1.14. Oxygen sensitive luminescence dyes 
Oxygen can be measured using both fluorescence and phosphorescence 
quenching. Fluorescent measurements use ruthenium complexes (Shahriari, Ding 
et al. 1993; Singer, Duveneck et al. 1994; McEvoy, McDonagh et al. 1996; 
McNamara, Li et al. 1998). A phosphorescence quenching oxygen measurement 
using metalloporphyrin was reported. This measurement system used 
phosphorescence lifetime measurements, which have a number of advantages over 
fluorescence measurements. However, fluorescence intensity measurements have 
been a more common method of measuring oxygen due to the availability of the 
problem of finding a suitable phosphorescence dyes (Gewehr and Delpy 1993). 
4.2 Conclusions of luminescence theory 
Phosphorescence lifetime quenching has several advantages over fluorescence 
measurements. It is unaffected by background light level and immune to 
variations in the excitation light pulse intensity. However, the lack of 
phosphorescence dyes stability at room temperature has been a problem and has 
led to fluorescence intensity measurements to dominate. 
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5 Experimental instrumentation and materials 
5.1 Introduction 
In this section, all of the apparatus and materials that were used in the 
experimental work will be described. 
5.2 The Paratrend 7 multi-parameter blood gas monitor 
The glucose sensor was developed by modifying a commercial blood oxygen 
sensor, the Paratrend 7 (P7) intravascular blood gas monitoring system. The P7 is 
produced by Diametrics Medical Ltd of High Wycombe, UK. The system 
continuously measures the temperature, pH, carbon dioxide (C02) and oxygen 
(02) tensions of arterial blood. The P7 sensing element, which is inserted into an 
artery, consists of a 0.5 mm diameter bundle of three fibre optic sensors and a 
thermocouple temperature sensor. All four sensors are encased in a biocompatible 
microporous hollow fibre (MPHF) as shown in figure 12. Photographs of the 
system are shown in Appendix B. 
The pH, CO2 and 02 measurements are made by the three fibre optic sensors and 
the temperature by a thermocouple. The pH and CO2 sensors are not used in this 
study and so will not be described any further here. The full P7 clinical system 
includes gas cylinders for calibrating the sensors, a display, controls and a printer 
system. All of the electronics needed to take the measurements are housed in the 
patient data module (PDM). 
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5.2.1. The P7 oxygen (P02) and temperature sensors 
As the research will only make use of the P02 sensor and the thermocouple these 
are described in detail here. 
The P02 sensor uses a fluorescence technique to measure oxygen. This involves 
using a fluorescent dye, ruthenium chloride (Chapter 4). When exposed to light of 
wavelength 470 nm (absorbance wavelength), the dye will absorb the light and 
then emit Stokes shifted light (emission wavelength) of 615 nm. The ruthenium 
dye is quenched by oxygen and therefore does not radiate the emission light. The 
amount of quenching and, therefore, emission intensity is proportional to the 
concentration of oxygen molecules in the surroundings of the dye. By measuring 
the intensity of the emission wavelength of the dye, the oxygen concentration can 
be calculated. The sensing area of the P02 sensor is shown in figure 13. 
The P7 is in clinical use in several countries. It is used in critical care situations 
and monitoring of neonates. The performance of the oxygen and temperature 
sensor in vitro and in vivo (in human clinical trials) are shown in table 6 and 7. 
Sensor type Oxygen (P02) Temperature 
Range 20 to 500 mmHg (2.7 to 66.7 KPa). 10 to 42 °C 
Accuracy ± 5% <120 mmHg (16.0 KPa) 
± 10%?: 120 mmHg (16.0 KPa) 
± 0.2 °C 
Drift <1 %/hour None 
Response time 0% to 90 %: 5 180 seconds @ 37 °C As P02 
Shelf life 12 months 12 months 
Table 6. The In vitro Performance of the Oxygen and Temperature Sensors in the P7 
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" These are the results of in-vitro tests of the sensors in tonometered solutions. 
Sensors meet 95% confidence limits of these specifications. The sensors are 
sterilized by gamma radiation exposure of >_ 25 kGy. 
Bias 0.5%, 0.4 mmHg (0.005 KPa) 
Precision 13.2%, 16.4 mmHg (2.186 KPa) 
Range 32 - 489 mmHg (4.266 to 65.195 KPa) 
Correlation coefficients 0.944 
Table 7. In vivo Performance of the P7 Oxygen Sensor 
Sensors were implanted into the femoral, radial or brachial arteries of 37 human 
subjects. The measurements taken were compared with a blood gas analyzer 
(BGA). The mean monitoring time was 87.5 hours with a total of 3764 hours of 
monitoring for all the sensors (Diametrics Medical Ltd., internal document). 
There are a number of papers on the application of the Paratrend 7 in the 
published literature. However, there are two versions of the P7 in use at time of 
print, one using a fluorescence oxygen sensor and the other using an 
electrochemical oxygen sensor. None of the papers published state which oxygen 
sensing system is being used in the research so the internal Daimetrics documents 
will be the source of reference of the performance of the P7 sensor. 
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Ruthenium filled hole I of 5 
Silicone carbinol outer layer 
. /encansulatino nitheninm 
error 
Excitatioi 
470nm 
Fluore: 
signal 
615nm 
a thin cladding of a fluorinated resin. 
Figure 13. The design of the fibre-optic oxygen sensor 
The dye filled holes in the fibre are each drilled at a different angle around the 
axis of the fibre. This results in the entire cross section of the fibre being covered 
by a ruthenium filled hole as shown in figure 14. 
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5. Experimental instrumentation and materials 
5.3 The fibre optic light delivery and collection system of the 
oxygen sensor 
The optical delivery and collection system of the oxygen sensor is shown in figure 
15. The fibre-optic cable of the oxygen sensor is connected to a bifurcated optical 
fibre bundle. One of the branches of the bundle is connected to a blue LED of 
peak wavelength 470nm, which generates the light that is used to excite the 
ruthenium dye. The other branch of the fibre-optic bundle is connected to a 
photodiode, which is used to measure the emission light intensity. An optical filter 
placed in front of the photodiode is used to remove wavelengths other than the 
fluorescence emission of the dye that arrive at the detector. 
The blue LED is pulsed at a frequency of approximately 1 Hz, this light pulse 
passes down the fibre bundle to the single fibre containing the fluorescent dye in 
holes in its tip. The light pulse then continues to the dye filled holes where a 
proportion of it is absorbed by the dye. The remainder of the light, which has not 
been absorbed, carries on to the end of the fibre where it is reflected back by a 
mirror on the tip of the fibre. The pulse then travels back along the fibre and is 
partially absorbed by the dye. 
Once excited, the fluorescent dye emits light in all directions but a proportion of it 
travels either back down the fibre, towards the optical bundle, or in the direction 
of the mirror where it is reflected towards the fibre bundle. When the light reaches 
the fibre bundle junction, half of it travels down the branch that is connected to 
the photo-detector where its intensity is measured. 
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5. Experimental instrumentation and materials 
5.3.1. Compensation of changes in optical efficiency of the 
measurement system 
If the sensor is moved during operation, the optical efficiency of the system (the 
amount of light lost as the signal passes through the fibre) will change. This will 
cause an unpredictable variation in the intensity of the emission and excitation 
light signals and therefore an error in the oxygen measurement. To compensate for 
this a second LED, situated next to the excitation LED, launches a reference light 
pulse that is sent down the fibre and follows the same path as the excitation and 
emission pulses. 
The reference light pulse is launched in-between the fluorescence measurement 
signal pulses and so does not interfere with the measurement itself. The reference 
light pulse does not excite the fluorescent dye as its wavelength is too long. 
However, the intensity of the pulse will be altered by changes in the optical 
efficiency of the optical system. The reference light pulse passes through the 
optical filter, in front of the photo detector, as it has the same wavelength as the 
fluorescence emission signal of the dye, and is measured by the same photodiode 
used for the oxygen measurements. The oxygen measurement signal is then scaled 
to the reference signal so that optical efficiency effects are removed. 
5.3.2. Application of the S-V relationship to the P7 oxygen 
measurements 
The oxygen concentration is calculated from measuring changes in the intensity of 
the emission light from the fluorescent dye using the S-V relationship discussed in 
Chapter 4. The equations have to be modified slightly to take account of the 
reference pulse and any interference light, which may have entered the optical 
fibre from outside. 
83 
5. Experimental instrumentation and materials 
Blue LED excitation 
470 
light pulses 
615 
.. 
Wavelength 
Fluorescence 
emitted light 
Figure 16. The spectral distribution of the LED and fluorescence signals, 
which are used in the sensor 
From figure 16, it can be seen that the excitation LED spectra overlaps with the 
fluorescence emission spectra of the dye. In addition, it has been found during the 
sensor development at Diametrics that some of the dye immobilised in the silicone 
rubber does not quench in the presence of oxygen but does fluoresce. Both of 
these facts have to be taken into account when the S-V calculations are made. The 
calibration LED intensity measurements also have to be considered to improve the 
accuracy of the oxygen measurement. 
First, the optical path calibration measurements are taken into consideration by 
scaling the fluorescent emission signal to the intensity of the reference signal to 
give the term R, referred to as the modulation, as shown in Equation 41. R is the 
ratio of the fluorescent signal to the reference signal. 
Equation 41. R= 
Fluorescent signal 
Reference signal 
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The overlap of the excitation and emission spectra, figure 16, and the contribution 
to the signal of dye that does not quench but does fluoresce are dealt with using 
the term C shown in Equations 42 and 43. 
The fluorescent signal when no oxygen present Io is shown below in Equation 42. 
In this situation, the emission of the fluorescent dye will be at a maximum. 
Equation 42.10 = (R0 - C) 
With oxygen present, the fluorescent signal decreases. As the dye is quenched to a 
value I shown in Equation 43. 
Equation 43.1= R-C 
Incorporating these new terms for 10 and I into the S-V (equation 39, chapter 4) 
gives Equation 44. 
The S-V equation derived in Chapter 4. 
Equation 44. 
j° 
=1+kgro[O2] 
This can be rearranged to Equation 45. 
Equation 45. [02 ]= 
ILO 
-1 * kgro 
The term m can be used to replace k T0 
=m 
g 
relationship shown in Equation 46. 
to give new form of the S-V 
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Equation 46. [02 ]=I -1 m 
Replacing the terms for I and Io yield s the modified S-V equation used in the P7 
oxygen sensor, as shown in Equation 47. 
Equation 47. [02]--L 
(R° - C) 
-1 m (R-C) 
The value m is the quenching efficiency, its value equates to the resolution of the 
sensor over a given oxygen range. 
Equation 47. has two unknown constants, C and m, as there are two unknowns, a 
three point calibration will therefore be needed to find these values. These are 
provided by the three calibration gas mixtures, which have precise 02 
concentrations covering the operational range of the sensor (Diametrics internal 
document). 
5.3.3. Calibration cycle of the P7 oxygen sensor 
The sensor is exposed to each of the three calibration gas mixtures in turn and the 
fluorescence intensity measurements are taken for each of the oxygen tensions in 
the three gas mixtures. With the three oxygen tensions and intensity 
measurements, the sensor is calibrated over its operational range. The calibration 
gas mixtures are; (a) 2% CO2, balance N2, (b) 5% C02,15% 02, balance N2 and 
(c) 10% CO2,50% 02 balance N2. Each gas is passed through a solution 
containing the sensor for ten minutes to ensure that the gas tensions have reached 
equilibrium within the solution. The solution is heated and maintained at 37°C 
throughout the calibration cycle. The calibration chamber (shown in figure 17) is 
also the storage container for the sensing end of the sensor, protecting it from 
damage and keeping it sterile until use (Internal documentation, Diametrics 
medical Ltd). 
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Figure 17. The P7 calibration and storage tonometer 
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Material Properties Supplier 
Glucose-oxidase Glucose oxidase (ß-D-Glucose: Oxygen 1- Sigma Aldrich 
(GOD) Oxidoreductase; EC 1.1.3.4) Co Ltd, Poole, 
From Aspergillus Niger Dorset, UK 
Activity form 50 to 229 unites/mg Unit 
definition: One unit will oxidise 1.0 
micromole of ß-D-Glucose to D-gluconic 
acid and H202 per minute at pH 5.1 at 
35°C. (If reaction is saturated in oxygen, 
the activity may increase 50-100%) 
(Sigma product numbers G9010, G2133 
and G7016) 
Phosphate Dissolve 1 tablet in 200 ml water to obtain Sigma 
Buffered Saline a 137 mM NaCl, 2.7 mM KCl and 10 mM 
(PBS) phosphate buffer solution, pH 7.4 at 25°C. 
(Sigma product number 79382) 
Catalase (CAT) Catalase: H202 (H2 oxidoreductase: EC Sigma 
1.11.1.6) 
From Bovine Liver 
Activity: 2000 to 5000 units per mg 
protein 
One unit decomposes 1.0 pmole of H2O2 
per min at pH 7.0 at 25°C, while the H2O2 
concentration falls from 10.2 to 9.2 mM. 
(Sigma product number C9322) 
HEMA HEMA: Poly(2-hydroxyethyl Sigma 
methacrylate) 
[-CH2C(CH3)(CO2CH2CH2OH)-](Sigma 
product number 192066 and P3183) 
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Glutaraldehyde Glutaraldehyde: Pentane-1,5-dial Sigma 
C6H802 
(Sigma product number G765 1) 
Tetrahydrofuran C4H80 Sigma 
(THF) (Sigma product number T4303) 
Ethanol 90% v/v Fisher Scientific 
C2H50H UK Ltd, 
(Fisher code F/0400/08) Loughborough, 
Leicestershire, 
UK 
Polyurethane Estane 5714 Goodrich 
Thermoplastic polyether based chemicals, 
polyurethane Hunslow, 
Middlesex, UK 
Glucose D-Glucose (Sigma code G-7528) Sigma 
C6H1206 
Precision gas 100% Nitrogen Linde Gas Ltd 
mixtures : - 7.5% oxygen balance nitrogen Newfield 
15% oxygen balance nitrogen Industrial estate, 
50% oxygen balance nitrogen Stoke-on-Trent, 
Staffs UK 
Table 8. Chemicals used in the research 
89 
5. Experimental instrumentation and materials 
5.4 Apparatus to control solution gas tensions and 
temperature 
The sensors were tested in a purpose built test apparatus shown in figure 18 based 
on the design developed by Diametrics Medical Ltd. at their High Wycombe, UK, 
site. The apparatus allows phosphate buffered saline (PBS) to be aspirated with 
precision gas mixtures. The temperature of the solution was also maintained at 
37°C by means of a water bath. The precision gas mixtures consisted of (a) pure 
nitrogen, (b) 15% oxygen balance nitrogen and (c) 50% oxygen balance nitrogen. 
These were adaptations of the P7 calibration gas mixtures, which also contain 
carbon dioxide for calibration of the pH and CO2 sensors, that were not used in 
this work. The humidifiers and tonometers were filled with PBS to ensure a pH of 
7. The experiments were carried out in 50 or 100ml of PBS at 37°C equilibrated at 
gas tensions of 15% oxygen and 85% nitrogen or 7.5% oxygen and 92.5% 
nitrogen that were aspirated into the tonometer at a rate of either 50 or 
100cm3/minute. 
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meter 
Glassware supplied by Robal Microspec. High Wycombe. UK. 
Figure 18. The humidifier and sinter 
As the precision gas mixtures are stored in a dry state, they are first passed 
through the humidifier to ensure that the gas has the correct saturated water 
vapour pressure (SVP). The sinter at the base of the humidifier is to ensure the gas 
was dispersed thoroughly throughout the liquid to increase the rate the gas 
dissolves into solution. The gas is then passed into the tonometer. where a second 
sinter ensures full aspiration of the tonometer solution. The tonometers and 
humidifiers are placed into a water bath maintained at 37°C. Five identical 
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humidifier-tonometer systems were used in the test apparatus. Three were used to 
calibrate the sensor, each one aspirated with one of the calibration gasses. When 
the auto. calibration process could not be used, the remaining two systems were 
used for testing the glucose sensors. 
92 
6. Sensor development and testing 
6 Sensor development and testing 
6.1 Introduction 
This chapter describes the development and testing of the glucose sensor 
produced in this research. The glucose sensor was created by coating the P02 
sensor of the P7 with the enzyme GOD held in a polymer support. The P02 
sensor was then used to measure the reduction in the partial pressure of 
oxygen inside the GOD layer. This oxygen reduction was caused by the 
oxidation of glucose promoted by the GOD enzyme. With this initial design, 
glucose was detected in solution at concentrations of up to 4mM/1 in 15% 
oxygen tensions. The sensor design was then improved by the addition of a 
second enzyme CAT to the membrane. This enzyme served the duel role of 
protecting the GOD and increasing the range of the sensor to cover higher 
concentrations of glucose up to 25mM/1 in 15% oxygen tensions. A range of 
membrane coating techniques and additional membrane materials were then 
investigated with the aim of producing a sensor of the desired characteristics 
stated in Chapter 1. A sensor thought to be potentially capable of acting as a 
hypoglycaemic alarm or to be used for insulin adjustment was produced. This 
design of sensor was tested in physiological pH (7.4), temperature (37° C), 
and oxygen tensions (7.5KPa) were produced. Finally, these sensors were 
tested for their ability to survive storage (3 months) and sterilisation by 
exposure to gamma radiation. Although suffering some changes in 
performance, the sensor design was found to still function after both these 
trials. 
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6.2 Fabrication of the glucose sensors membranes 
As discussed in Chapter 2, the diffusion reaction-characteristics of enzyme 
membranes control how the sensor will perform. The reaction-diffusion 
process is controlled by the composition and thickness of the membrane 
coated onto the oxygen sensor. 
To produce the enzyme membranes, GOD and CAT were dissolved in 
distilled water or PBS solution and mixed with HEMA dissolved in ethanol. 
The sensors were then dipped into the mixture to coat the sensors in a thin 
layer of the enzyme HEMA (EH) mixture. As the sensor design improved, the 
composition of the mixtures was changed to improve the coating of the 
sensor. To improve the immobilisation of the GOD and CAT in the 
membranes, the enzymes were cross-linked (chemical connections formed) 
by dipping the coated sensors into glutaraldehyde. 
6.3 Testing of the sensors performance 
The sensors were tested in solutions of PBS of controlled temperature, pH 
and oxygen tension using the apparatus described in Chapter 5. Glucose 
concentrations were increased by adding appropriate volumes of 1M glucose 
solutions to the tonometer, using a precision pipette (Pipetteman P200 and 
P1000 Gilson Inc USA) the increases were made in controlled steps, usually 
1mM/1. Decreases in glucose concentrations were achieved by adding 
appropriate volumes of PBS equilibrated at the required gas tensions and 
temperature. 
94 
6. Sensor development and testing, 
6.4 Initial experiment on a modification of the P7 sensor 
to detect glucose. 
This initial experiment was carried out to investigate if the principle of the 
sensor design was sound. The experiment simply involved dip coating a P7 
sensor in an EH mixture. In theory, this should create a sensor whose oxygen 
reading is proportional to the concentration of glucose in the solution. 
6.4.1. Sensor construction and testing 
Sensor 1 was made by dip coating the P7 sensor into an EH mixture that 
contained 100 mg/ml of HEMA in a 75% ethanol and distilled water, figure 19. 
The enzyme solution consisted 70mg of GOD dissolved in distilled water. This 
was mixed with the above HEMA solution in a 5: 1 ratio to form a homogenous 
suspension (Shaw, Claremont et al. 1991). The P7 sensor was left intact, 
although it was allowed to dry out for 30 minutes before coating that would 
damage the pH and CO2 sensors. 
After being dip coated in the EH layer, the sensor was allowed to dry for a 
further 30 minutes and then rinsed with PBS. The sensor was then placed into a 
tonometer containing PBS at 15 % oxygen, balance nitrogen aspirated into the 
tonometer at 100 cm3/min and tested. The P7 oxygen sensor had already been 
calibrated in the P7 base unit before it was dip coated. Calibration following 
coating would have been preferable, however, once removed from its calibration 
tonometer, the sensor could not be replaced; hence, post coating calibration was 
not possible. Once a steady signal was observed from the P02 sensor, glucose 
solution was added to the tonometer to raise the glucose concentration in steps of 
1 MM/l. 
The results of the initial glucose test of sensor one are shown in figures 20 and 
21, which are scans of printouts from the P7. Figure 20 shows the response of 
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the sensor to an increase of from 0 mM/l to 1 mM/l of glucose. Figure 21 shows 
the full range of the sensor, demonstrating that after the glucose concentration 
reaches 3mM/l the sensor no longer responds to increases in glucose 
concentrations. 
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6. Sensor development and testing 
6.4.2. Results of the tests of the prototype sensor, 
Sensor l 
The results of the initial test, the addition of the HEMA laver and the 12-hour 
glucose solution test, are shown in figure 21 and Table 13. 
Figure 20. The P7 printout of a glucose step from 0 to l mM/l for sensor 1. 
The temperature was intended to be 37 °C. however, the water bath available at 
this time had poor thermostatic control, and caused the temperature to vary from 
the desired value. It can be seen here that the temperature of the solution was 
41°C. 
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Figure 21. The P7 printout of P02 values against time for increasing 
glucose concentrations before the outer HEMA coat was added. 
6.4.3. Extension of the range of sensor I using an outer HEMA 
coat 
Having shown that the basic design of the sensor was sound. it was decided to 
attempt to increase the range of the sensor using a diffusion limiting outer 
membrane. } IEMA was readily available and so it was decided to dip coat the 
sensor in a layer of HEMA. 
Sensor I was then dip coated in the HEMA solution used in its construction and 
re-tested. using the protocol described above. Finally, to test the longevity of the 
sensor. it was left in solution containing 6 mM/l overnight (approximately 12 
hours). This is roughly the blood glucose concentration of a healthy individual. 
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From figure 22 and Table 10, it can be seen that the addition of the HEMA layer 
caused the range of the sensor to double from 3 to 6 mM/l. and increase in the 
sensitivity of the sensor from 0.7 to 1.1 KPa/mM/l. There was no corresponding 
increase in the 90% response time of the sensor. After 12 hours in 6 mM/l of 
glucose, figure 23, both the range and sensitivity of the sensor had decreased from 
6 to 4 mM/1 and 1.1 to 0.4 respectively. Also the response time has increased by a 
factor of three. Table 9 shows the experimental conditions of the three 
experiments. 
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The sensor with only the EH coating _0- , after the addition of the outer HEMA 
coating --1- and after being left in 6mM/1 of glucose PBS overnight at 
atmospheric gas tensions and room temperature -A- . The temperature of the 
tonometer solution for the outer HEMA coat experiment was 39.9°C and for the 
post over night experiment was 38.9°C. 
Figure 22. A plot of glucose concentration against P7 oxygen reading for 
Sensor 1. 
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Figure 23. The response of Sensor I after 12 hours in glucose 
concentration of 6 mM/1 
is of -q c o_c 
-50-2 
41 
a1 G0 
Initial 
experiment 
With outer 
HEMA coat 
After 12 hour run 
Atmospheric pressure (KPa) 100.1 100.1 ' 99.92 
Temperature (°C) 41.0 36.1 38.9 
Dry P02 tension (KPa) 15.0 15.0 14.9 
SVP corrected P02 tension 
(KPa) 
13.8. 14.1 13.9 
' Taken at start of initial experiment 2 Taken at end of experiment 
All atmospheric pressure measurements were taken using the barometer on board 
the P7. 
Table 9. The oxygen tensions and SVP adjusted partial pressures used in the tests of Sensor 1 
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" Sensor 1 with Sensor 1 with Sensor 1 with extra 
only HEMA extra outer outer HEMA layer 
and enzyme HEMA layer after 12 hours 
coating 
Operational range 0-3 0-6 0-4 
(MM/1) 
Linear range (mM/1) 0-3 0-5 0-4 
Sensitivity 
(over linear range) 0.7 1.1 0.4 
(KPa/mM/1) 
Approximate 90% 
Response time 
<100 <100 100 to 200 
(over linear range) 
(seconds) 
Table 10. The characteristics of Sensor 1 
The response times of the sensor are only approximate values because it was 
impossible to know the rate at which the added glucose mixed with the PBS 
solution. 
6.4.4. Conclusions of the initial glucose sensor tests 
The prototype sensor has proved very successful; it covers the healthy and 
hypoglycaemic range and has response times well within those desired. The 
sensor does respond to the presence of glucose in solution, so the theory of the 
sensor design has been shown to be sound. However, even in this elevated oxygen 
tension of 15%, which is above those seen in subcutaneous tissue, its range is 
limited to 6 mM/l and its operation is significantly degraded by exposure to 
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glucose solutions of 6 mM/l for a 12 hours period. The increase in 90% response 
time of the sensor may indicate that it is now operating in reaction-controlled 
mode due to enzyme deactivation, as described in Chapter 3. The range of the 
sensor will have to be increased and the operational stability will have to be 
improved if this were to become a practical blood glucose sensor. This should be 
achievable with better enzyme loading and immobilisation and the use of 
diffusion limiting membranes. The use of polyurethane in particular should help 
the sensor to operate in physiological oxygen tensions. 
The HEMA outer coat has been shown to extend the range and sensitivity of the 
sensor without increasing response time. This is encouraging from the point of 
view of using it to extend the range of the sensor. 
The readings of the P7 oxygen sensor are above the SVP corrected values, even 
when the error of the sensor (± 5%) is taken into account the reading is still 
approximately 0.5KPa above the correct reading. This could be a result of damage 
to the sensor during construction or the experimental conditions, such as 
temperature or gas tension errors. As the sensor is dried out during construction, 
there will be some shrinkage and then re-expansion of the membrane in the 
sensor. This could have a detrimental effect on the oxygen sensor leading to 
performance characteristics outside of those expected during the oxygen sensor 
calibration procedure. The elevated temperature of the first experiment (41 °C) is 
unlikely to be the source of the problem, as the oxygen reading would be lowered 
rather than increased. This is due to the greater value of water vapour pressure at 
this temperature than at 37°C, which the P7 is calibrated to operate. It is possible 
that the gas has not reached full saturation with water vapour during its passage 
through the humidifier. 
Ideally the sensor design would have been improved in single steps, however, as 
there was only a small number of P7 sensors available for experimentation, two 
features were put into the next sensor. 
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To improve the range of the sensor, a thicker outer HEMA coat was employed in 
the next sensor and, to improve the operational stability, CAT was included in the 
EH layer. This should protect the GOD in the sensor from the action of H2O2, 
which was possibly the cause of the degradation seen in the previous sensor. 
6.4.5. Construction and testing of Sensor 2 
Sensor 2 used GOD and CAT in its EH layer. The CAT has two roles, first to 
recycle oxygen from the H202 to help redress the stoichiometric limit and 
secondly, protect the GOD as described in Chapter 2. Sensor 2 was also dip 
coated twice in HEMA to provide a diffusion limiting outer layer of twice the 
thickness of that used in Sensor 1. With these two features, it was expected that 
the range of the sensor would be greater than Sensor 1. 
The EH layer consisted of 0.5m1 of 2400 active units/ml of GOD' and 360,000 
units/ml of CAT dissolved in distilled water. This was mixed with 0.5m1 of 
HEMA solution containing 100mg/ml of HEMA dissolved in 75% ethanol water. 
The same HEMA solution was used for dip coating the sensor to produce the 
outer membrane. The experiment was extended to include a test of the sensor's 
response to decreasing glucose concentrations. The decreasing glucose 
concentrations were achieved by adding appropriate volumes of PBS to the 
tonometer, which had been equilibrated at the appropriate temperature and oxygen 
tensions. 
The results of the sensor tests are shown in Figure 24,25 and Table 12. It can be 
seen that the sensor reading at 0 mM/1 of glucose is below the 14.0 KPa. The 
sensor showed a maximum response to glucose concentrations of up to 7 MM/l, 
only 1 mM/1 greater than the maximum response to glucose of Sensor 1. Also, at 7 
1 The difference in this and the previous GOD value was due to small variations in weighing out of 
the GOD. 
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mM/l a large amount of noise was seen in the signal from Sensor 2, this was in the 
order of ; tý0.5KPa, 50% of the sensitivity, as can be seen in figure 25. Lowering 
the glucose concentration caused no change in the signal from the sensor, which 
remained at 4.2 KPa, the same reading as 7 mM/l of glucose, still exhibiting the 
noise observed at the end of increasing glucose concentrations. There was little 
difference in the sensitivity of Sensors 1 and 2, with sensitivities of 1.1 KPa/mM/l 
and 1.2 KPa/mM/1 respectively. The experimental conditions are shown in Table 
12. below. 
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Figure 24. The performance of sensor 2. The oxygen signal from the 
enzyme coated P7 oxygen sensor against glucose concentration. 
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Figure 25. The response of Sensor 2 to increasing and decreasing glucose 
concentrations. 
Sensor 2 
Operational range (mM/1) 0-7 
Linear range (mM/1) 0-6 
Sensitivity 
(over linear range) l 
(RPa/mM/1) 
Approximate 90% 
Response time 
<100 
(over linear range) 
(seconds) 
Table 1 1. The performance characteristics of Sensor 2 
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Atmospheric pressure 
99.92 
(KPa) 
Temperature (°C) 37.6 
Dry P02 tension (KPa) 15.0 
SVP corrected P02 tension 
14.0 
(KPa) 
Table 12. The experimental conditions during the testing of sensor 2. 
6.4.6. Conclusions of sensor 2 experiments 
Sensor 2 shows little improvement on the performance of Sensor 1. The lack of 
response of the sensor to decreasing glucose concentrations could have been a 
fault with the experiment, possibly with the temperature or oxygen tension of the 
solution that was added to lower the glucose concentration. These may have 
equilibrated with the atmospheric gas tensions and temperature during the transfer 
of the solution between the tonometers. However, temperature is lower than the 
tonometer and the atmospheric oxygen tension is greater than those of the 
solution. As the solubility of oxygen in water increases with decreasing 
temperature so the lower temperature would cause increased oxygen tension in the 
solution. This is coupled with the atmospheric oxygen tension that the fluid is 
temporarily exposed to, being higher than the 15% supply, so that had the fluid 
absorbed oxygen from the atmosphere again an increase in oxygen tension should 
have been observed. Therefore, the oxygen tension of the solution would have 
increased instead of reduced. Because of this, these causes were discounted. The 
double HEMA coat did not increase the range by a large amount and, most 
importantly, the sensor did not respond to decreasing glucose concentrations. The 
2 Atmospheric pressure taken using the onboard P7 barometer at the start of the experiment 
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next sensor constructed was given a thinner HEMA layer to investigate if this will 
allow the sensor to measure decreasing glucose concentrations. Although not 
thought to be a factor, the transfer of the solution for dilutions will be carried out 
more quickly to reduce changes in temperature and oxygen tensions in transit. 
6.4.7. The detection of decreasing glucose concentrations 
Sensor 3 had essentially they same design as Sensor 2, except that it was only dip 
coated in HEMA once instead of twice as with Sensor 2. The EH solution was 
identical to those used in sensor 2. When a glucose concentration of 5mM/1 had 
been reached, PBS equilibrated at 37°C and 15% oxygen 85% nitrogen gas 
tension was added to the tonometer to lower the glucose concentration. The flow 
rate of the gas mixture was reduced to 50 cm3/min, as this reduced the gas used 
but still allowed full aspiration of the tonometer. This was the case for all the 
following experiments. The sensor was then tested after 12 hours in a solution 
containing 5 mM/l of glucose. 5 mM/l of glucose was chosen as opposed to 
6mM/l as it was thought that 5 mM/l better reflected a normal physiological value. 
6.4.8. The performance of sensor 3 to decreasing glucose 
concentrations 
The sensor did respond to decreasing glucose concentrations, although an 
increased level of noise can be seen in the signal, shown in figure 26. This noise 
could be due to temperature and gas tensions changes in the added PBS during 
transfer to the test tonometer. The signal from the tests of the sensor range can be 
seen to be relatively noise free compared to the dilution experiment, figure 27. 
After 12 hours in 5mM/1 glucose concentrations, the response of the sensor had 
degraded significantly with a range reduction of 4 mM/l from 5 to 1 mM/I and 
sensitivity degradation from 1.1 to 0.4 KPa/mM/1. The 90% response time had 
also increased from 60 to 120 seconds. The results of all the experiments are 
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shown in Table 15 and figure 28. In this experiment the zero glucose. reading did 
match the SVP adjusted oxygen values. 
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Figure 26. The response of the Sensor 3 to increasing and decreasing 
glucose concentrations. 
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Atmospheric pressure (KPa) 102.5 
Temperature (°C) 37.4 
Drv P02 tension (KPa) 15.0.4 
SVP corrected P02 tension 
(KPa) 
14.4 
Table 13. The SVP corrected oxygen tension 
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Figure 27. The test of the full range of Sensor 2 
Atmospheric pressure (KPa) 102.5 
Temperature (°C) 37.7 
Dry P02 tension (KPa) 15.0.4 
SVP corrected P02 tension 
(KPa) 
14.4 
Table 14. The SVP corrected oxygen tension 
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Initial test Maximum range Test of sensor after 
test 12 hours operation 
Operational range 
(MM/1) Only tested 
0-6 
to 5mM/l 
Linear range (mM/1) 
0-5 
0-4 NOT LINEAR 
Sensitivity 
(over linear range) 1.1 1.1 0.3 
(KPa/mM/1) 
Approximate 90% 
Response time 
(over linear range) <100 <100 100 to 200 
(seconds) 
Table 15. The characteristics of Sensor 3 
6.4.9. Conclusions of the response of the sensor to decreasing 
glucose concentrations 
Sensor 3 successfully measured glucose concentrations up to 9 mM/1 and 
responded to decreasing glucose concentrations with minimum hysteresis. The 
90% response time of 60 seconds is well within the desired level for the glucose 
sensor. However, after 12 hours in 5 mM/l, the sensors maximum range had 
reduced to only 1 mM/I and its 90% response time had increased to 120 seconds. 
The thinner HEMA layer does not seem to have reduced the range by a large 
amount. However, the sensor does respond to decreasing glucose concentrations, 
which may be a result of the thinner HEMA layer or better experimental 
procedure. This loss of sensor response after 12 hours is most likely due to 
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leaching of the enzyme out of the sensor into the tonometer solution as the CAT 
should protect it from the action of hydrogen peroxide. The leaching out of GOD 
into the tonometer solution may possibly be detected by looking for oxygen 
tension changes in the tonometer solution when glucose was added. 
The normal test of GOD is complex and it may be deactivated quickly in free 
solution preventing its detection. As a second P7 unit had become available at this 
point, it was now possible to take measurements of the oxygen tension in the 
tonometer concurrently with glucose measurements and look for this effect. The 
matching zero glucose concentration readings may be due to the lower flow rate 
of the oxygen into the tonometer, allowing the gas to become fully humidified. 
6.4.10. Investigation of the integrity of the EH membrane 
The aim of these experiments was to look for signs of any GOD leaching into the 
test tonometer solution out of the EH layer. This was to be detected by virtue of 
the decrease in the oxygen tension of the solution, brought on by the GOD 
reacting with glucose. This oxygen change was detected by using a second P7 
sensor to measure the oxygen tension of the test solution in the test tonometer 
during the experiment. The second sensor also allowed differential oxygen 
measurement to be taken between the glucose sensor and the oxygen sensor. This 
will allow any oxygen fluctuations in the tonometer solution to be accounted for, 
removing any error in the glucose measurement from this source. The detection of 
escaped GOD in solution using this method makes several assumptions. First is 
the assumption that the oxygen is not replaced into the tonometer solution, 
through aspiration, at such a rate that no change can be measured. Switching off 
the gas supply caused the oxygen tension to change in an unpredictable manner. 
As the solution equilibrated with atmospheric oxygen tensions, this means that 
GOD induced changes would be masked. Second, it is assumed that enough GOD 
has leached into the solution to change the oxygen tension by a measurable 
amount. Third, if GOD is leaching into the solution then it is logical to assume 
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that CAT is also entering the solution through the same mechanism. The CAT will 
reduce the effect of GOD by recycling oxygen from the H202, perhaps reducing 
the effect below a level that could be detected. 
Sensor 4 was constructed using identical materials and methods as Sensor 3. The 
sensor and a second P7 sensor were then put in a tonometer and tested under the 
same condition as Sensor 3. 
6.4.11. The results of the membrane integrity experiment 
The response of the glucose sensor and the reference oxygen sensor to the initial 
increase of the tonometer glucose concentration from 0 to 1 mM/1 was identical as 
can be seen in figure 29. This indicated that GOD had leached into the solution 
and was causing a drop in the oxygen tension of the solution when glucose was 
added. Following this experiment, the glucose sensor was rinsed thoroughly in 
PBS to remove any free enzymes which may have been on the surface. The sensor 
was then re-tested with fresh tonometer solution. In the second test the oxygen 
sensor showed no change when the glucose concentration was increased. 
However, the glucose sensor did show a response that is shown in figure 30. 
Due to time constraints on the availability of the equipment, the sensor was only 
taken up to 4 mM/l so no maximum range was found, the performance of the 
sensor, after rinsing, is shown in table 16 and the experimental conditions are 
shown in table 17. 
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Test after rinsing with PBS 
Operational range (mM/1) Only taken to 4 
Linear range (mM/1) 4 
Sensitivity 
(over linear range) (KPa/mM/1) 
1.1 
90% Response time 
(over linear range) <100 
(seconds) 
Table 16. The characteristics of Sensor 4 after washing with PBS 
Atmospheric pressure (KPa) 99.6 
Temperature (°C) 37.7 
Dry P02 tension (KPa) 14.9 
SVP corrected P02 tension 
(KPa) 
14.0 
Table 17. The SVP values for the sensor 4 experiment 
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Figure 29. The response of the glucose Sensor 4 and the reference oxygen 
sensor 
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6.4.12. Conclusions of the membrane integrity experiment 
After washing, the sensor with PBS, the reference oxygen sensor showed no 
detectable GOD activity. This suggests that the GOD, which had entered the 
solution in the first test of Sensor 4, had not leached out of the sensor but instead 
had washed off the surface of the sensor. The washing of the sensor with PBS 
removed this loose GOD. Therefore, more thorough rinsing of the sensor than 
used previously should prevent this error occurring. 
6.5 A differential oxygen measurement glucose sensor of 
reduced size 
As the sensor measures glucose through the depletion in oxygen, background 
oxygen fluctuations could introduce an error in the measurement, see Chapter 3. 
To solve this problem a differential sensing system can be used. A differential 
measurement system takes two simultaneous measurements, one of the property 
being measured and a second reference measurement of the environment. By 
using the difference between these two values any environmental affects will be 
removed (Skoog and Leary 1992). This type of sensor uses a GOD coated oxygen 
sensor to detect glucose and a second reference oxygen sensor to measure the 
background oxygen tension. By calculating the differential signal between the two 
sensors, any background oxygen fluctuations will be cancelled out and the 
difference in the two signals will be exclusively due to the concentration of 
glucose. This will create a sensor insensitive to oxygen tension changes in the 
environment, provided those changes do not reach a value so low that the sensor is 
deprived of oxygen and can no longer function. The use of the differential oxygen 
signal introduces another source of error in the measurement. As there are now 
two oxygen sensors involved in each single measurement of glucose the 
uncertainties in each sensor measurement will contribute to the final uncertainty in 
the glucose value. 
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In addition to the use of reference oxygen sensor, the design was also improved by 
miniaturising the sensor. Having demonstrated, using Sensors 1 to 4, that the 
fundamental design of the glucose sensor was sound, the design was improved by 
coating on the EH directly onto the P02 sensor rather than onto the surface of the 
whole P7 sensor bundle. This would allow the construction of a much smaller 
sensor that could be incorporated into an MPHF sleeve along with a second 
oxygen sensor. 
These two improvements were now possible because a variant of the P7 sensor 
which possessed two oxygen sensors rather than the pH, CO2 and 02 sensors of 
the standard design that had become available. The initial sensor design involved 
dip coating a P02 sensor into EH solution in the same way that the whole P7 
sensors were dip coated in the previous sensors. The Diametrics production 
facilities had become temporarily available, allowing the P02 sensor to be coated 
and then placed inside the MPHF sleeve as shown in figure 31. Previously the 
P02 sensors had not been coated directly with EH. This was because cutting open 
the MPHF sleeve of the P7 would almost certainly result in damage to one or 
more of the sensors causing the P7 software to reject the sensor and stop 
functioning. However, with the P7 fabrication facility at our disposal it was 
possible to coat the P02 sensors before they were inserted into the MPHF sleeve. 
The GOD loading of these mixtures was increased from the previous experiments 
in an attempt to improve the longevity of the sensor, as the previous sensors had 
shown limited operational lifetimes. By having excess enzyme in the membrane 
layer, it was hoped that enzyme deactivation would take longer to affect the 
sensors performance. Initially, one of the oxygen sensors was dip coated in a 
HEMA, GOD and CAT mixture consisting of 60 mg of GOD and 60 mg of CAT 
dissolved in distilled water. This was mixed with 0.5m1 of the HEMA solution 
containing 100mg/ml of HEMA dissolved in 75% ethanol balance. Once coated, 
the P02 sensor was then put through the Diametrics production line used to build 
its standard P7 sensors. This resulted in the GOD coated sensor and an uncoated 
P02 sensor being enclosed in MPHF and Acrylimide as in figure 31. 
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Sensor 5, was then tested in PBS equilibrated at 15% oxygen 7% CO2 and 78% 
nitrogen (the standard P7 calibration gas mixture). The oxygen sensors were 
calibrated manually using a research and design (R&D) variant of the P7 software, 
which allowed the sensor to be calibrated outside the normal calibration chamber 
of the P7. Calibration was instead carried out in three tonometers in a water bath, 
each equilibrated with one of the three calibration gas mixtures and maintained at 
37°C. 
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6. Sensor development and testing 
6.5.1. Response of Sensor 5 to glucose in solution 
As can be seen in figure 32, no response was seen for increases in glucose 
concentrations from 0 to ImM/l. The glucose concentration was then increased up 
to 12 mM/1 but still no response was seen from the glucose sensor. 
Figure 32. The first test of the duel sensor with its MPHF sleeve intact the 
glucose step was from 0 to I mM/1. 
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6.5.2. Reasons for the failure of Sensor 5. 
The failure of the sensor has several possibilities; 
a) The enzymes have been destroyed by heat or chemicals used in the P7 
sensor fabrication procedure. 
b) The GOD had been washed away during the production process, as the 
sensors were rinsed to remove chemicals used in production. 
c) The EH layer was so thin that oxygen could easily diffuse into the layer 
and replace that used up in the oxidation of the glucose. 
Before points (a) and (b) could be investigated, it had to be shown that coating the 
P02 sensor with EH would produce a working sensor. This was not certain, as the 
previous sensors had possessed EH layers covering the MPHF sleeve. Firstly, this 
was much larger than the P02 sensor, 0.5 mm diameter compared to 150µm 
respectively, which meant that much more GOD was present in the larger sensors. 
Secondly, the EH readily adhered to the MPHF material, allowing uniform layers 
of EH to be built up. In comparison, the coating of the P02 sensor caused 
irregular layers to form on the sensor when it was dip coated. Unfortunately there 
was insufficient time to create new sensors as the production of the sensors took 
12 hours and the Diametrics fabrication facility was no longer available. It was 
decided that the MPHF sleeve could possibly be removed from the P7 without 
destroying the P02 sensor. 
Using a digital capture microscope, the MPHF sleeve and acrylamide filling of 
Sensor 5 were removed and the oxygen sensor was re-coated with the same EH 
mixture. After several attempts, a mass of HEMA and enzyme was built up on the 
end of the sensor over the five dye filled holes, using a `painting technique' which 
involved using a piece of wire to apply the EH to the sensor, as shown in figure 
33. This mass was approximately five times the diameter of the fibre and highly 
irregular in shape (many times the thickness of membrane deposited in the first 
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experiment). The sensor was then calibrated and re-tested. A second normal P7 
sensor was also used as an external oxygen reference to monitor the oxygen 
tension of the tonometer solution. 
MPHF coating, which had been cut 
away to allow re-coating of the 
Oxygen sensor 
becona oxygen 
sensor, used as 
3andCAT 
in HEMA 
Figure 33. The sensor with the MPHF removed and the primary oxygen 
sensor coated with EH 
6.5.3. Performance of the re-coated differential oxygen sensor 
After re-coating, the sensor showed a response to glucose concentrations of up to 
3 mM/l, with no cross-talk between the glucose and oxygen sensors despite the 
close proximity (;: z 10 mm), as shown in figures 34,35 and table 18. 
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Figure 34. The response of Sensor after being split open and re-coated. 
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6. Sensor development and testing 
Operational range (mM/1) 0-3 
Linear range (mM/i) 0-2 
Sensitivity 
(over linear range) (KPa/mM/l) 5.1 
Approximate 90% Response time 
(over linear range) 
<100 
(seconds) 
Table 18. The performance characteristics of Sensor 5. 
Although the sensor had a range of only 3mM/1, it is the first operational sensor 
constructed by coating the oxygen sensing fibre directly with EH. The two oxygen 
sensors act as a reference, showing that the oxygen changes are localised to the 
sensor and are not a result of GOD leaking into the tonometer solution. To 
increase the range of the sensor will require outer diffusion limiting membranes or 
a change to the EH layer dimensions or consistency. 
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6.6 A P7 oxygen sensor coated with HEMA entrapped GOD 
and CAT in an MPHF sleeve 
From the previous experiment, it was evident that the GOD, CAT and HEMA 
mixture did not readily adhere to the silicone carbinol coating of the oxygen 
sensor. Due to this problem, the dip coating technique, used in Sensors 1 to 4, was 
not an option for coating the P02 sensor directly. A possible alternative was to 
provide a support to hold the HEMA and enzyme in place on the P02 sensor until 
it had dried. A section of MPHF tubing used in the P7 construction was thought to 
be a good candidate, as its pore filled structure would provide a diffusion-limiting 
layer to reduce the glucose flux and the material is biocompatible. The 
construction and sensor design is shown in figures 36 and 37. As the front and 
rear ends of the sensor will not be covered with MPHF, the glucose will be able to 
diffuse freely into the sensor from the front or rear ends of the MPHF tube. 
Glucose should also be able to diffuse into the sensor through the MPHF tube, 
although the flux will be reduced as the glucose can only diffuse through the pores 
of the MPHF. This will make a radially-symmetric design sensor similar to that 
built by Gough, Lucisano et al. 1985; Gough, Armour et al. 1986 described in 
Chapter 2. 
6.6.1. Construction and testing of Sensor 6 
A P7 sensor, previously split open and the MPHF and acrilyimde filling removed, 
was used to construct the glucose sensor. The P7 oxygen fibre was isolated from 
the other three sensors and a section of MPHF tubing (pelathane 400µm outside 
diameter, wall thickness of 20-25µm and 20% porosity) was placed over it. The 
space between the MPHF and the oxygen sensing fibre was then filled by placing 
the fibre end into an EH mixture, see figure 36. Capillary action drew the EH 
mixture into the space between the MPHF and the sensor. This mixture consisted 
of 60 mg GOD and 60 mg of CAT dissolved in 0.5m1 of distilled water. It had 
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been decided to increase the enzyme loading of the sensor to further ensure an 
excess enzyme. It was hoped that this would allow the sensor to operate in a 
diffusion-limited mode, even after operation for 12 hours. This solution was 
mixed with 0.5 ml of 100 mg/ml of HEMA in a 75% ethanol and distilled water 
solution. Later I ml of 90% ethanol was added to this mixture to lower its 
viscosity, so that it would move into the MPHF more easily. It should be noted 
that some of the EH mixture coated the exterior of the sensor. 
S 
Enz 
HET 
Figure 36. Construction of Sensor 6 using capillary action. 
d holes 
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MPHF 
P7 Oxygen 
sensor 
EH layer 
Dye filled holes 
Figure 37. The design of Sensor 6; an oxygen sensor coated with an 
enzyme -HEMA matrix and with an outer MPHF cover. 
After construction, the sensor was placed in a beaker of PBS and left for 
approximately one hour, after which it was thoroughly rinsed with PBS to remove 
any loose enzyme. The soaking procedure was to improve the removal of any 
loose enzyme or enzyme leaching out of the EH layer. The sensor was then 
manually calibrated using the R&D software now installed on the P7 system. This 
allowed the sensor to be calibrated using tonometers in the water bath which were 
aspirated with the calibration gas mixtures. This removed the need to either 
calibrate the sensor before enzyme coating or attempting to re-insert the sensor 
into the P7 calibration tonometer, a process that often caused sensors to break. By 
calibrating after coating the sensor, any changes caused to the performance of the 
oxygen sensor would be taken into account by the calibration. 
130 
6. Sensor development and testing 
6.6.2. Performance of the MPHF coated sensor 
Figure 38 shows the data captured from the P7 via a serial port connection using 
software written for the task, which is described in Appendix A. The resolution of 
the data is slightly less than that displayed on the P7 plots for reasons discussed in 
Appendix A. This was a built feature of the P7 base unit and could not be 
changed. However, the ability to continuously take measurements and insert time 
flags when glucose was added or dilutions made was thought to outweigh this 
small resolution loss. Glucose was added to the tonometer to raise the 
concentration in steps of 2 mM/l, as it was wrongly assumed that the MPHF 
would create a sensor to have a large range by virtue of its diffusion 
characteristics. However, the full range of the sensor was reached in the first 
glucose step, as can be seen in figure 38. After the full range had been reached at 
the appropriate temperature and oxygen tensions PBS was added to the tonometer 
to lower the glucose concentration to 0.25 mM/l, the maximum dilution that could 
be achieved with this tonometer volume. The experimental conditions and 
performance characteristics of the sensor are shown in table 19 and 20 
respectively. 
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6. Sensor development and testing 
Atmospheric pressure (KPa) 100.9 
Temperature (°C) , 
39.3 
Dry P02 tension (KPa) 15.2 
SVP corrected P02 tension 
(KPa) 
14.0 
Table 19. The SVP corrected oxygen tension and temperature of the tonometer solution used in 
the experiment 
Operational range (mM/1) 2 
Linear range (mM/1) N/A 
Sensitivity 
(over linear range) (KPa/mM/1) 4 
90% Response time 
(over linear range for increasing 
concentration) 100 to 200 
(seconds) 
Approximate 90% Response time 
(over linear range for decreasing 
concentration) <100 
(seconds) 
Table 20. The performance characteristics of sensor 6. 
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6.6.3. Conclusions of the MPHF sensor experiments 
In figure 38, the response to both decreasing and increasing glucose changes can 
be seen to overshoot its final value and then return. This was thought to be due to 
the complex nature of the reaction-diffusion process in the EH membrane. A 
marked difference in the 90% response times between the increasing and 
decreasing concentration changes can be seen in table 20. This was attributed to 
the fact that when the concentration is increased only a small amount of 1M 
glucose solution is added to the tonometer, typically 1001l to 50m1. This then has 
to diffuse throughout the tonometer to affect the concentration near the sensor, 
which may take several seconds, even though the solution is effectively stirred by 
the gas perfusion. However, when a dilution is carried out the volume of PBS in 
the tonometer, in this case, increased form 25m1 to 100ml. The extra 75ml will 
have a much faster effect on the sensors' environment compared to the glucose 
solution. 
Both the increasing and decreasing response times are much shorter than the 180 
seconds stated earlier for the P7 sensor. This is due to the conservative values 
quoted by Diametrics Medical Ltd for their sensor to avoid the possibility of 
making false performance claims about the sensor. Also the HEMA may have less 
diffusion coefficients than acrylimide. The use of the MPHF left little room for 
control of the EH and dimensions. If a dip coating technique could be developed 
to coat the P02 sensor, this would allow smaller sensors to be made and the 
control of the EH thickness could be used to construct a sensor of the appropriate 
response parameters. The manual calibration had caused errors as can be seen in 
figure 38 and table 19. Both SVP and the uncorrected values are different from the 
oxygen reading of the sensor. However, this may be a result of calibrating P02 
sensors with no acrylimide or MPHF cover. So a new technique was still required. 
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With MPHF and the acrylamide removed from the sensor, the oxygen sensor 
would equilibrate more quickly with the calibration gasses causing a difference in 
the calibration compared with a standard P7 sensor. If this equilibration time is 
taken into the account in the calibration algorithm, this would create an error. The 
coating technique used in Sensor 7 left the pH, temperature and CO2 sensors 
exposed and made the sensor virtually impossible to re-insert into the calibration 
tonometer and made them vulnerable to being damaged. 
6.7 An improved method for coating the P02 fibres in 
enzyme 
Several methods of applying the EH coat to the oxygen sensing fibre were 
considered and attempted on sections of P02 sensors cut from the previously used 
sensors. After trial and error, a painting technique, was developed, similar to that 
used to coat Sensor 5. This involved using a piece of fine copper wire to apply the 
EH mixture to the oxygen sensor. In this way, a thick but irregular layer of EH 
could be coated directly onto the oxygen sensor. 
Several P7 sensors had their MPHF sleeves removed at the Diametrics facility and 
were provided to investigate coating the EH directly onto the P02 sensors. One of 
these sensors was used to develop the enzyme coating technique. The P02 sensor 
was coated with a layer of EH as shown in figure 39. This was applied to the 
sensor over the dye filled holes in the oxygen fibre. The enzyme mixture used 
contained 0.5m1 of 63 mg of GOD and 63 mg of CAT dissolved in distilled water. 
This was mixed with 0.5ml of 100 mg/ml of HEMA in 75% ethanol solution. The 
layer deposited was highly irregular but did adhere to the silicone carbonyl 
coating of the oxygen sensor once the ethanol in the mixture had evaporated. The 
sensor was then soaked in PBS for around one hour and then rinsed repeatedly 
with PBS to remove any loose enzyme. 
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Once constructed the sensors were automatically calibrated in a modified P7 
calibration tonometer. The neck had been widened to allow insertion of the three 
separate optical fibres and the thermocouple. The reason for returning to the auto 
calibration technique was to remove any calibration errors that could be 
introduced during the manual calibration as seen in the previous experiment. 
The sensor was then tested for its response to glucose and its upper range found to 
be 8mM/l. PBS, at appropriate temperature and gas tensions, was added to the 
tonometer to lower the glucose concentration to 4 and then 2 mM/1. 
The results are shown below in figures 40,41 and table 22, the sensor exhibited 
hysteresis shown when the glucose concentrations were decreased. The maximum 
range of the sensor was only 8mM/l and the initial readings at zero glucose 
concentrations were below the SVP oxygen tension, indicating an error in the 
calibration despite the automatic calibration process that was used, see table 21. 
A second P7 had become available for use on the research at this time; this was a 
variant of the P7 known as a satellite unit. The satellite system operated 
identically to the normal P7 except that it was unable to calibrate sensors lacking 
the calibration gasses and calibration chamber. This sensor was used as an oxygen 
reference to measure the oxygen tension of the test tonometer solution. 
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oxygen 
HEMA and 
yn cx. '-'2 
fibres 
Figure 39. Sensor 7 created using the EH painting technique 
Sensor 7 has a range of only 0 to 8mM/l but its sensetivity is very low only 
roughly (0.4 KPa/mM/l) at maximum. The 90% response times are approximately 
45 seconds and this low sensetivity and short response time were probably due to 
the dimensions of the EH layer, which will define the response of the sensor. In 
this case, the EH was very thick around ten times the oxygen sensor diameter. 
With development of the coating technique, it may be possible to control the 
dimensions of the EH layer precisely enough to construct a sensor with greater 
range. It was noticed during the construction that the EH mixture would adhere to 
all four sensors due to capillary action. It was decided to use this process as a 
means to coat the sensors. 
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6. Sensor development and testing 
Atmospheric pressure (KPa) 100.3 
Temperature (°C) 37.6 
Dry P02 tension (KPa) 15.0 
SVP corrected P02 tension (KPa) 14.1 
Table 21. The SVP corrected oxygen tension 
Operational range (mM/1) 6 
Linear range (mM/1) N/A 
Sensitivity, increasing and decreasing. 
(KPa/mM/1) 0.05 to 0.4 
Approximate 90% Response time 
For increasing and decreasing concentration 
<100 
(seconds) 
Table 22. The performance characteristics of Sensor 7. 
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6.8 P02 oxygen fibres coated with GOD and CAT in a 
HEMA matrix cross linked with glutaraldehyde 
The previous sensor coating technique had proved to be problematic and formed 
an irregular EH layer which was hard to control. In addition, it was noted that 
when coated the EH would flow around the other optical fibres probably by 
capillary action. It was decided to try an alternative design where all of the four 
sensors were dipped into the EH mixture. The capillary action effect would then 
help the EH to form a layer covering all of the sensors including the P02 sensor, 
see figure 42. In this way, it was found that a regular layer of EH could be formed 
over the sensors. This approach had two advantages. Firstly, as the sensors were 
bunched together and enclosed in a layer of EH, they were far less likely to 
fracture during calibration or testing. Secondly, a dip-coating technique could be 
used with this approach, allowing much more regular controlled layers to be built 
up than with the painting technique used previously. 
To further improve the stability of the EH layer, glutaraldehyde was used to cross- 
link the enzymes in the HEMA layer. It was hoped that this would give the 
sensors longer operational lifetimes by improving the resistance of the enzymes to 
damage or loss as discussed in Chapter 3. 
Eight sensors (8a to 8h) were made using this new technique. P7 sensors, which 
had previously had their MPHF coating removed, were used in this construction. 
Following the removal of the MPHF coating the four internal P7 sensors were all 
dipped into the EH mixture, as shown in figure 42. This enzyme mixture 
contained 60 mg of GOD and 60 mg of CAT dissolved in 0.5 ml of PBS mixed 
with 0.5 ml of HEMA solution containing 100 mg/ml in 90% ethanol 10 % water. 
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The sensors were not stored in PBS as with previous experiments. Instead, the 
sensors were refrigerated, dry, overnight to avoid leaching out the enzymes into 
the solution. The following day. they were dipped in glutaraldehyde to cross-link 
the enzymes and improves the integrity of the EH layer. The sensors were then 
refrigerated again, dry. Dry storage was used as it was considered that this would 
limit chemical reactions taking place in the EH layer. It was hoped, therefore, that 
the sensor would not suffer degradation in storage. However, a problem with dry 
storage was that the HEMA layer would swell when placed in the PBS solution to 
be calibrated and tested. This may cause an error during testing as the dimensions 
of the EH layer changes over time. The sensors were stored for between 6 and 21 
days before testing. 
oxygen 
HEMA and 
pH and CO2 
fibres 
Figure 42. The layout of the enzyme based sensors 8a to 8h 
The sensors were manually calibrated in the experimental tonometers, which, 
although possibly less reliable, reduces the amount of breakages that often 
occurred when sensors were inserted into the P7 calibration tonometers for 
automatic calibration. A standard P7 sensor was also calibrated and used as a 
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reference oxygen sensor in each experiment. The sensors were then tested as 
described previously. 
6.8.1. The performance of the cross linked sensors 8a to 8h 
The results of the tests sensors 8a to 8h are shown in figure 43 to table 23. After 
the test of sensor 8c the oxygen reference sensor failed and with no replacement 
available, the rest of the experiments 8d, 8e, 8f and 8g were conducted without a 
reference. The initial zero glucose oxygen values for all of the sensors except 
Sensor 8d are close or within the tolerance for a normal P7 sensor in that oxygen 
tension. The SVP for these sensors and from now on were not calculated, as the 
effect on the measurement was small, usually in the order of 0.5 KPa. 
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6. Sensor development and testing 
Sensor 
8a 8b 8c 8d 8e 8f 8g 
Operational range (mM/1) 
0-7 0-8 0-7 0-3 0-7 0-10 0-5 
Linear range (mM/l) 
0-6 0-7 0-6 0-2 0-7 0-10 0-5 
Sensitivity 
2.6 0.8 2.3 2.4 1.8 1.3 2.6 
(over linear range) (KPa/mM/l) 
Approximate 90% Response 300 300 200 100 200 100 
time (over linear range) to <100 to to to to to 
(seconds) 400 400 300 200 300 200 
Sensor 8h was excluded due to the large amount of noise it exhibited when tested. 
Table 23. Summary of the performance characteristics of Sensors 8a to 8g 
The variation in the sensor performance is most likely due to differences in the 
EH layer dimensions. Sensor 8d may have become either incorrectly calibrated or 
damaged during construction, resulting in its incorrect oxygen reading at 0 mM/1 
of glucose following calibration. 
The variation in the sensors performance is most likely due to the differences in 
the EH dimensions on the sensors, which resulted from the crude coating 
technique used. The range of the sensors was below the 25mM/l desired. In 
addition, it has to be noted that although the sensors have a range of up to 10 
mM/1(sensor 8f) it has to be remembered that the sensors are being tested in 15% 
oxygen tensions that are much higher than those that would be seen in 
subcutaneous tissue. 
Increases in range could be achieved by increasing the EH membrane layer depth 
but this would probably result in a corresponding increase in response times. A 
better approach would be to use a partial polyurethane outer coat, as described in 
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Chapter 3. It was decided to use the polyurethane coating method to attempt to 
increase the range of these sensors. 
6.9 Extension of the range of the Sensors 8a to 8e using a 
polyurethane outer coat 
In order to attempt to increase the range of the sensors, an incomplete 
polyurethane outer coat was applied to Sensors 8a to 8e using a dip coating 
technique described by Shaw, Claremont et al. 1991. The response of the sensors 
to glucose was then evaluated and compared with the results of the sensors before 
coating with polyurethane. The performance characteristics of the sensors in 
different oxygen tensions were also investigated, to observe the dependence of the 
sensors on oxygen. 
6.9.1. Method of coating of Sensors 8a to 8g in polyurethane 
After the completion of the previous set of experiments the sensors were dried in air 
for approximately two hours. The sensors were then dip coated in a solution of 4% 
polyurethane (Estane 5714) dissolved in THE and left to dry for two hours. The 
sensors were then returned to their P7-tonometers, which had been refilled with 
PBS. All of the sensors were then refrigerated in PBS for a further three weeks until 
oxygen reference sensors became available for use. 
6.9.2. Testing of the polyurethane coated sensors 
To investigate the response of the sensor in different oxygen tensions the 
experimental apparatus was modified to allow two different oxygen tensions 7.5% 
and 15%, balance nitrogen. For each increase in glucose concentration, the sensors 
were first tested in a 15% oxygen environment, once a steady state reading had been 
reached the gas supply was lowered to 7.5% oxygen. The sensors were manually 
calibrated and once a steady state reading had been reached, the glucose 
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concentration was increased. When the sensor showed a steady state signal at this 
glucose concentration, the gas tension was increased back up to 15% oxygen. The 
process was then repeated until the sensor showed no changes to increasing glucose 
concentration, or the oxygen tension reading reached zero. A second unmodified P7 
sensor was used as a reference to measure the oxygen tension of the tonometer 
solution. 
6.9.3. The effect of the polyurethane membrane on sensor 
performance 
Of the five sensors coated with polyurethane one, 8c, fractured. Sensor 8a 
exhibited cross talk between the glucose sensor and the oxygen reference, 
indicating that GOD had leached into the solution. Sensor 8b initially showed a 
response to glucose but its reading began to climb steadily with the progression of 
time. The reference sensor measured no corresponding oxygen tension change. 
The sensor was rinsed and the experiment repeated. In the second experiment, the 
sensor showed a very limited response to glucose with readings of 30.4 to 26.0 
KPa for glucose concentrations of 0 to 52 mM/1 respectively. Sensors 8d and 8e 
gave a usable signal, however, their oxygen tension readings did depart from the 
oxygen tensions in the tonometer. However, problems were encountered with the 
reference sensors, which also showed incorrect measurements of the oxygen 
tensions in the solution. This was attributed to a calibration fault but the 
experiment was continued without a reference due to the shortage of reference 
sensors. 
The results of the sensor calibration tests before and after coating of the sensors 
are shown in figure 44. The uncoated sensors (dark triangles and squares) can be 
seen to have inferior range to the polyurethane coated sensors (open triangles and 
squares). The characteristics of the sensor calibrations are shown in table 24. A 
comparison of the sensors performance in the two oxygen tensions (filled squares 
and triangles for 15% oxygen and unfilled symbols for 7.5% oxygen) are shown 
in figure 45 and table 25. 
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6. Sensor development and testing 
Coating 
EH only Polyurethane 
Sensor 
8d 8e 8d 8e 
Operational range (mMIl) 0-3 0-7 0-21 0-17 
Linear range (mM/1) 0-2 0-7 0-21 0-11* 
Sensitivity 
(over linear range) 2.4 1.9 0.6 0.5 
(KPa/mM/1) 
Approximate 90% 
NA due to NA due 
Response time 200 to 100 to 
signal to signal 
(over linear range) 300 200 
noise noise 
(seconds) 
Table 24. The Summary of the characteristics of Sensors 8d and 8e before and after 
polyurethane coating in 15% oxygen tensions 
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Sensor 
8d 8d 8e 8e 
Oxygen tension 
7.5% 15% 7.5% 15% 
Operational range (mM/1) 0-8 0-21 0-17 0-17 
Linear range (mM/1) 0-8 0-21 0-17 0-11* 
Sensitivity 
NA 0.6 NA 0.5 
(over linear range) (KPa/mM/1) 
90% Response time 
NA due to noise 
(over linear range) 
(seconds) 
* Large noise seen at 17 and 23mM/lof roughly 50% of the sensitivity. 
Table 25. The Summary of the characteristics of Sensors 8d and 8e after polyurethane coating 
in 7.5 and 15% oxygen tensions 
6.9.4. Conclusions of polyurethane coated sensor experiments 
Adding the polyurethane has increased the range of sensors, 8d and 8e, but it has 
also caused a large increase in the response times. The response of the 
polyurethane coated sensors in two oxygen tensions shows that the sensors are 
relatively oxygen independent over this range. The range differences are caused 
by the sensors running out of available oxygen in the 7.5 % saturated solution to 
carry on breaking down glucose, although there are some differences in the 
profiles. Sensor 8e has good performance characteristics for our purposes as its 
range of 0 to 17 mM/l would provide a possible practical glucose sensor 
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6.10 Sensors constructed by direct coating of the EH onto a 
P7 oxygen sensing fibre with the pH and CO2 sensors 
removed. 
In the previous design, Sensors 8a to 8g, all three of the P7 internal sensors were 
dipped into the EH mixture. To improve the sensor design it was necessary to coat 
the P02 sensor alone, as this would reduce the size of the sensor and allow better 
control of the EH dimensions. However, previously the other sensors in the P7 
could not be easily separated from the P02 sensor. A research and design (R&D) 
version of the P7 software had become available and was installed on the P7, this 
allowed the pH and CO2 fibres to be removed from the sensor while allowing the 
oxygen sensor to still operate. Previously the removal of the pH or C02 sensors 
would prevent the oxygen sensor from operating as the P7 software would detect 
the sensor loss and stop operating. The thermocouple was left intact as this was 
required for the calibration of the oxygen sensor and was a useful measurement in 
itself due to the dependence of oxygen solubility on water temperature. 
The CO2 and pH sensors were cut away from the P7 sensor to leave the P02 and 
temperature sensor exposed. The new sensor construction is shown in figure 46. 
Two further sensors, 9c and 9d were also created and tested. To avoid repetition, 
the results from these two sensors will be reported later in sensor gamma 
sterilisation investigations. 
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Normal P7 sensor bundle Sensor with the pH and CO2 fibres 
removed 
thermocouple 
oxygen 
sensor 
Dye fill 
holes 
pH sensor 
widened end for 
attachment of MPHF 
sleeve 
ygen sensor 
EH layer 
Dye filled 
holes 
Figure 46. The Sensor design with the pH and CO2 optical fibre sensors 
removed. 
Sensor 9a was then dip coated into an enzyme mixture, that consisted of 30 mg of 
GOD and 30 mg of CAT dissolved in 0.25 ml of PBS, mixed with 0.25 ml of 
0.25m1 of 10 % HEMA solution, dissolved in 90 % ethanol 10 % distilled water. 
The EH mixture was applied to the oxygen sensors using the `painting' technique 
as used in Sensor 7. To cross-link the enzymes the sensor was dipped into 
glutaraldehyde. As it was considered that little or no chemical reactions will take 
place while the GOD is in its dry form, the sensor was left dry and refrigerated 
overnight to minimise any degradation that the sensor would suffer as GOD was 
broken down. The coating technique allowed a layer of uniform thickness of EH 
to be deposited on the sensor. 
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6.10.1. Initial results of EH coating on an isolated P02 sensor 
The range of the initial sensor design was only 1mM/1 with a 90% response time 
of 60 seconds as can be seen in figure 47. The sensor was coated in polyurethane 
to attempt to increase its range. However, the sensor failed to give a signal 
probably due to a fracture occurring during the coating process. 
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6. Sensor development and testing 
6.10.2. Conclusions EH coating on an isolated P02 sensor 
Although a much more regular thickness EH layer has been created, its thinness 
compared to previous designs has limited the sensors -range to only 1mM/l. 
Although showing that an EH can be laid down on the sensor, the membrane will 
have to be made thicker, polyurethane or an outer HEMA coat was used to 
increase the range. The painting technique, although usable, made control of the 
membrane thickness virtually impossible. This sensor, although of no practical 
use, demonstrates the sensitivity of glucose sensors that can be produced using 
this technique. The development of a dip coating technique, similar to the one 
used in the first experiment, applied to the P7 sensors in experiment one to four 
would be the most desirable solution and this was now investigated. 
6.11 An isolated P02 sensor coated by absorption of enzymes 
from solution 
A new approach to coating enzymes onto the HEMA sensor was investigated; this 
involved coating the oxygen sensor with HEMA and then absorbing enzymes into 
the HEMA layer from solution. Initial investigations had shown that without the 
GOD and CAT mixed in with the HEMA the pure HEMA solution did not adhere 
to the coating silicone carbinol of the oxygen sensing fibre. To lay a HEMA layer 
a method of improving the adhesion of the HEMA to the silicone carbinol was 
needed. Coating the oxygen sensing fibre with agrose before the EH was proposed 
3 as a possible approach . 
3 Suggested by staff at Salisbury District Hospital, UK 
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6.11.1. Experimental protocol 
The pH and CO2 sensor were removed and the oxygen sensor was dip coated in a 
solution of 2% agrose. The sensor was then repeatedly dipped into the EH mixture 
until a round mass had built up over the five dye filled holes. The sensor was then 
placed in a solution containing 30 mg of GOD and 30 mg of CAT. After 30 
minutes the sensor was removed and dip coated in the HEMA to add a final outer 
layer. The sensor was finally dipped in glutaraldehyde to cross-link the enzymes. 
The sensor was then refrigerated dry overnight and tested the following morning. 
The sensor was tested using the same method as previously described except that 
7.5% oxygen balance nitrogen tensions were used to perfuse the solution. From 
this point on, sensors were tested in 7.5% oxygen tensions as these better reflected 
the oxygen tension of tissue (Zhang and Wilson 1993). A second normal P7 
sensor was used as a reference. The sensor was then dried and dip coated in 4% 
polyurethane to increase its range and was then re-tested the following day. 
6.11.2. Performance of the absorption coated sensor 
The sensor had a range of 15mM/i and a 90% response time of approximately 200 
seconds, as shown in figure 48 and table 26. The reference sensor showed no 
change in oxygen readings during the experiment confirming that no GOD was 
leaching into solution. This was expected as no immobilisation procedures had 
been used to entrap the enzyme. To further increase the range, the sensor was dip 
coated in 4% polyurethane immediately following the experiment. The sensor was 
then refrigerated, dry, overnight and tested the following day. The sensor initially 
showed a response to increasing glucose concentrations but after 4mM/i the 
oxygen reading climbed to a level above the 0mM/1 concentration as shown in 
figure 49. 
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6. Sensor development and testing 
Operational range (mM/1) 
0-7 
Linear range (mM/1) 
0-15 
Sensitivity NA due to low 
(over linear range) (KPa/mM/l) sensitivity of 
sensor 
90% Response time NA due to low 
(over linear range) sensitivity of 
(seconds) sensor 
Table 26. The performance parameters of Sensor 9b 
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6. Sensor development and testing 
The construction method has produced an operational sensor. Even without its 
polyurethane outer coat, the sensor had a good range (15mM/l) and response time 
of 159 seconds. After the addition of the polyurethane, the sensor showed a 
greatly reduced response to glucose concentrations. The increase in the oxygen 
tension registered by the sensors after 4 mM/l seems to be due to phenomena 
internal to the glucose sensor, as the reference sensor showed no deviation. In 
addition, the sensor signal reaches a level of oxygen tension higher than its 
starting place with no glucose present. 
The only source of oxygen apart from the gas supplied to the tonometer and the 
atmospheric gas is from the action of catalase breaking down H202. It is possible 
this oxygen increase is a result of a reaction diffusion system set up inside the 
sensor membrane. Alternatively, a calibration fault in the P7 R&D software may 
have cause a drift in the sensor signals. 
Putting aside the failure of the sensor after coating with polyurethane, this 
construction method has proved effective. However, it is essential for 
performance and lifetime considerations that the enzyme membrane is loaded to 
excess with enzymes, which cannot be guaranteed with this approach. A dip 
coating method, adapted to operate on the oxygen sensor would be the most useful 
method. 
6.12 Development of a precision dip coating using a laser 
micrometer 
In an attempt to find a technique of dip coating the P02 sensor with EH, the 
viscosity of the EH mixture was varied. After some trial and error, using used 
P02 sensors from previous experiments, and EH solution mixture ratios ranging 
from 0.25 ml enzyme mixed with 0.25 ml of HEMA solution to 0.25m1 enzyme 
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solution to 1 ml of HEMA solution and dip coating techniques, an effective 
method for coating the P7 oxygen sensor was found. 
The enzyme solution contained 30 mg of GOD and 30 mg of CAT dissolved in 
0.75 ml of PBS. The HEMA solution consisted of 10 % HEMA solution dissolved 
in 90 % ethanol 10 % distilled water. The P02 sensor was dipped once into the 
EH mixture and then allowed to dry in air for 20 minutes. The process was then 
repeated until a layer of EH of twice the sensor diameter was built up. Although 
this took approximately 12 hours, a uniform EH layer of controlled thickness was 
built up. 
To examine the dimensions of the layer deposited on the sensor a laser 
micrometer (available for a short time) was used to take measurements. 
6.12.1. Laser measurement of the diameter of EH coated 
glucose sensors 
The diameter of the sensor was measured using the ALS13XY/100B00 laser 
micrometer (Scantron, Taunton, UK). This device measures diameters to within 
0.1 µm in two perpendicular axes. This allows ovalarity to be measured (the ratio 
of the diameter of the two axes). The laser is scanned across the fibre at 100 Hz in 
each axis and an average measurement displayed. The ovalarity in this case is 
caused by two possible sources, first the EH could be thicker on some sides than 
others, secondly the sensor could be held at an angle of less than 90° to the laser 
beams causing a gross section to be measured at an angle see figure 50. 
Normally, when wires are measured by this diverse they are held in place 
mechanically to ensure they are positioned at 90° to the beams, however, in this 
case, the sensor is too fragile and small to be gripped in this way. As a result, the 
sensor had to be held by hand and this introduced two possible sources of error. 
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Firstly, shaking of the hand and secondly holding the sensor at less than 90° as 
shown in figure 50. 
Five measurements were taken of the bare fibre over the region of the dye filled 
holes and the diameter and the ovalarity were then averaged. The sensor was then 
dip coated in the above solution until a layer of roughly twice the sensor diameter 
had been deposited. This was allowed to dry and the sensor was then measured 
again, over the same section of the fibre also taking an average of five 
measurements. 
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SIDE Light 
TOP 
sensor 
u' 
Laser 
light 
Oxygen 
fibre 
Oxygen sensor held at less than 90 degrees to the 
SIDE TOP 
Light 
sensor 
U , 
Laser 
light 
Oxygen 
fibre 
Figure 50. Measurement of the diameter of the sensor 
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The results of the measurement are shown in table 27; the coating technique has 
laid down a layer of 60 µm with an ovalarity of r, -28 µm across the diameter. 
Bare oxygen Standard Dip coated Standard 
sensor deviation sensor deviation 
Average diameter 
174.4 1.0 296.0 53.8 
(µm) 
Average ovalarity 
1.3 1.1 28.0 30.0 
(µm) 
Table 27. The diameter and ovalarity of a coated and uncoated P02 sensor 
6.12.2. Performance of the improved dip coating technique 
The dip coating technique has laid down a uniform EH layer of only 60 µm 
thickness. The ovalarity measured in the EH layer was probably in part due to 
incorrect positioning of the sensor in the laser beam. Therefore, the true ovalarity 
of the membrane layer is probably less than 28 µm. This coating technique should 
allow better control over sensor performance through control of membrane 
dimensions. 
165 
6. Sensor development and testing 
6.13 Performance of sensors produced using the new dip 
coating technique 
The aim was to use the new dip coating technique to coat two sensors and then 
measure their characteristic response to glucose. Two sensors, 9c and 9d were 
constructed using the dip coating method described above. The solution mixture 
ratio had been further improved from the previous experiment by reducing the 
amount of HEMA in the mixture. This allowed the EH layer to be more easily 
coated onto the P02 sensor. The P7 sensors had their pH and CO2 sensors cut 
away and were then dip coated as described above using a mixture of 0.25m1 of 
PBS containing 30 mg of GOD and 30 mg of CAT, mixed with 0.5 ml of 10% 
HEMA dissolved in a 90% ethanol and 10% water. Once a depth of 
approximately half the oxygen sensor diameter (100 µm) had been built up, the 
sensors were then refrigerated, dry, overnight and then dipped into glutaraldehyde 
to cross-link the enzymes in the membrane. After being air-dried, the sensors were 
tested for their response to glucose. 
After the sensors had been tested, they were dried and then dip coated in 4% 
polyurethane solution dissolved in tetrahydrafuran. The sensors were dried and 
refrigerated overnight and re-tested. 
6.13.1. Performance of the sensors dip coated using the 
improved technique 
As can be seen in figure 51, before coating with polyurethane, Sensor 9b 
displayed over shoot in its response to glucose concentration changes. However, 
after coating with polyurethane, this feature was lost and the sensor responded 
closely to concentration changes as shown in figure 52. Sensor 9c faithfully 
responded to glucose concentration changes both before and after coating with the 
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polyurethane. The response of both sensors before and after coating with 
polyurethane to glucose concentrations changes are shown in figures 53 and 55 
for Sensors 9b and 9c respectively and the sensor characteristics are given in table 
28. 
The spike seen in figure 51 at the 4 mM/l glucose concentration was caused by a 
recurring fault in the P7 R&D software, which occasionally caused oxygen values 
below a value of 1 KPa to be falsely displayed as ten times its true value. In this 
case 0.3 is represented as 3. 
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6. Sensor development and testing 
Coating EH only Polyurethane 
Sensor 
9c 9d 9c 9d 
Operational range (mM/1) 
0-4 0-7 0-24 0-24 
Linear range (mM/1) NA 0-7 0-15 0-5* 
Sensitivity 
(over linear range) NA 1.8 0.16 0.3 
(KPa/mM/1) 
90% Response time 
(over linear range) NA <100 NA NA 
(seconds) 
noise level approaches resolution above this concentration 
NA - not applicable due to low sensitivity or the response of the sensor to step 
change 
Table 28. The characteristics of Sensors 9b and 9c with and without polyurethane coats 
The over shoot observed in the response of Sensor 9b was probably a result of the 
reaction-diffusion process in the membrane layer being such that the system 
essentially behaved as a heavily damped oscillator. In this situation, each increase 
in glucose concentration caused a transient drop in the oxygen tension in the 
membrane as oxygen was consumed faster than it could be re-supplied by oxygen 
from outside or from that recycled by the action of CAT. This led to the reaction 
in the membrane slowing down until the consumption of glucose could be 
matched by diffusion of oxygen from outside and from recycling of oxygen by the 
CAT. The sensor then settled down to a steady state value. The polyurethane coat 
solved this problem probably by reducing the glucose flux to below a value that 
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could trigger this oscillation. Sensor 9c did not show this oscillating behaviour, 
which was possibly due to differences in the EH membrane deposited on the two 
sensors, indicating that there is still some variation in EH layer formation using 
this technique. 
The addition of the polyurethane layer increased the range of both the sensors by a 
large amount (between two and three times the original). The range of both 
sensors covers the whole hyperglycaemic range required. However, this was 
obviously at the expense of sensitivity. 
6.14 Comparison of HEMA and polyurethane outer coatings 
to extend the range of the glucose sensors 
After the initial EH coating there were three possible ways to extend the range of 
the sensor. Firstly, more EH could be added to the sensor, but this would cause the 
sensor to become much larger. Second, a layer of HEMA could be added to the 
sensor to increase the range, as with sensors 1 to 4, with a smaller increase in 
sensor size. Finally, polyurethane could be used as with the sensors 9c and 9d 
above. 
The smallest possible sensor was aimed for and adding more EH was discarded as 
an option. This left a polyurethane coat or extra HEMA as the available options. 
To compare these two techniques two glucose sensors, 10a and 10b were given an 
EH coat and tested. One of the sensors, 10a, was then coated with HEMA and the 
other, IOb with the incomplete polyurethane coat, both of the sensors were then 
re-tested. 
The enzyme mixture used contained 60 mg of GOD and 76mg of CAT dissolved 
in 0.5m1 of PBS. This was then mixed with iml of HEMA solution. The HEMA 
solution contained 100mg/ml of HEMA in 100% ethanol. Once an EH had been 
173 
6. Sensor development and testing 
built up, the sensors were left to dry for another 20 minutes and dipped into 
glutaraldehyde to cross-link the enzymes. The sensors were then dried and 
refrigerated in PBS for 24 hours. before being tested. 
It was decided to store sensors in PBS, as opposed to dry as with the previous 
experiments, to ensure that the EH layer had fully hydrated. If left dry the EH 
membrane would swell, causing changes in the sensors performance. In addition, 
overnight storage in PBS will allow any loose enzymes to diffuse out of the EH 
layer reducing the chances of contamination of the test tonometer with GOD. 
After the initial tests, Sensor I Oa was dried for one hour and then dipped into the 
HEMA solution described above. It was then dried for another hour before being 
dipped again. The sensor was then allowed to dry before being replaced in PBS 
and refrigerated. Following testing, Sensor 10b was also dried for one hour and 
then dip coated in 4% Estane as described earlier. 
Finally, after both sensors had been recalibrated and re-tested with their new outer 
coats, sensor I Oa was dried and dip coated in polyurethane and then re-tested. 
6.14.1. The performance of the two sensors before and after 
HEMA and polyurethane coating 
Initially both sensors had a maximum range of only 1mM/l with sensitivity of 6.6 
and 6.5 KPa/mM/l and a 90% response times of the two sensors of <100 and 100- 
200 seconds for sensors 10a and 10b respectively, see figures 55 and 59. The 
results of adding the HEMA layer to Sensor 10a and the polyurethane layer on 
10b are shown in figures 57 and 58. Sensor 10a failed after the dip coating with 
the polyurethane solution, probably through a fracture in the fibre. The responses 
of both sensors with all of the coatings are shown in figure 59 and table 29. The 
HEMA has extended the range of the sensor to 4mM/l with a 90% response time 
of 180 seconds and the polyurethane has given the sensor a range of 8mM/l with a 
90% response time of 90 seconds. 
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6. Sensor development and testing 
The oxygen reference sensor shows no change, indicating that no enzyme is 
leaking into the tonometer and that all the oxygen tension changes are localised 
inside the EH layer of the glucose sensors. The error in the R&D software can be 
seen in figure 56, where a spike can be seen at 700 seconds. More data that are 
faulty can be seen in figure 58, where the error can be seen at 7000 seconds. 
Although the polyurethane is clearly the better solution in this case, neither 
method has extended the range of the sensor to cover the upper glycemic levels 
seen in diabetics of around 25 mM/l. To increase the range of the sensors it was 
decided to try using both the extra HEMA outer layer and the polyurethane coat. 
To this end, Sensor 10a was dried for one hour and then dipped in the 4% 
polyurethane solution (Estane 5714) dissolved in THF, allowed to dry for one 
hour and then refrigerated in PBS. 
Two days later it was calibrated for a test of its range with the new membrane, 
however, the sensor signal failed through fracture of the fibre. 
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6. Sensor development and testing 
'I 
Coating 
EH only HEMA Polyurethane 
Sensor 
10a 10b 10a 1Ob 
Operational range (mM/1) 
0-1 0-1 0-4 0-8 
Linear range (mM/1) N/A N/A 0-4 None 
Sensitivity 
(over linear range) 6.7 6.6 1.4 NA 
(KPaJmM/1) 
Approximate 90% 
Response time 100 to 100 to 
100 to 200 NA 
(over linear range) 200 200 
(seconds) 
* noise level approaches resolution above this concentration 
NA - not applicable due to low sensitivity or the response of the sensor to step 
change 
Table 29. The characteristics of Sensors 10a and 10b with and without polyurethane and 
HEMA outer coats 
With no diffusion limiting membranes, both sensors reached their maximum range 
at only 1mM. This was most likely due to the EH layer being extremely thin only 
X6O µm, which puts up an inadequate resistance to glucose causing all oxygen to 
be consumed inside the sensor faster than it can be replaced by diffusion from 
outside. The polyurethane coat is the better of the two solutions however the range 
of the polyurethane sensor is still only 8mM/l. 
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It may be possible to increase the range of the sensors by increasing the EH layer 
depth and then adding polyurethane. However, this would have the effect of 
increasing the size of the sensor. Also, the result of increasing the EH layer depth 
may not be linear, possibly causing a reduction in range, increase in response time 
or complex response to glucose concentration changes. As the current coating 
method created sensors of very similar and stable responses, it was decided to use 
a combination of both HEMA and polyurethane coats. This would minimise the 
size increase of the sensor, whilst increasing range sufficiently to cover the upper 
hyperglycaemic ranges. 
6.15 Investigation of dip coated P02 sensors with both HEMA 
and polyurethane outer coats 
The variation between sensors constructed using the new dip coating technique 
and the effect of adding both a HEMA and polyurethane outer coat were now 
investigated. 
Eight sensors, were made using the dip coating technique and given an outer 
HEMA coat. The sensors were tested and then coated in polyurethane and re- 
tested. 
The first two of the sensors, 10c and 10d, were constructed identically to sensor 
I Oa and tested. They were then coated in polyurethane, however due to a problem 
with the polyurethane, the concentration of which had increased in storage, the 
sensors failed to give useful data. 
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6.16 Extension of the range of sensors 1 Of to 1 Oj using HEMA 
and polyurethane 
Sensors 1Of to 10j were constructed identically to sensor 10a, dried for one hour 
and dip coated in HEMA, they were then dip coated in HEMA twice more 
to form a triple HEMA layer. The sensors were then tested in the 7.5% oxygen 
tensions. Following testing, the sensors were then dried and dip coated in the new 
4% polyurethane solution and then re-tested. 
Sensor 10h broke during construction, and of the surviving fibre sensors, there is 
still a lot of variation, with two of the sensors having a range of 3mM/1 and 
another of 6mM/l. After polyurethane coating, Sensor 10e fractured, Sensor 10g 
showed some contamination of the PBS by GOD, as the reference oxygen sensor 
showed a drop in the ambient oxygen tension of form 6.8 to 5.7 for glucose 
concentrations 0 and 15 mM/1 respectively. Sensor 10j exhibited a very noisy 
signal and showed little response to glucose. After testing the sensors were dip 
coated in 4% polyurethane. The results of the sensors, which did not fail or 
showed cross talk, 10f, lOg and 10i, are shown in figures 60,61 and table 30. A 
comparison of their performance before and after polyurethane coating is shown 
in figure 62 and table 31. The loss of so many sensors during construction is most 
likely a reflection of the fragile nature of the fibre-optic cables. The P7 oxygen 
sensing fibre is only 174µm in diameter (see section 6.12.1) and is consequently 
easily damaged by even slight mechanical stress during the dip coating technique. 
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6. Sensor development and testing 
The dip coating technique and outer HEMA coating has produced sensors of 
similar range and 90% response times. The lack of correlation in response times 
and ranges is probably a product of the complex nature of the reaction-diffusion 
process occurring in the enzyme membrane layer. This complexity causes the 
sensors performance, range response time and linearity of the sensor to be non- 
linearly dependent on the membrane dimensions and composition. 
The response times and sensitivity of the sensors were similar, although, there 
does not seem to be any correlation between range and response time. In table 31 
it can be seen that for Sensor 10f, the range of the sensor doubles after 
polyurethane coating but the response time remains virtually unchanged. For 
Sensor 10i, polyurethane coating actually reduced the response time while 
increasing the range by a factor of three. 
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6.17 Gamma sterilisation of glucose sensors 
Before the sensors can be implanted in vivo, they will need to be sterilised. The 
method of sterilisation used in the production of the P7 is exposure to gamma 
radiation. The sterilisation process involves exposure to 25 - 40 KGy of gamma 
radiation, however this also causes the optical fibre to become opaque. To redress 
this the sterilisation is followed by five days of heating at 55°C, by heating the 
fibre for this period the fibre regains its transparency. 
6.18 The effect of gamma sterilisation on glucose sensors 
while dry 
Following the completion of the previous experiments using sensors, 9b and 9c, 
(Section 6.13) the sensors were dried in air and posted to the Diametrics factory 
where they were forwarded to the gamma sterilisation facility. After 15 days, the 
sensors were returned from sterilisation and were re-tested. The sensors were not 
sterilised in PBS, as this removed the need to re-insert them into the tonometers, 
often leading to fractures. The response of the sensors was then compared to their 
response before sterilisation and with their response before coating with 
polyurethane. 
6.18.1. The results of gamma sterilisation 
The results of the tests of the sensors are shown in figures 63 and 64 for sensors 
9c and 9d respectively. The characteristics of the sensors are shown in table 32. 
The gamma sterilisation has reduced the range of the sensors compared to the 
polyurethane tests. 
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6. Sensor development and testing 
Coating Post gamma EH only Polyurethane 
Sterilisation 
Sensor 
9c 9d 9c 9d 9c 9d 
Operational range 
0-4 0-7 0-24 0-24* 0-14 0-14 
(mal) 
Linear range (mM/1) 
0-4 0-7 0-15 0-5* 0-14 0-4 
Sensitivity 
(over linear range) 1.7 1.8 0.16 0.3 NA NA 
(KPa/mM/1) 
Approximate 90% 
Response time 
NA <100 NA NA NA NA 
(over linear range) 
(seconds) 
* noise level approaches sensitivity above this concentration. 
NA - not applicable due to low sensitivity or the response of the sensor to step 
change. 
Table 32. The response of Sensors 9b and 9c with and without polyurethane and following 
gamma sterilisation 
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The gamma sterilisation of the sensors has reduced the range of the sensor. The 
change in response times is less clear-cut with an increase for sensors 9c and a 
decrease for sensor 9d. This is most likely due to changes in the parameters of the 
membrane, mainly the diffusion coefficients, through chemical changes in the 
HEMA support, due to the complex nature of the reaction diffusion process. The 
polyurethane coat may also be affected, possibly increasing the area through 
which glucose can diffuse, hence lowering the range. 
6.19 Gamma radiation sterilisation of the glucose sensors in 
PBS 
The sensors have been shown to survive gamma sterilisation in a dry state. 
However, as the HEMA used in the sensor will swell when placed in PBS, this 
may cause changing in the sensors characteristics and introduce a measurement 
error. For this reason, the sensor will probably have to be in PBS so that it could 
be used immediately when needed. 
To test the effect of gamma sterilisation in sensors in PBS six sensors were used, 
half were dispatched to be gamma ray sterilised in PBS. The remainder were kept 
refrigerated in PBS until the sterilised sensors returned and were the controls for 
the experiment. Six sensors 8a, 8d, 8e, 8f and 8g from the previous HEMA and 
polyurethane tests, (section 6.9), were used in this investigation. 
Once all of the sensors had been tested, the six sensors were randomly split into 
two groups. Sensors 8a, 8d and 8f were returned to their calibration tonometers 
which had been filled with PBS and were posted to Diametrics Medical Ltd where 
they were forwarded to the gamma sterilisation facility. The remaining sensors, 8e 
and 8g, were also returned to their tonometers, which had been filled with PBS 
and were refrigerated until the other sensors returned from gamma sterilisation. 
These sensors were the control group for the experiment. 
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6. Sensor development and testing 
The time delay between the initial tests and the post sterilisation tests was 
approximately two months as the sensors had to be included in the scheduled 
sterilisation batch at the Diametrics facility. The seal on the P7 tonometer had to 
be removed to insert the sensors, as shown in figure 17. 
6.19.1. The performance of the sensors following gamma 
irradiation in PBS 
Upon the return of the sterilised sensors, all of the sensors were re-tested. When 
the control sensors were removed from refrigeration, it was found that sensors 8b 
and 8g appeared to be `frozen' into their tonometers either from ice crystals or 
from salts from the PBS that had crystallised out in the neck of the tonometer. 
With the use of fresh PBS, the sensors were freed but both sensors failed to 
calibrate almost certainly due to breaks in the optical fibres caused by the crystal, 
or ice formations. However, sensor 8e was still operational and calibrated 
normally following removal from refrigeration. The results of the tests of the 
sensors before and after irradiation are shown in figure 65 and control in figure 
66. 
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6. Sensor development and testing 
The sensors survived gamma sterilisation, although the process changes the 
performance of the sensors. The sensors are heated for five days above forty 
degrees (55°C), which also should destroy the GOD (section 2.2.5). However, 
immobilisation seems to have imparted thermal and radioactive stability on the 
enzyme, (section 2.3.5). Deactivation of large amounts of the enzyme, which 
would cause the sensor to operate in reaction-limited mode, is also possible, see 
Chapter 2. However, it is probably not the case as enzyme deactivation on that 
scale would probably destroy all of the GOD in the sensor, the chances of 
destroying just enough enzyme to leave the sensor partially operational are 
probably slim. The one surviving control showed good repeatability despite being 
stored for one month, indicating that the sensors have a good shelf life. However, 
due to the compromise of the watertight seal in the tonometer it is possible that the 
PBS in whole or part had leaked out of the P7 tonometer. 
6.20 Gamma sterilisation of a dip coated P02 sensor 
Following the previous test of Sensor 1 Of, the sensor was rinsed, placed into the 
tonometer and posted to Diametrics medical to be sent for gamma sterilisation. 
The sensor was sterilised and returned one month later. In the previous 
experiments, the sensor was either sterilised dry, or in PBS, but with the 
watertight seals compromised to allow the sensors to be re-inserted into the 
tonometer without damage. This meant that the PBS solution may have leaked 
from the tonometer during transit. 
In the previous experiment, the silicone watertight seal was removed from the 
tonometer to allow the sensor to be re-inserted. This meant that the solution inside 
the tonometer could possibly have escaped. So there is no guarantee that the 
sterilisation of the sensor was done wet. 
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To improve the experiment by ensuring that the PBS did not escape form the 
tonometer, the gas permeable vents were sealed with epoxy resin to prevent water 
loss through evaporation. The silicone washer, which was removed in the previous 
experiment, was cut in half to allow it to be re-fitted after the sensor was inserted 
into the tonometer. A piece of cotton was tied around it to allow the washer to be 
removed without damage to the sensor as shown in figure 67. 
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Silicone washer, 
cut to allow re- 
fitting. 
Thermocouple 
Enzyme 
coated sensor 
PBS 
solution 
Figure 67. The modified P7 tonometer 
Cotton thread, used 
to pull out washer 
when the sensor 
was removed. 
Epoxy 
sealed gas 
channels. 
6.20.1. Performance of the sensors after gamma sterilisation in 
PBS 
After the return of the sensor, it was removed from the tonometer, manually 
calibrated and tested. The PBS remaining in the tonometer was removed using a 
hypodermic syringe and its volume measured at 3m1. This was a sufficient volume 
to keep the sensor wet during the sterilisation process. The results of the glucose 
calibration are shown in figure 68 and table 33. 
200 
an 
^v c 
cu 
E 
0 
10 
G 
I'D 
O 
r 
0 N 
0 
ö 
0 
Co 
0 
0 
v 
O 
04 
I4,1 I10 
O 
OOOOOOOOO 
co N tD in Cl) N0 
(edM) 6uipeaJ Ld 
E 
C 
O 
w 
CC 
d 
V 
C 
O 
U 
0 
h 
O 
V 
7 
0 
Z 
E 
E 
0 
rn 
0 
0 
t) w 
on 
0 
.. C 
O 
O 
U 
Qr 
0 
0 
0 
t, 
0 
00 
do 
Gz. 
ö 
N 
6. Sensor development and testing 
Sensor lOf lOf lOf 
(HEMA) (poly) (gamma) 
Operational range (mM/1) 
0 to6 0 to13 0 to4 
Linear range (mM/1) OtoS 0 to13 0 to3 
Sensitivity 
1.3 0.5 1.8 
(over linear range) (KPa/mM/l) 
Approximate 90% Response time 
(linear range) 100 to 200 100 to 200 NA 
(seconds) 
Table 33. The performance of sensor 1 Of before and after gamma exposure 
The sensor has survived wet sterilisation with the reduction in range observed in 
previous sensors exposed to radiation. It was considered that the smaller volume 
of enzyme-layer might have caused the sensor to be more susceptible to the 
effects of irradiation than a larger one. As there was less enzyme in the sensor 
there is less spare enzyme, so any deactivation may quickly lead to the sensor 
working in reaction controlled mode. The effects observed could also have been 
caused by the destruction of the polyurethane. 
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6.21 Shelf life tests of dip coated P02 sensors 
To be of use as a practical glucose sensor, the sensor will have to be stored 
probably for extended periods in the order of three months. To investigate this 
testing, Sensor 10i was stored in refrigerated PBS for two months and then re- 
tested. Two further sensors, 10f and 10g, were stored for three months and then 
re-tested. The performance of the sensors before and after storage was then also 
compared. The performances of the three sensors before and after storage are 
shown in figure 69 and table 34. 
203 
on 
N aý b 
c R 
E 
0 äý 
aý 
0 
a> vn 
No 
O 
Ö 
N 
0 
Go 
O 
Co 
0 
v 
O 
E 
c 
0 
dm 
V 
c 0 V 
0 
v 
o C9 
0 
Co 
0 
v 
0 
04 
0 
0 
on 
eu 
aý 
J., 
oA 
0 
b 
cC 
cam 
ON 
ti 
O 
H 
O 
U 
wo 
an 
w 
000000000 
ad tý cö 46 vC) cri ö 
(ed)) 6uipeeJ ueße(xo Ld 
an c r, N 
V 
b 
c 
c 
E 
a. 0 ä 
aý 
L 
0 
y 
i 
110 
Cn 
p 
r 
Ö 
e 
O 
O 
O ^; 
N 
_O 
O 
N O 
O 
p 
p p 
N 
O 
- 
O O O 
r_ cu 
O O 
N O 
O O O 
N 
. -r m 
C 
to 
O 
N 
O 
O 
N 
O 
O 
vi 
O 
O O 0 
"+C 
p 
r 
O 
M 
O 
M 
O 
O 
O 
O 
N 
O 
O 
O 
.. r 
z 
w- O 
z z 
O 
pz 
vý 
C 
Ö ä 
C 
>, 
v0 
C°c 
o a) 
¢Q 
c R 
s 
aý L 
ö 
a 
s w 
3 
cn 
0 U 
L 
R 
.a _ 
R 
N L 
22 
N 
M 
Co 
LI.: 
y 
L 
0 
H 
N 
h 
4. 
N 
L 
ce 
R 
L 
R 
a 
0) 
U 
R 
L 
N 
a 
v s E- 
M 
N 
.. O ß 
E"' 
0 N 
6. Sensor development and testing 
The sensors performance had degraded in all three cases, although the range of the 
sensors had not degraded to the. point where they could not be used as a potential 
glucose sensor. After storage, the 90% response times for the sensors decreases 
for sensors 10f and lOg but increased for sensor 10i. This is probably an 
illustration of the non-linear nature of the reaction taking place in membrane 
layers. 
6.22 Effect of 24-hour operation on sensor performance 
The sensors will have to operate from between 12 and 24 hours to provide 
nocturnal monitoring and to minimise the number of times the sensor is changed 
when in operation. To investigate the effect of 12 and 24 hour operation on the 
sensor performance characteristics, two sensors, 1 Og and 1 Oi, were operated for 24 
hours in 5mM/l of glucose. 
After the conclusion of the previous experiments, two sensors, IOg and 10i were 
rinsed with distilled water and placed in PBS containing 5mM/1 of glucose in 
7.5% oxygen for a 24-hour period. At the end of the 24 hours the sensors were re- 
calibrated and re-tested. Their performance before and after the 24 hour run was 
then compared. 
The performance of both sensors had changed after the 24-hour run as can be seen 
in figure 70 and table 35. Sensor lOg showed the greatest change, with its 
maximum range dropping form 15 to 11 mM/l, Sensor 10i actually shows an 
increase in range form 6 to 7 mM/l. The response time of sensors IOg and 10i, 
shown in table 35 has reduced. 
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6. Sensor development and testing 
The effects of the 24-hour run on the sensors are significant enough to necessitate 
a recalibration at least oncq during this period if this were an in vivo situation. The 
effect of 24-hour exposure to the glucose solution on the sensors is unclear. The 
changes cannot be attributed to calibration drift in the P7 sensor, as response times 
have changed with range. A calibration drift may change the range of the sensor 
by lowering or increasing the oxygen reading, but this would not affect the 
response time. Two other possible explanations are deactivation of the enzyme, 
pushing the sensor into a reaction-diffusion limited state, (Chapter 2) or some 
structural change in the membrane that is changing the mass transport resistance 
values. Either way, the error in measurement is sufficient to require recalibration 
at regular intervals of every six hours. 
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6.23 Summary of the sensor development and testing 
6.23.1. The initial experiments on a standard P7 sensor 
The initial glucose sensor (sensor 1) was made by dip coating the complete P7 
sensor bundle in a GOD and HEMA mixture. This was then tested in a 15% 
oxygen tension at 37°C and pH 7.4. The sensor was found to have a range of 0 to 
4mM/I with a 90% response time of <100 seconds. This range was extended using 
an outer coat of HEMA, which extended the range to 7 mM/l with no increase in 
response time. However, the sensor was found to have a range and sensitivity (1.1 
to 0.4 KPa/mM/l) after 12 hours in a solution at 6mM/l. Catalase was added to the 
enzyme HEMA mixture in Sensor 2 to improve the design. Sensor 2, although 
performing well to increasing glucose concentrations, failed to show a response to 
decreasing glucose concentrations. Sensor 3 was made with a thinner outer 
HEMA coat than its predecessor and was shown to respond to decreasing glucose 
concentrations. A second oxygen sensor was used with Sensor 4 to provide a 
differential oxygen measurement. Initially this experiment indicated that GOD 
was leaving the HEMA layer and dissolving into solution. After rinsing with PBS 
solution this problem was resolved and the sensor was tested to up to 4 mM/l. 
6.23.2. Coating of the enzyme HEMA mixture directly onto the 
P7 oxygen sensing fibre 
A glucose sensor (Sensor 5) was then made by splitting open the P7 sensor bundle 
and coating the oxygen sensing fibre (P02) directly. A riadially-symmetric sensor 
design was then made by enclosing the GOD, CAT and HEMA in a MPHF sleeve 
(Sensor 6). This sensor had a maximum range of 2 mM/l and was shown to 
respond to decreasing concentrations with T90 of <100 to increasing and 
decreasing concentrations. Sensors were then constructed using a different 
technique, which involved coating the P02 sensors of the P7 sensor directly with 
HEMA, CAT and GOD. The coating technique produced a sensor (Sensor 7) with 
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an operational range of 6 mM/l and a 90% response time <100 seconds. A 
variation of this coating technique was used to produce Sensors 8a to 8g. This 
technique involved coating all four of the sensors in HEMA, GOD and CAT. This 
technique produced a wide variation in sensor performance with sensor ranges 
from 3 to 10mM/l. 
6.23.3. The application of polyurethane for improved 
performance in low oxygen tensions 
Two of these sensors (8a and 8g) were then improved by coating the sensors with 
polyurethane. The polyurethane coating increased the range of the sensors from 3 
and 7mM/l to 21 and 17mM/1 respectively. However, the signal produced by these 
sensors exhibited a large amount of noise in their signal. The sensors were also 
tested in both 7.5 and 15% oxygen tensions to investigate their performance in 
varying oxygen tensions. The profiles of the sensors were found to be similar in 
both oxygen tensions, suggesting an immunity to background oxygen variations. 
Following this experiment, all of the sensors were tested in 7.5% oxygen tensions 
as this better reflected the oxygen environment of the subcutaneous tissue. 
6.23.4. An enzyme coating technique using an absorption 
method 
The coating technique was then improved to allow a dip coating approach; this 
involved the removal of the pH and CO2 sensors and the dip coating of only the 
P02 sensor. Initially the sensors (9a) had a range of only 1mM/l. A new coating 
technique was tested which used an absorption coating technique where HEMA 
was applied to the surface of a P02 sensor and then GOD and CAT absorbed into 
it from solution. This produced a sensor (Sensor 9b) with a range of 15 mM/l in 
7.5% oxygen. The sensor' was then coated in polyurethane but showed a spurious 
response following coating. 
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6.23.5. Improvement of the dip coating technique to optimise 
sensor performance 
The dip coating technique was then optimised using a laser micrometer to 
measure the depth of the enzyme layer deposited. It was found that an enzyme 
layer of as thin as 60µm thick could be deposited using this new technique. This 
new optimised coating technique was then used to construct a sensor (9c) that had 
a range of up to 4mM/l. Sensor 9c and a second sensor (9d) constructed using the 
same method were then coated in polyurethane to extend their range. The 
polyurethane increased the range of the Sensor 9c from 4 to 24mM/1 and sensor 
9d from 7 to 24 mM/l, although the signal from the polyurethane coated sensors 
was noisy. Sensitivity for Sensor 9d changed from 1.8 to 0.3 KPa/mM/1 after 
coating the response time, where it could be discerned, was <100 seconds for 
Sensor 9d before coating. Six sensors 10e to 10j were then created using the dip 
coating technique and the variation between sensors examined. Variations in 
performance were found, with sensing ranges from 10 to 20mM/l following 
coating with polyurethane. 
6.23.6. Sterilisation of the sensors using gamma irradiation 
Two sensors, 9c and 9d were then gamma sterilised while dry, both had an initial 
maximum range of 24mM/l. Following sterilisation with 25-40KGy gamma 
radiation the range of both sensors was reduced to 14 mM/l, although the 
performance profiles of the sensors were not identical. Sensors 8f, 8d, 8a and 10f 
were then gamma sterilised while in PBS solution, with similar results, the range 
of Sensor I Of for example, was reduced from 13 mM/l to 4 mM/i. 
6.23.7. Investigations of the shelf life of the sensors 
The effect of storage in refrigerated PBS for up to three months was then 
investigated using three sensors. The storage caused a decrease in range from 4 to 
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3mM/1 (sensor 101), 20 to 15mM/1 (sensor 10g) and 10 to 6mM/1 (sensor 10i). 
Response times were reduced in one case but unchanged in the second case, the 
third sensor's response was not linear so no response time was measured. 
6.23.8. The effect of 24-hour operation on the sensors 
Sensors I Og and IOi were finally tested over a 24-hour operation period in 5mM/l 
of glucose. It was found that the range of the sensors was reduced from 15 to 
11mM/l for Sensor lOg and increased from 6 to 7mM/1 for Sensor 10i. The 
response times for both sensors remained unchanged at between 200 to 300 
seconds for Sensor lOg and 100 to 200 seconds for Sensor 10i. 
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7 Overall summary and conclusions 
7.1 Introduction 
In this chapter, the objectives of the research are briefly reviewed and the research 
carried out to fulfil these goals is summarised. The performance of the sensors 
produced is then evaluated and compared to the research goals. Limitations of 
both the sensors produced and the experimental method used to develop and test 
them is then discussed. The glucose sensor system produced is then compared 
with the general field of blood glucose sensors described in the literature. A 
comparison is then carried out between this sensor system and the most closely 
related fibre-optic sensors that have been developed by other groups. Finally, 
areas of further work on the research are considered and the contribution of the 
research to the field of blood glucose sensors is discussed. 
7.2 Review of the goals of the research 
The objective of this research was to develop a sensor capable of continuously and 
reliably monitoring blood glucose levels to improve the management of type I 
diabetes. Its development could help reduce or prevent both the long-term 
complications and hypoglycaemic episodes of insulin treated type I diabetes. 
Rather than an investigation of the glucose sensing technology, the research was 
aimed at producing a practical glucose sensor that could possibly be put to clinical 
use as quickly as possible if the development proved successful. To this end the 
Paratrend 7 oxygen sensor was chosen as it was already in clinical use and 
therefore clinically safe and reliable. This sensor provided a solid core technology 
around which the glucose sensor could be developed without concerns about the 
reliability, safety or performance of the oxygen sensor. 
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As discussed in Chapter 1, for such a sensor to be of use it was decided that the 
sensor should fulfil various performance requirements. Briefly, these were a 
measurement range of 0 to 25 mM/1 with a resolution of lmM/l and an error no 
greater than 10% of the total signal (above 2.8mM/1). The 90% signal response 
time was required to be below 240 seconds and the sensor, if an implanted needle 
type, was to be no larger than 0.5 mm in diameter. As well as these requirements 
the sensor was to be sterilised, operate for between 12 and 24 hours and have a 
shelf life of the order of 3 months. 
7.3 Summary of the research carried out 
A commercial fibre optic oxygen sensor (Paratrend 7, Diametrics medical Ltd) 
was modified into a glucose measurement system capable of fulfilling all of the 
requirements stated above. From a crude prototype, the sensor design was 
developed into a ; 300µm diameter needle style fibre optic glucose sensor, which 
could withstand sterilisation by gamma radiation and still operate. The same 
design was shown to survive storage for up to three months followed by operation 
for 24-hours and still measure glucose concentrations well enough to detect 
hypoglycaemic episodes. The sensor design incorporated two active enzymes, 
glucose oxidase and catalase, a HEMA support matrix. HEMA and polyurethane 
diffusion controlling membranes were developed and incorporated into the sensor 
to increase the range and reduce sensitivity to background oxygen fluctuations. 
An experimental system capable of recreating physiological oxygen, temperature 
and pH conditions was constructed and used to test the sensors. 
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7.4 The performance of the glucose sensor produced by the 
research 
The performance requirements of the sensors were described in detail at the start 
of the thesis, in this section these aims and what was achieved are compared. 
7.4.1. The range and resolution of the sensors produced 
by the research 
The first sensor performance goal to be considered will be the range of the sensor. 
A sensor with a range of up to 25 mM/l, see table 2, Chapter 2, was aimed for. 
With the crude dip coating techniques used in this research, there was an 
uncontrollable variation in the enzyme membrane dimensions and therefore the 
range of the sensors produced. Some sensors demonstrated high sensitivity but 
low maximum range, with one Sensor, 10a, having a maximum range of 1 mM/1 
with a resolution down to --0.1 mM/l, others could measure glucose 
concentrations of up to 24 mM/l (Sensor 9d) with reduced sensitivity. This range 
is equal to or better than that observed with the electrochemical and fibre optic 
glucose sensors discussed in Chapter 2. However, most of those sensors were 
tested in atmospheric oxygen tensions, whereas in this research the sensors were 
tested in low oxygen tensions in order to replicate the subcutaneous environment. 
The other sensing techniques, such as MRS and microdialysis, have also been 
shown to cover similar ranges to this sensor. 
The range and sensitivity of this sensor design and all oxygen based GOD based 
designs are inextricably tied together. As described in Chapter 3, the glucose 
concentration is calculated from the decrease in oxygen tension, measured as the 
glucose concentration increases. The initial oxygen tension is the ambient of the 
environment of the sensor. In the case of this experimental work, the ambient 
oxygen tension of the sensor was at 7.5 KPa (for the later experiments). This 
means that the entire glucose range being covered must be effectively divided up 
into 7.5 KPa. This problem is further complicated by the fact that the Paratrend 7 
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performance specifications give a lower measurement limit of 2.7 kPa (table 6). 
Although in the experimental work it was observed that the sensor appeared to 
continue functioning below this tension, however, the validity of these values is 
uncertain. This leaves only the oxygen tension region form 2.7 to 7.5 kPa, a total 
of 4.8 kPa, to cover the entire glucose range. If we were to attempt to build a 
sensor that could cover the range 0 to 25 mM/I this would mean that the oxygen 
sensor would have a sensitivity of 4.8/25 or 0.192KPa/mM/l. 
The next consideration in the resolution of the sensor is the error in the P7 oxygen 
measurement. Initially the in vivo performance characteristics of the sensor, table 
7, Chapter 5, would seem the best indication of the error in a sensor operating in 
an in vivo environment. However, these values, in particular the precision of 
13.2%, are calculated from the differences between the blood oxygen tension 
measured using the reference method and those reported by the P7. Differences in 
these measurements can be caused by many physiological factors; for example, 
placement of the sensor into the wall of the blood vessel as opposed to the centre 
of the vessel or coating of the sensor surface with biological material that would 
create a diffusion barrier to oxygen. It is unlikely that errors resulted from 
interference from other gasses as the sensor is unaffected by gasses found 
naturally occurring in the blood stream and its hydrophobic coating prevents 
analytes in solution from entering the sensor. In its application here, as a glucose 
sensor core, the P7 oxygen sensor is only being used to measure the oxygen 
tension in its immediate environment, in this case around ; 100-200µm, from its 
surface. This means that none of the physiological effects that probably played a 
role in the in vivo errors will be relevant and therefore the in vitro sensor test 
results, table 6 chapter 5, are the correct ones to apply to any calculations of 
accuracy. This will mean that the measurement error is now reduced to 5% from 
13.2% (tables 6 and 7, chapter 5). 
However, there is another consideration in calculating the error, as the proposed 
sensor was to use a second oxygen sensor as a reference to compensate for 
variations in environmental oxygen tensions. In the case of this reference oxygen 
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sensor, the in vivo results may be more relevant. The reference sensor is only 
being called upon to measure the oxygen tension, inside the MPHF coating, not 
the true environmental oxygen tension. So again, the in vitro measurements are 
probably more relevant. 
The use of the reference sensor will also increase the possible error in the 
measurement. As there are now two sensors, an oxygen sensor with a possible 
error of 5% and the glucose sensor with a 5% error in its oxygen core 
measurement and then a further error caused by the response of its enzyme 
membrane. 
This means that there is, in the worst-case scenario a possible error of a minimum 
of 10% of the true oxygen value in any single measurement. However if the 
sensors readings were averaged over time, say 30 seconds, with one measurement 
per second, this would allow 30 measurements to be averaged, and the error could 
then be reduced. 
Considering a glucose sensor with a measurement error of 10% in the oxygen 
tension measurement, assuming a glucose sensor and oxygen reference sensor 
with a 5% error each (table 6, chapter 5). As the oxygen tension measured is 
inversely proportional to the glucose concentration the largest error will occur at 
the lowest glucose concentration. Therefore, at 0 mM/l of glucose, the oxygen 
tension measured at both the reference and the glucose sensor will be 7.5kPa. A 
5% error in each sensor will give a oxygen tension range of 7.5 ± 0.4 kPa, the 
largest error that will be encountered. Assuming the worst-case scenario, this 
gives a total error in the oxygen tension measurement of at least 0.8 kPa. 
So if a sensor was constructed to cover the full range from 0 to 25 MM/1 the 
maximum error would be 0.8/0.192 = 4.2mM/l. This would obviously be a 
dangerous error. If however, two sensors were used, one to cover low glucose 
concentrations (0 to 10 mM/l) and the second to cover higher levels (10 to 25 
mM/1). The lower range sensor (0 to 10 mM/1) would give a sensitivity of 4.8/10 = 
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0.48 kPa/mM/l. At the maximum error at 7.5 kPa i. e. 0 mM/I glucose 
concentration the error would be 0.8/0.48 = 1.7 MM/l. This is above the 1 mM/1 
error limit aimed for at the beginning of the thesis but is still small and will 
decrease with increasing glucose concentration. For example at 5 mM/I the error 
in the glucose sensor would be (7.5-(5x0.48))xO. 05 = ±0.26 kPa and for the 
oxygen reference the error would be ±0.4 kPa. This gives a total maximum 
possible error of ±0.66 kPa which equates to ±1.4 mM/l. For the sensor covering 
the upper concentrations, the errors are less significant as the concentration of 
glucose is higher, i. e. they are a smaller percentage of the glucose concentration. 
For example, the sensor covering the range 10 to 15mM/I will have a sensitivity of 
4.8/15 = ±0.32 kPa/mM/l. At 20 mM/1 the error in the oxygen tension will be (7.5- 
(lOxO. 32))xO. 05 = ±0.22 kPa, with a reference error of 0.4kPa this gives a total 
possible error of ±0.62 kPa which equates to ±1.3 mM/I which is only 6.5% of 
the glucose concentration measured. 
Sensors that covered this range 0 to 10 mM/1 between 7.5 and 2.7kPa were 
constructed; namely sensors 9d (after coating with polyurethane) and 8a 
(following gamma irradiation). Others sensors had a similar range but invaded the 
2.7 to 0 kPa zone namely 8f (with polyurethane coat), 10i (with polyurethane 
coat), 10f (with polyurethane coat). Comparing this to the other fibre optic 
sensors, the multiple sensing sight sensor created by (Li and Walt 1995 ; Healey, 
Li et al. 1997) had an accuracy of 0.6m /l but only covered the range of 0 to 2 
mM/l and, like the other sensors, this sensor was tested in much higher 
concentrations of oxygen than this sensor. The electrochemical sensors have 
problems with interference from other blood constituents that have to be 
considered when their accuracy is calculated. Disregarding this however, these 
types of sensor have been shown to have resolutions equal or better than this 
sensor. The exudate and microdialysis sensors have also been shown to have 
similar or better resolution but are hampered by the delay in signal response. 
Although in some cases the MRS has similar resolution the random interference 
they suffer makes them unreliable as a means to measure blood glucose 
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concentrations. The other techniques, such as PAS and kromoscopic analysis have 
insufficient data published to make comparisons. 
Hysteresis in the sensor response is another potential source of measurement 
error. This was highlighted in the tests of sensor 7, section 6.7, where a glucose 
sensor was cycled through a glucose increase followed by a decrease and followed 
a hysteresis loop. Due to the complex nature of the reaction diffusion process at 
work in these sensors it is difficult to predict if hysteresis is likely to play a 
significant role in their behaviour. However, if it is present it could be a 
serious source of error, particularly following large changes in the blood glucose 
levels as the sensor would fail to return to a true value. 
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7.4.2. The response time of the sensors produced 
Nearly all of the sensors produced demonstrated 90% response times well inside 
the 240-second limit. Some sensors showed response times in the order of below 
100 seconds (9d). However, the majority operated in the 100 to 200 second range. 
The response time of the sensor is dependent on the dimensions and structure of 
the enzyme membrane through the diffusion resistance that the membrane puts up 
to glucose and oxygen. A membrane with a higher permeability should allow the 
membrane to equilibrate with its surroundings more quickly. 
Some of the sensors were observed to reach their 90% response in below the 180 
seconds limit of the P7 sensor, this was probably due to two reasons. Firstly, the 
values given for the performance of the Paratrend 7 are deliberately conservative 
for reasons of safety. Secondly, the removal of the MPHF coat and acrylimide 
filling would reduce the diffusion resistance to oxygen of the system, allowing it 
to respond to changes in the oxygen tension more quickly. The response times of 
the sensor presented here are superior to the exudates and microdialysis systems. 
Compared to the electrochemical and fibre optic sensors, similar response times 
are seen or in some cases are superior as in Rosenzweig and Kopelman 1996, 
whose sensor showed a response of 1.5 seconds due to its small size. The LAIRS 
and PAS systems, in theory, can make measurements in a matter of seconds also 
depending on the equipment being used to collect the optical or acoustic signal. 
7.4.3. Storage of the sensors and 24 hour operation 
The requirements for the sensors to survive storage for 3 months were 
investigated using sensors 1 Of, IOg and 10i. All of these sensors showed a change 
in performance after storage. The reason for the changes in performance could 
have been due to enzyme diffusing out of the membrane into the storage solution. 
If this were the case, the loss of enzyme may have changed the operation of the 
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sensor into reaction controlled mode, or altered the diffusion resistance of the 
membrane to glucose and oxygen. The enzyme could also have been deactivated 
by some chemical process in the solution during storage, this would also possibly 
lead to the sensor moving to a reaction controlled mode of operation. 
Alternatively, the changes in performance could have been due to some long-term 
alterations in the structure of the HEMA or polyurethane membranes. This again 
would have led to alterations in the diffusion characteristics of the sensor and 
therefore its performance profile. There was no change in the response times of 
the sensors indicating that perhaps they are not operating in a reaction controlled 
mode where response time is dependent on glucose concentration, see Chapter 3. 
If the sensors were operating in reaction controlled mode it would explain the 
changes in sensor operation in the following 24-hour operation test. However, this 
could also have been caused by deactivation of the GOD by hydrogen peroxide 
generated during the 24-hour operation. 
The changes encountered during storage would have to be removed or reduced in 
a practical sensor. This could probably be achieved through a better 
immobilisation of the enzymes in the membrane using a longer soaking in 
glutaraldehyde or the use of a more efficient immobilisation technique. In 
addition, the enzyme loading of the membrane could be increased to allow more 
spare capacity in the system to handle enzyme loss or deactivation. From a safety 
point of view, the loss of enzyme into the body would not be acceptable as it 
would probably trigger an immune system response to the sensor, threatening both 
sensor operation and patient safety. 
Compared to the other similar sensing technologies, i. e. electrochemical and fibre 
optic glucose sensors, this sensor's 24 hour operation was shorter than expected. 
Electrochemical sensors have been built which operated for several weeks in in 
vivo situations. Other fibre optic sensors have been shown to operate for several 
days before failing. This quickly reduced operational range of the sensor could be 
the result of insufficient loading of GOD into the membrane layer causing 
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deactivation of the enzyme which affected the sensors performance. Alternatively, 
the diffusion limiting membranes could have prevented the hydrogen peroxide 
from quickly leaving the sensor causing it to build up and deactivate the GOD 
despite the action of the CAT. 
7.4.4. Sensor dimensions 
Individual glucose sensors could be made with diameters from between 0.26 and 
0.30 mm in diameter as was shown in section 6.12. However, the final glucose 
sensor will have to include a reference oxygen sensor and a temperature sensor 
enclosed in an MPHF sleeve. The combination of these sensors with the MPHF 
sleeve will probably be slightly larger than the 0.5 mm diameter aimed for at the 
beginning of the research. The size of the sensor could probably be further 
reduced through the use of a more precise enzyme membrane coating technique 
and a membrane with an increased mass transport resistance to glucose. The 
sensor size is comparable to its counterpart electrochemical and fibre optic sensors 
apart from (Rosenzweig and Kopelman 1996), which was only 100µm in diameter 
but was not constructed for in vivo operation. 
7.4.5. Sterilisation of the sensors 
The gamma sterilisation experiments proved an unexpected success with all of the 
sensors sterilised, either dry or in PBS surviving. It was expected that exposure to 
such radiation levels (20-40 KGy) and heating at 55°C for five days would 
destroy the enzymes in the sensors. However, although showing degradation in 
performances, which were probably due to structural changes in the HEMA and 
polyurethane matrices, the sensors did function. The cross linking of the GOD and 
CAT using glutaraldehyde probably played a role in helping the enzymes survive 
these conditions by allowing the enzyme to absorb the thermal energy and 
radiation without being denatured. The increased thermal stability has been 
described in the literature, see Chapter 3. The presence of catalase may have also 
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played a role in breaking down any hydrogen peroxide created by the process 
before it could damage the GOD in the enzyme layer (Bobbioni-Harsch, Rohner- 
Jeanrenaud et al. 1993; Woedtke, Julich et al. 2002). 
7.5 Limitations of the experimental work 
With only two P7 sensor base units, it was only possible to test one sensor and 
reference at a time. Although the basic principles of operation of the P7 oxygen 
sensor were available, as described in Chapter 5, details on the electronics and 
calculations carried out in the software were unavailable. This lead to the 
operation of the P7 oxygen sensor becoming slightly `black box'. The dip coating 
technique used, although it proved effective enough to provide working sensors, 
was crude. This meant that the dimensions and therefore performance of the 
sensors could only be controlled to a very low tolerance. Because of this it was 
impossible to create identical sensors in order to compare their performance under 
various conditions. A working mathematical model of the sensor would possibly 
have been a useful tool during the research. However, with the crude dip coating 
technique used here, a model would have been of little use as it would not have 
been possible to control the membrane dimensions to match any values predicted 
as being ideal by such a model. Consequently, until a more precise coating 
technique is found a mathematical model would be of little use. In addition, the 
development of such a model was not a trivial endeavour and would probably 
constitute a research project of at least equal size to this thesis. 
The measurement of the response times of the sensors was only an approximate 
measure, as the volumes of glucose being added to the solution were small (50µl) 
compared to the volume in the tonometer (50m1 or 100ml). This meant that there 
was a random delay when the glucose solution mixed with the much larger 
volume of PBS solution in the tonometer. For the experiments where the glucose 
concentration was reduced, the change in glucose concentration was much faster 
than for increasing concentrations as large volumes of PBS, equal to the volume 
225 
7. Conclusions 
previously in the tonometer, were added. This would lower the glucose 
concentration almost instantly and hence led to faster response times for the 
reducing glucose concentrations. 
7.6 Comparison of the developed sensor with other glucose 
sensing technologies 
The sensor described in this thesis is composed from several different 
technologies described in the literature; these are combined into a new glucose 
sensing approach. As with the other fibre optic glucose sensors, the interference 
problems of the electrochemical sensors are overcome by the florescence oxygen- 
measuring core (Moreno-Bondi, Wolfbies et al. 1990; Schaffar and Wolfbeis 
1990; Li and Walt 1995; Healey, Li et al. 1997). The oxygen stoichiometric 
problem is attacked using polyurethane as with the electrochemical glucose sensor 
designs (Shichri, Yamasaki et al. 1982; Claremont, Sambrook et al. 1986; Shaw, 
Claremont et al. 1991). In addition, catalase is employed to also help redress 
oxygen limitation as well as to protect the GOD (Tse and Gough 1987; Wilson 
and Turner 1992). A major strength of this sensor design is the clinically proven 
oxygen sensing core technology of the P7. This tried and tested oxygen sensing 
base leaves only the GOD-CAT-HEMA technology to be developed and adapted. 
The use of this clinically proven sensor gave the produced glucose sensor an 
extremely stable and reliable core and was chosen so as to give the research the 
best chance of producing a working glucose sensor that could be developed for the 
treatment of diabetes. 
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7.7 Comparison of the developed sensor with other fibre- 
optic glucose sensors described in the published literature 
In the published literature, the closest group of sensors to the sensor developed 
here are the fibre-optic glucose sensors described in Chapter 2, namely Moreno- 
Bondi, Wolfbies et al. 1990; Schaffar and Wolfbeis 1990; Li and Walt 1995; 
Healey, Li et al. 1997, which all used oxygen sensitive fluorescent dyes 
surrounded by GOD. Although these sensors did not employ CAT in their enzyme 
coatings, despite this the sensors constructed by Moreno-Bondi, Wolfbies et al. 
1990 had a storage lifetime of 12 months when stored at 4°C. The sensor 
developed by Li and Walt 1995 showed similar performance to the sensors 
developed here although the lowest oxygen tensions tested were 10.1 KPa, so the 
sensor presented has been shown to operate in lower oxygen tensions. The sensor 
developed by Li and Walt 1995 also had a much smaller diameter than the sensor 
design presented in this thesis and measured oxygen as well as glucose. The 
multiple sensing sites, each covering a different range of glucose concentrations, 
would also allow the sensor to cover a wide range of glucose concentrations. 
None of the other sensors cited in the literature use both glucose oxidase and 
catalase in their construction. Polyurethane outer membranes also do not appear to 
have been employed in the construction of any of the other fibre optic glucose 
sensors. The use of gamma radiation to sterilise a fibre-optic glucose sensor seems 
to be unique among fibre optic sensors although it has been used with 
electrochemical sensors (Bobbioni-Harsch, Rohner-Jeanrenaud et al. 1993; 
Woedtke, Julich et al. 2002). 
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7.8 Further work 
The membrane coating technology should be developed and improved, possibly 
using a different technique to the dip coating methods described here. A technique 
needs to be developed where the membrane dimensions can be strictly controlled 
and hence the range and other parameters of the sensor dictated at will. 
With a precision enzyme membrane coating technique the use of a mathematical 
model of the sensor may become viable. Such a model could be used to predict 
the performance of various sensor designs without the need for lengthy 
construction and experimental work. This would allow future work to be targeted 
towards designs that were most likely to provide the required performance 
parameters. 
The lifetime of the sensors, in both storage and operation, needs to be improved; 
this could possibly be achieved through longer exposure to glutaraldehyde or 
some other means of improving enzyme immobilisation. Alternatively, greater 
amounts of enzyme could be loaded into the membrane layer. 
To cover the full physiological range, a second sensor should be developed that 
can cover the upper range of glucose concentrations following gamma 
sterilisation. Combined with the sensors developed here, which cover the lower 
ranges, this would enable three sensors, an oxygen reference, the lower and upper 
range glucose sensors and a thermocouple, to be encapsulated in the MPHF sleeve 
in the same way as the current P7 multi-parameter sensor. 
Following the development of the sensor to cover the upper range, the sensors 
should be put through the Diametrics manufacturing line to produce a sensor 
encapsulated in the MPHF sleeve. The performance of the sensor may be changed 
significantly by this and the enzyme-HEMA membrane changed appropriately. 
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Hysteresis in the sensors response should also be investigated in depth, both 
through mathematical models and experimental work. Appropriate membrane 
configurations could then be chosen to avoid this source of error in the 
measurement. 
Finally, the sensor needs to be tested in vivo in subcutaneous tissue. The 
application of biocompatible and angiogenic membranes may also have to be used 
to overcome tissue response. 
7.8.1. Contribution 
A clinically proven commercial blood oxygen sensor (Paratrend 7) has been 
modified to detect glucose over the physiological concentration range and in vivo 
pH and temperature values. The sensor has been shown to operate in low oxygen 
tensions (7.5kPa) in order to potentially operate in the subcutaneous tissue where 
oxygen tensions of as low as this may be encountered. The range, sensitivity and 
response times of the sensor developed are sufficient to allow it to function as an 
hypoglycaemic alarm and as a means to adjust insulin. The sensor has also been 
shown to survive storage for three months and operation for 24 hours in 
physiological concentrations of glucose (5mM/1). The gamma ray sterilisation of 
the glucose sensors and its effect on performance investigated here has also not 
been previously reported. The use of catalase and GOD in a fibre optic glucose 
sensor has not been previously reported. In addition, the use of polyurethane as a 
glucose diffusion limiting membrane does not seem to have been applied to fibre 
optic glucose sensing systems before. 
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Software Developed to Interface Multiple P7 Monitors with a PC and Collect 
Data 
Previously, the results were gathered in the form of printouts from the Paratrends. 
This was a time consuming process and did not allow the data to be saved or 
processed. A much more efficient method would be to download data from the P7 
and to save this to the hard disk of a PC. It was also desirable to be able to insert 
markers in the data to indicate the time of addition of glucose or water to the 
tonometer during an experiment. To solve these problems, software was written 
which could interface a PC with two P7 via a serial port connection. This allowed 
data to be captured directly from the P7 and stored on the PC hard drive as digital 
data. 
The software was written in Visual C++ using the Borland CBuilder package and 
a freeware serial port utility used was written by Giles Biddison (201 W, 
California 1407 Sunnyvale, CA 94086 USA). The software was designed to 
operate on a Windows 95 (Microsoft USA) system. 
The software, `Due1P7E. exe' collected data from two Paratrends simultaneously 
via two RS232 serial port connections and saved the data to two separate data files 
on a PC hard drive. The user could specify the file names and locations of the 
saved data. The program also allowed the user to insert markers in the saved data 
when glucose or water is added to a tonometer. The program had a graphical user 
interface as shown in figure A. 1. 
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Figure A. 1. The User interface for the DUELP7E software 
Lights 
indicate if the 
data stream 
from the two 
P7's has failed 
itiatise the system 
save button I 
data collect? I* 
QUIT 
SEN 
The two file 
names for the 
data storage 
The current 
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E. pdQment Start time 
ýA (PORT 1) SENSOR B (PORT 3) 
0 40 
Time 
l3I 
A: s 
The locations and names of the saved files are displayed at the top of the screen. 
The program will not start data collection until file names have been specified. 
The data are stored as plain text files. The program is controlled using the four 
buttons to the top left of the screen. The start time of the experiment and the 
current time are displayed at the top right of the screen. The two red circles are 
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indicator lights, which flashed during data collection, to alert the user to any 
system failure (by their absence) during an experiment. The large green square 
labelled `glucose added' and the blue square labelled `dilutions' are buttons 
which, when clicked by the mouse cursor, will inset a marker in the data files. A 
safety feature is built into the button operation to prevent accidental double 
clicking of the buttons by the user. A running total of glucose or water events 
were displayed below these buttons. The `stop data collect' and `quit' buttons 
have built in fail safes which ask the user to confirm the command before it is 
carried out. The captured and stored data is shown in figure A. 2 
Figure A. 2. An example of the data saved by the program. 
T14: 37: 15 
T14: 37: 161828456, "JUL 15,1999", "14: 38: 15", 037150,7.0,38.4, "ppp^" 
T14: 37: 17 
T14: 37: 181828458, "JUL 15,1999", "14: 38: 17", 037150,7.0,38.5, "pppY' 
T14: 37: 19 
99999 
1828460, "JUL 15,1999", "14: 38: 19", 037150,7.0,38.5,11ppp^" 
TI4: 37: 20 
T14: 37: 21_1828462, "JUL 15,1999", "14: 38: 21", 037150,7.0,38.5, "pppc" 
The format in which the data was captured from the P7 could not be altered. The 
data also arrived asynchronously from both the P7 sensors. The Borland software 
used could not suspend other Windows 95 program calls, meaning that the system 
was sometimes busy when data arrived at one of the serial ports. This caused 
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occasional overwriting of individual measurements by proceeding data strings. 
However, this happened infrequently and would only result in the loss of a few 
data points. 
The text string at the top of figure A. 2. is the standard output from the P7 serial 
port. The P02 values are 7. OKPa and the temperature is 38.5 °C which are near 
the end of the string. The numbers beginning with `T' are time values that are 
inserted into both files. This is the PC system time, and was inserted into both 
files when it was found that the clocks in the Paratrends could only be 
synchronised to within 1 minute of each other. This would lead to a time 
discrepancy in the measurements, so the PC system time was inserted into the 
files to be used as the time measurement in the data. A glucose or water event is 
shown by a `ggggg' (shown in figure A. 2). or `wwwww' string inserted in the file 
for glucose or water respectively. The data can then be retrieved and processed 
using a spread sheet application. 
Data sorting and formatting 
Once the experiment was completed the data was sorted to a more usable format 
by a second program `Duelsort. exe'. Duelsort. exe sorts through the data file, 
removing any corrupt data strings and creating a tab delineated file. An example 
of the file format is shown in figure A. 3. below. 
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Figure A. 3. The formatted data file 
2204 7.4 0 0 
2206 7.4 0 0 
2209 7.4 0 0 
2211 7.4 0 0 
2212 7.3 1000 0 
2214 7.3 0000 0 
2216 7.1 0000 0 
2218 7.0 0000 0 
The time signal inserted in the raw data is used to create the time value in the left 
column. The next column is the P02 value at that time the third column is the 
glucose signal which is represented as a 1000, and the fourth column is the 
dilution flag which is also represented by a 1000 value. Once sorted and 
formatted, the data is plotted and analysed using the EXCEL spreadsheet package, 
Microsoft Ltd USA. 
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Photographs of the Paratrend 7 system. 
^-43 
.m 
Figure B I. The Paratrend 7 senior system (foreground) 
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Figure B2. A close up of the P7 senior system. 
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Figure B3. The P7 satellite system with oxygen sensor attached. The patient data 
module is shown labelled 'A' 
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.- 
Figure B4. A close up of a standard P7 sensors tip, the white area is the MPHF 
sleeve encasing the three fibre optic sensors and the thermocouple. A scale in cm 
is shown at the bottom of the picture. 
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